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Man's liver is a brownish blob
That does a most prodigious job.
It manufactures gall, or bile
And normally keeps some on file
Stored neatly in a pear-shaped sac.
From there the liver's yields attack
The food man eats, to change its state
By methods man can't duplicate,
Or even halfway understand.
He ought to treat this outsize gland,
With due respect and loving care
To keep it in top-notch repair,
Because to get along at all
Man needs an awful lot of gall.
Irene Warsaw, JAMA, 1975, v. 231, p. 1260

iv

The

known

is

finite,

the

unknown

infinite;

intellectually we stand on an islet in the midst of an
illimitable ocean of inexplicability.

Our business in

every generation is to reclaim a little more land.
- T.H. Huxley, 1887
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The

collective

microbial

genomes

within

our

gut

(microbiome) represent a powerful metabolic force, leading
many authors to call our GI flora an “organ within an
organ”, and the metagenomic sequencing of our microbiome,
“the

second

human

genome

project”.

Bile

acids,

endogenously produced by the host liver, represent both a
strong
well

selective

as

pressure

substrates

for

for

potential

microbial

colonizers,

metabolism.

as

Indeed,

microbes have evolved enzymes to deconjugate bile salts,
epimerize bile acid hydroxyl groups, and 7α-dehydroxylate
primary

bile

acids.

The

products

xvii

of

microbial

7α-

xviii

dehydroxylation, secondary bile acids, are suggested by
numerous lines of evidence to be involved in promoting
colon

carcinogenesis.

multi-step

pathway,

7α-dehydroxylating
genes

of

which

activity
have

is

only

a

been

identified in a small number of organisms within the genus
Clostridium.

The

biochemistry

largely worked out.
introduction
product(s)

of

of

this

pathway

has

been

The third step in the pathway is
Δ4-double

a

responsible

have

bond;
not

however,

been

the

identified.

gene
The

baiCD and baiH genes were cloned, expressed and shown to
NAD+-dependent

have

3-oxo-Δ4-steroid

oxidoreductase

activity showing stereospecificity for 7α-hydroxy and 7βhydroxy bile acid, respectively.
In

addition,

hylemonae

bai

genes

were

isolated

from

C.

TN271 by bidirectional genome-walking by PCR.

This represents the first report of bai genes from a “low
activity”

7α-dehydroxylating

bacterium.

The

gene

organization and sequence of the baiBCDEFGHI operon was
highly conserved between C. hylemonae TN271 and the “high
activity”
12708.

7α-dehydroxylating

bacterium

C.

scindens

VPI

The baiA gene was located by PCR using degenerate

oligonucleotides.

Bi-directional

genome-walking

revealed

what appears to be several novel genes involved in bile
acid metabolism which were also located in C. scindens VPI
12708.

Expression of a 62 kDa flavoprotein and reaction

with [24-14C] 3-oxo-DCA and NADP resulted in a product of
greater

hydrophilicity

than

deoxycholic

acid.

identity of this product was not determined.

The

A second

gene appears to share a common evolutionary origin with

xix

the

baiF

gene.

A hypothesis is offered regarding the

function of these homologues as Type III CoA transferases
recognizing
acids).

A

5β-bile
third

acids,

gene

or

5α-bile

encodes

a

acids

putative

(allo-bile

short

chain

reductase, similar in size and predicted function to the
baiA gene, which may be involved in the final reductive
step in the pathway. These novel genes also contained a
conserved

upstream

regulatory

region

with

the

bai

oxidative genes. Finally, two genes were identified which
may serve as potential drug targets to inhibit bile acid
7α-dehydroxylation.
may

be

The first is an ABC transporter which

co-transcribed

with

the

other

novel

bile

acid

metabolizing genes, and what appears to be a bile acid
sensor/regulator
protein

similar

to

(TspO)/mitochondrial

the

Tryptophan-rich

peripheral

receptor (MBR) family of proteins.

sensory

benzodiazepine

INTRODUCTION
Bile salt metabolism by intestinal bacteria
The human large intestine harbors a complex
microbial flora (1).

Bacterial density in the human colon

is among the highest found in nature, approaching 1012
bacteria/ gram wet weight feces (2, 3).

In contrast, the

host suppresses significant bacterial colonization of the
small intestine by a variety of mechanisms including rapid
transit times, antimicrobial peptides, proteolytic
enzymes, and bile (4).

Failure of these mechanisms leads

to bacterial overgrowth of the small intestine, resulting
in malabsorption as bacteria compete with the host for
nutrients.

Under normal conditions, bacterial

fermentation in the colon represents an important salvage
mechanism.

Complex carbohydrates, which are

intrinsically indigestible, or which escape digestion and
absorption in the proximal gut, are fermented by colonic
bacteria to yield short chain fatty acids.

It has been

estimated that these short-chain fatty acids constitute 39% of our daily caloric intake (4).

Colonic bacteria

also contribute to salvage of bile salts that escape
1

2

active transport in the distal ileum.

The major bile

salt modifications in the human large intestine include
deconjugation, oxidation of hydroxy groups at C-3, C-7 and
C-12, and 7α/β-dehydroxylation (Figure 1).

Deconjugation

and 7α/β-dehydroxylation of bile salts increases their
hydrophobicity and raises their pKa, thereby permitting
their recovery via passive absorption across the colonic
epithelium.

However, the increased hydrophobicity of the

transformed bile salts also is associated with increased
toxic and metabolic effects.

Elevated concentrations of

secondary bile acids in feces, blood and bile have been
linked to the pathogenesis of cholesterol gallstone
disease and colon cancer (5).

The following is a current

review of the microbiology of bile acid metabolism in the
human gastrointestinal tract focusing on understanding the
biochemical mechanisms and physiological consequences of
such metabolism on both the bacterium and the human host.

The enterohepatic circulation of bile acids
Bile acids are saturated, hydroxylated C-24
cyclopentanephenanthrene sterols synthesized from
cholesterol in hepatocytes.

The two primary bile acids

3

Figure 1.

Bacterial bile salt-biotransforming
reactions in the human intestinal tract.
Hydroxy group carbons of cholate are
numbered and the AB rings are identified.
The 3, 7, and 12 carbons of cholic acid (CA)
are numbered. Nomenclature is that of
Hofmann et al. (160). BSH, bilesalt
hydrolase; HSDH, hydroxysteroid
dehydrogenase.

4

OH
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CO-NH-CH2-COOH
HO

HO

OH

H

cholylglycine

H
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12
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Multi-step 7α-dehydroxylation
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12β-HSDH

OH

OH

OH
H
7-epicholic acid

HO

H

OH

12-epicholic acid
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synthesized in the human liver are cholic acid (CA) (3α,
7α, 12α-trihydroxy-5β-cholan-24-oic acid) and
chenodeoxycholic acid (CDCA) (3α, 7α-dihydroxy-5β-cholan24-oic acid).

Bile acids are further metabolized by the

liver via conjugation (N-acyl amidation) to glycine or
taurine, a modification that lowers the pKa to around 5.
Thus, at physiological pH, conjugated bile acids are
almost fully ionized, and may be termed bile salts (6).
Bile salts are secreted actively across the canalicular
membrane and are carried in bile to the gallbladder where
they are concentrated during the inter-digestive period.
Following a meal, release of cholecystokinin from the
duodenum stimulates the gallbladder to contract, causing
bile to flow into the duodenum (7).

Bile salts are highly

effective detergents that promote solubilization,
digestion and absorption of dietary lipids, and lipid
soluble vitamins throughout the small intestine.

High

concentrations of bile salts are maintained in the
duodenum, jejunum and proximal ileum, where fat digestion
and absorption take place.

Bile salts are then absorbed

through high-affinity active transport in the distal ileum
(6).

Upon entering the bloodstream, bile salts are

6

complexed to plasma proteins and returned to the liver.
Upon reaching the liver they are cleared efficiently from
the circulation by active transporters on the sinusoidal
membrane of hepatocytes and rapidly secreted into bile.
This process is known as the enterohepatic circulation.
Figure 2 depicts the enterohepatic circulation in the
context of the gastrointestinal anatomy and also indicates
the relative numbers and genera of the predominant
bacteria inhabiting each section of the GI tract.
During the enterohepatic circulation, bile salts
encounter populations of facultative and anaerobic
bacteria of relatively low numbers and diversity in the
small bowel.

Bile salt metabolism by small bowel microbes

consists mainly of deconjugation and hydroxy group
oxidation.

Ileal bile salt transport is highly efficient

(~95%), but approximately 400-800 mg of bile salts escape
the enterohepatic circulation daily and become substrate
for significant microbial biotransforming reactions in the
large bowel (6). Comparison of bile acid composition in
the gallbladder and feces illustrates the extent of
microbial bile acid metabolism in the large intestine
(Figure 3).

Secondary bile acids deoxycholic acid (DCA)

7

Figure 2.

Anatomy, physiology, and microbiology of the
gastrointestinal tract. Large arrows denote
the enterohepatic circulation of bile acids,
which begins with contraction of the
gallbladder, releasing bile into the
duodenum. Small arrows denote the passive
absorption of bile acids that escape active
transport. * Secondary bile acids produced
by 7α-dehydroxylation are passively absorbed
in the large intestine and returned to the
liver (see Fig 3). The genera of predominant
bacteria isolated from each region of the
lower gastrointestinal tract are listed.
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Small Intestine

A: Duodenum (25cm)
pH 5.7~6.4
~103 bacteria/ml
Lactobacillus
Streptococcus

Liver

Gallbladder

Portal circulation

B : Jejunum (1.0m)
pH 5.9~6.8
~104 bacteria/ml
Lactobacillus
Streptococcus
Staphylococcus
Veillonella

C : Ileum (2.0m)
pH 7.3~7.7
106~108 bacteria/ml
Enterobacteria
Enterococcus
Bacteroides
Clostridium
Lactobacillus
Veillonella

A

B
Large Intestine
C
D: Cecum/Colon (150c
m)

D
Rectum

pH 5.7-6.8

pH 6.6~6.8

~1011 bacteria/g

95% Absorption
(Active transport)
Excretion
* Passive Absorption/
Secondary bile acids

(400-800 mg/day)

Bacteroides, Eubacterium,
Bifidobacterium,
Ruminococcus,
Peptostreptococcus,
Propionibacterium,
Clostridium, Lactobacillus,
Escherichia,
Streptococcus,
Methanobrevibacter
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Figure 3.

Composition of bile acids in the gallbladder
and feces of healthy individuals. ‘‘Other’’
bile acids refer to oxo- and 3β-hydroxy
derivatives of secondary bile acids. Values
were derived from published sources (6, 93,
161, 162). CDCA, chenodeoxycholic acid; DCA,
deoxycholic acid; LCA, lithocholic acid;
UDCA, ursodeoxycholic acid.

10

Biliary Bile acid Composition
UDCA

1% LCA
DCA

2%
Other 2%

25%

35%

CA

35%
CDCA

Bacterial enzymes

Fecal Bile acid composition
2%

CA

CDCA 2%

Other

28%
34%

12-oxo-LCA

3%
29%
UDCA

2%

LCA

DCA
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(3α, 12α-dihydroxy-5β-cholan-24-oic acid) and lithocholic
acid (LCA) (3α-hydroxy-5β-cholan-24-oic acid) are produced
solely by microbial biotransforming reactions in the human
large intestine. DCA accumulates in the bile acid pool
(LCA to a much lesser extent) due to passive absorption
through the colonic mucosa and the inability of the human
liver to 7α-hydroxylate DCA and LCA to their respective
primary bile acids.

LCA is sulfated in the human liver at

the 3-hydroxy position, conjugated at C-24 and excreted
back into bile (6).

The resultant bile acid sulfate is

poorly reabsorbed from the gut.

Even though 3-sulfo-LCA

glycine and taurine conjugates are deconjugated and to
some extent desulfated by intestinal bacteria, 3-sulfoLCA/LCA is lost in feces and does not normally accumulate
in the enterohepatic circulation (8).

Deconjugation of Bile Salts
Characteristics of bile salt hydrolase(s) (BSH)
Deconjugation refers to the enzymatic hydrolysis of
the C-24 N-acyl amide bond linking bile acids to their
amino acid conjugates.

This reaction is substrate

limiting and goes to completion in the large bowel.

BSH

12

are in the choloylglycine hydrolase family (EC 3.5.1.24)
and have been isolated and/or characterized from several
species of intestinal bacteria (Table 1).

The importance

of the position, charge, shape, and chirality of various
analogues of taurine/glycine conjugates on the rate of
hydrolysis by BSH has also been investigated (9). BSH
differ in subunit size and composition, pH optimum,
kinetic properties, substrate specificity, gene
organization and regulation. BSH do, however, share in
common several conserved active site amino acids (Cys2,
Arg18, Asp21, Asn175, and Arg228) and share a high degree
of amino acid sequence similarity with the penicillin V
amidase (PVA) of Bacillus sphaericus (Figure 4).

The

conservation of Tyr82 in PVA and Asn82 in BSH are likely a
result of differing steric requirements for their
respective substrates (10).

Recently, a bsh from

Clostridium perfringens has been crystallized both in the
apo-enzyme form and in complex with TDCA (hydrolyzed
product) at resolutions of 2.1 and 1.7 Å, respectively
(11).

The structure revealed the Cys2 residue is in

position for nucleophilic attack of the N-acyl amide bond.
Site directed mutagenesis of the Cys2 residue from the BSH
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Figure 4.

Multiple sequence alignment of cholylglycine
hydrolases. Protein sequences were obtained
from the National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov/).
Alignments were made with the ClustalW
program (http://www.ebi.ac.uk/clustalw/)
using the GONNET 250 matrix. Residues
highlighted in yellow are predicted active
site amino acids based on the crystal
structure of the BSH from C. perfringens
(11) as well as on site-directed mutagenesis
and biochemical data (10, 12–14). Residues
highlighted in gray correspond to residues
involved in substrate binding in the BSH
from C. perfringens (11). The secondary
structural elements, which are based on the
conjugated bile acid hydrolase from C.
perfringens (CBAH-1) crystal structure, are
shown above the alignment. The a and b
designations of Lactobacillus johnsonii
refer to the two isoforms of the genes found
in this bacterium.
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of Bifidobacterium longum and Bi. bifidum (9, 17) as well
as sulfhydryl inhibition of several BSH have shown the
importance of this residue in catalysis (10, 12, 13).
Alignment of amino acid sequences from BSH shows the Cys2
residue is conserved in all BSH characterized to date
(Figure 4).

The broad substrate specificities reported

(Table 1) are potentially a function of a lack of
conservation observed in residues making up the substrate
binding pocket of the conjugated bile acid hydrolase gene
product (CBAH-1) of C. perfringens and the corresponding
residues predicted in amino acid multiple sequence
alignment with other BSH (Figure 4).

The sterol moiety is

bound primarily through hydrophobic interactions in the
CBAH-1 of C. perfringens (residues highlighted in grey in
Figure 4) as well as hydrogen bonds to the carboxylate
group. While the crystal structure of CBAH-1 did not
reveal specific recognition of the taurine/glycine moiety,
kinetic data from several BSH suggest the conjugates are
important in substrate specificity (Table 1).

Therefore,

additional crystallization and site-directed mutagenesis
(preferably with mutagenesis of Cys2) of BSH from
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different species will be helpful in explaining kinetic
observations of substrate specificity.

Distribution, genetic organization, and regulation of BSH
Genes encoding BSH have been cloned from C.
perfringens (14), Lactobacillus plantarum (15), La.
johnsonii (16, 17), Bi. longum (10), Bi. bifidum (18), Bi.
adolescentis (19), and Listeria monocytogenes (20, 21).
Homologues and putative bsh genes have also been
identified recently through microbial genome analysis. The
organization and regulation of genes encoding BSH differs
between species and genera.

Monocistronic BSH genes have

been reported in La. plantarum (15), La. johnsonii (17),
Li. monocytogenes (21), and Bi. bifidum (18).

A gene

encoding BSH (CBAH-1) cloned from C. perfringens (14)
differed significantly in size and amino acid sequence
from a BSH purified from a different strain of C.
perfringens (12).

The inactivation of the gene encoding

CBAH-1 resulted in only partial reduction in BSH activity
(BSH activity 86% of WT) suggesting multiple BSH genes in
C. perfringens.

Furthermore, the crystal structure showed

that the enzyme encoded by the CBAH-1 gene forms an active
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homotetramer (11).

These observations, coupled with

detection of both intracellular and extracellular BSH
provides further evidence for multiple isoforms though
organization and regulation of the bsh gene(s) from C.
perfringens are not presently known (22).

Polycistronic

operons encoding three genes involved in bile salt
deconjugation (cbsT1, cbsT2, cbsHβ) have been
characterized in La. johnsonii and La. acidophilus (17).
Genes cbsT1 and cbsT2 appear to be gene duplications each
of which encode TCA/CA antiport proteins of the major
facilitator superfamily while cbsHβ encodes the BSH βisoform (23).

In addition, an uncharacterized

extracellular factor has been detected in La. johnsonii
100-100 which stimulates BSH activity and uptake of
conjugated bile salts during stationary growth phase (17,
24).

BSH expression is also growth phase dependent.

Stationary phase expression has been reported in
Bacteroides fragilis (25) while exponential phase
expression was reported for Bi. longum (10).

Benefits of BSH to the bacterium
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BSH appear to enhance the bacterial colonization of
the lower GI tract of higher mammals.

The physiological

advantages of BSH are not fully understood and may vary
between bacterial species and genera.

It has been

hypothesized that deconjugation may be a mechanism of
detoxification of bile salts.

De Smet et al (1995)

observed significantly higher rates of deconjugation of
GDCA over TDCA in La. plantarum (26).

Mutants lacking

functional BSH (bsh−) exhibited pH and concentration
dependent toxicity of GDCA as compared to wild type cells;
whereas, this effect was not demonstrated with TDCA.

De

Smet et al. (1995) hypothesized that the difference in
dissociation constants between GDCA and TDCA resulted in
the collapse of cellular proton motive force by
intracellular deprotonation with the glycine-conjugate
(26).

The presence of a functional BSH results in the

intracellular accumulation of free bile acids which become
protonated in a stoichiometric fashion decreasing energy
dependent H+ ATPase driven proton efflux.

BSH from human

intestinal lactobacilli generally have higher affinity for
glycine conjugates (26-29). This observation may lend
weight to the hypothesis of De Smet et al. (1995) or the
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higher affinity of BSH for glycine conjugates may have
evolved because glycine conjugates are generally higher in
proportion (3:1) than taurine conjugates in human bile
(6). Tannock et al. (1989) argued against the hypothesis
of deconjugation as a means of detoxification in
lactobacilli, pointing to the fact that free bile acids
are more cytotoxic than their conjugates (30).

However,

when the free bile acids become 7-dehydroxylated by other
intestinal bacteria in vivo, the resultant secondary bile
acids tend to precipitate (extent depending on luminal pH)
and bind to insoluble fiber or may be absorbed through the
colonic membrane, and may exist in low concentrations in
the bacterium’s microenvironment.

Therefore, additional

studies comparing various characteristics of bsh knockouts
with their isogenic parent strain will be needed to
determine the function of deconjugation in Lactobacillus
spp.
Strategies to resist bile salt toxicity have been
observed in pathogens that colonize the intestinal tract
(31-33).

Recently, a BSH from Li. monocytogenes was shown

to be a novel virulence factor (21).

Comparative genome

analysis revealed the absence of a bsh gene in the closely
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related non-virulent Li. innocua (20).

The bsh gene is

positively regulated by PrfA, which is a transcriptional
activator of numerous virulence genes in Li.
monocytogenes.

Deletion of the bsh gene results in

decreased resistance to bile salts, and significantly
reduced infectivity in vivo.

These results demonstrate

the importance of BSH activity for survival in vivo and
infection in the intestinal and hepatic phases of
listeriosis.

The mechanism by which BSH activity in L.

monocytogenes enhances survival and virulence is currently
unknown.
Deconjugation may provide a means of obtaining
cellular carbon, nitrogen, and sulfur for some bacterial
species.

This has been demonstrated in bacteroides (34)

and is suggested in Bi. longum (10).

In fact, the bsh

gene from Bi. longum is co-transcribed with the gene
encoding glutamine synthetase adenylyltransferase (glnE);
a component of the nitrogen regulation cascade (10).

In

this regard, hydrolysis of the conjugated bile acid may
provide amino nitrogen; providing a possible explanation
for coordinate regulation of these seemingly
physiologically unrelated genes (10).

Taurine utilization
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is also widespread and can serve as an energy source under
both aerobic and anaerobic conditions (35).

Glycine can

be utilized as an energy source by certain clostridia by
the Stickland reaction (36). The Stickland reaction is a
form of amino acid fermentation where one amino acid
donates electrons which are accepted by another amino acid
distinct from the electron donor. Another hypothesis
suggests BSH are detergent shock proteins enabling
survival during stress (37).

De Smet et al. (1995) found

no evidence for this in lactobacilli after growth with
various detergents (26).
The widespread distribution of BSH across gram
negative and gram positive intestinal bacteria coupled
with a wide range of substrate specificities, genetic
regulation and the occurrence of multiple isoforms in
certain strains have created conflicting reports regarding
the physiological benefit to the bacterium in hydrolyzing
bile acid conjugates. Determining the mechanism(s) by
which BSH aid bacteria in colonization of the mammalian
intestine will be of great interest, especially in regards
to bacterial pathogenesis.
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Taurine, hydrogen sulfide production and colon cancer
The bile acid conjugates glycine and taurine serve as
substrate in microbial metabolism.

Unlike glycine,

taurine contains a sulfonic acid moiety which is reduced
and dissimilated to hydrogen sulfide following
deconjugation (38, 39).

Hydrogen sulfide is highly toxic,

and has been shown to increase colonocyte turnover (40).
Activation and upregulation of the ERK 1/2 signaling
pathway has been suggested as a possible mechanism for
sulfide induced colonocyte proliferation (41). Hydrogen
sulfide also inhibits butyrate metabolism in colonocytes,
a key nutrient and regulator of cell turnover in the gut
(40).

Levitt et al (1999) demonstrated that colonocytes

have evolved a highly efficient mechanism to detoxify
volatile reduced sulfides through oxidation to thiosulfate
(42).

Defects in this detoxification system are suggested

to play a role in the etiology of ulcerative colitis, a
known risk factor for colon cancer (42, 43). Recently,
sulfide has been implicated in preventing apoptosis in the
adenocarcinoma cell line HCT116 after exposure of cells to
β-phenylethyl isothiocyanate (PEITC), a phytochemical
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found in cruciferous vegetables, which has been shown to
prevent colon carcinogenesis (44, 45).
A diet high in meat has been shown to significantly
increase the levels of both taurine conjugation to bile
acids (46, 47), and the production of hydrogen sulfide in
the colon (48).

A relationship exists between generation

of hydrogen sulfide in the colon and chronic
gastrointestinal illness such as inflammatory bowel
disease and colon cancer (5, 49).

Populations such as

native black Africans with low incidence of colon cancer
consume low meat diets (50). Native black Africans also
have low ratios of taurine to glycine conjugation (1:9)
and low hydrogen sulfide production when compared to
populations consuming a “Western diet” (46, 47).

In human

fecal slurries obtained from individuals consuming a
“Western diet”, taurine addition generated some of the
highest sulfide levels of any organic or inorganic sulfur
source added (43).

Taurine addition to a co-culture of a

species of bacteroides and an unidentified 7αdehydroxylating bacterium resulted in significant sulfide
production, which stimulated increased rates of DCA
production (34).
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While the extent to which taurine metabolism
contributes to total colonic sulfide production has yet to
be established, several key points have been made: 1) the
extent of taurine conjugation in the bile acid pool is
largely affected by diet;

2) the same dietary factors

which increase taurine conjugation are hypothesized to
increase colon cancer risk; 3) taurine metabolism by
intestinal bacteria results in hydrogen sulfide
generation; 4) sulfide generation is linked to the
carcinogenesis process through enhanced cell
proliferation, inhibition of butyrate metabolism and
activation of cell signaling pathways; 5) sulfide
generation may enhance DCA formation in the gut through
stimulation of the microbial bile acid 7α-dehydroxylation
pathway.

Microbial bile acid hydroxysteroid dehydrogenase(s) (HSDH)
Oxidation and epimerization
Oxidation and epimerization of the 3-, 7-, and 12hydroxy groups of bile acids in the gastrointestinal tract
are carried out by HSDH expressed by intestinal bacteria
(Figure 1).

Epimerization of bile acid hydroxy groups is
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the reversible change in stereochemistry from α to β
configuration (or vise versa) with the generation of a
stable oxo-bile acid intermediate.

Epimerization requires

the concerted effort of two position-specific,
stereochemically distinct HSDH of intraspecies or
interspecies origin.

For example, the presence of both

7α- and 7β-HSDH in C. absonum allow epimerization by a
single bacterium (51); whereas epimerization also can be
achieved in co-cultures of intestinal bacteria, one
possessing 7α-HSDH and the other 7β-HSDH (52, 53).
The extent of the reversible oxidation and reduction
of bile acid hydroxy groups by HSDH depends in part on the
redox potential of the environment.

Addition of oxygen to

the culture medium increases the accumulation of oxo-bile
acids (51).

Generation of oxo-bile acids may be more

favorable under the higher redox potentials found on the
mucosal surface (4); while reduction of oxo-bile acids may
be more favorable under the low redox potential (-200 to 300mV) in the large intestinal lumen.

Thus, while the

redox potential of the colon is net reductive,
microenvironments at the mucosa may provide oxidizing
conditions favorable for certain microbial reactions.
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HSDH differ in their reductive and oxidative pH optima,
NAD(H) or NADP(H) requirements, Mr, and gene regulation
(Table 2).

3α- and 3β-HSDH
3α/β-HSDH specifically catalyze the reversible,
stereospecific oxidation/reduction between 3-oxo-bile
acids and 3α- or 3β-hydroxy bile acids.

3α-HSDH have been

detected in some of the most prevalent intestinal bacteria
including C. perfringens (54), Peptostreptococcus
productus (55) and Eggerthella lenta (formerly Eubacterium
lentum) (56, 57) as well as intestinal bacteria present in
lower numbers (≤ 105/g wet weight feces) including C.
scindens (58), and C. hiranonis (59), and in nonintestinal bacteria including Pseudomonas testosteroni
(60, 61).

3β-HSDH activity has been described in species

of Clostridium and Rumminococcus (62-64).

It appears that

intraspecies 3-epimerization favors the 3α-position.

In

fact, growing cultures of C. perfringens in the presence
of 3-oxo-CDCA formed CDCA (84%) preferentially over isoCDCA (16%) under anaerobic conditions (65).
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Pyridine nucleotide cofactor requirements differ
between 3α/β-HSDH.

3α-HSDH require NAD(H), with the

exception of the enzyme purified from C. perfringens,
which uses NADP(H) and that purified from C. scindens
which can use either NAD(H) or NADP(H) (54, 56-58, 61).
3β-HSDH have been shown to preferentially require NADP(H),
with the exception of C. innocuum which uses NAD(H) (6264).

Dihydroxy bile acids (DCA, CDCA and UDCA) are

generally better substrates than trihydroxy bile acids
(CA) (62, 65).
3α/β-HSDH characterized to date are constitutively
expressed with the exception of C. scindens and C.
hiranonis which are induced by primary bile acids CA and
CDCA.

In fact, three copies of 3α-HSDH genes (baiA1,

baiA2 and baiA3) have been identified from C. scindens
(66-67) and the baiA1 gene has been expressed in E. coli
and characterized (58). The baiA gene products are unique
among 3α/β-HSDH due to their high specificity toward CACoA and CDCA-CoA conjugates and relatively low activity
toward free bile acids (58).

7α- and 7β-HSDH
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7α/β-HSDH catalyze the reversible, stereospecific
oxidation/reduction of the 7α- and 7β-hydroxyl groups of
bile acids.
bacteria,

While 7α/β-HSDH are common among intestinal

the extent of 7α/β-dehydrogenation in the

intestine, or in mixed fecal suspensions is difficult to
interpret due to the competing, and irreversible 7α/βdehydroxylation of bile acids (see section 6) (68).
7α/β-HSDH are widespread among the bacteroides and
clostridia as well as Escherichia coli, and Ruminococcus
sp. (Table 2) (54, 64, 69-74).

In addition, several

intestinal clostridia express both 7α- and 7β-HSDH and
have been shown to epimerize the 7α/β-hydroxy group (75,
76-78).

7α/β-HSDH have been partially purified from

intestinal bacteria including Ba.

fragilis (71, 79), Ba.

thetaiotaomicron (74), C. scindens (80), C. sordellii
(70), E. coli (73), as well as the soil isolates
Xanthomonas maltophilia (81), C.
bifermentans (83).

absonum (82),

and C.

Interestingly, several intestinal

bacteria with 7α/β-HSDH activity also possess BSH
including: Ba. fragilis (25), C. sordellii (70), C.
perfringens (84), C. innocuum (63), and the soil isolate
C. bifermentans (83).
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7α-HSDH generally utilize NADP(H) as a cofactor, with
the exception of E. coli (85), and Ba. thetaiotaomicron
(74).

C. bifermentans, C. absonum, and Ba. fragilis 7α-

HSDH can utilize either NAD(H) or NADP(H) as a cofactor
(76, 79, 83).

7β-HSDH enzymes characterized to date

utilize NADP(H) as a cofactor (53, 62, 75, 76).

7α/β-HSDH

enzymes have higher affinity for dihydroxy bile acids
(CDCA, 7-oxo-LCA) than trihydroxy (CA, 7-oxo-DCA).

C.

limosum cell extracts utilized both free and conjugated
bile acids, while whole cells only oxidized free bile
acids (75, 85).

This is due to intracellular location of

the 7α-HSDH, and the inability of the organism to take up
a conjugated bile salt.

The genes encoding 7α-HSDH have

been cloned from E. coli (73), C. scindens (69), and C.
sordellii (70).

Sequence similarity suggests these

enzymes belong to the short-chain polyol dehydrogenase
family.

Regulation of 7α/β-HSDH expression is generally

growth phase dependent and inducible by bile acid
substrates (Table 2).

C. scindens and E. coli

constitutively express 7α-HSDH and are non-inducible (69,
85).

Unexpectedly, the non-substrate DCA can induce 7α-

HSDH expression in C. absonum and C. sordellii though the
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reason for this induction remains unclear (70, 76).
Macdonald et al. (1983) observed the expression of five
soluble and two membrane polypeptides upon exposure of C.
absonum to DCA and CDCA in the culture medium although the
functions of these additional polypeptides have not been
determined (82).
Crystal structures of the E. coli 7α-HSDH binary and
ternary complexes have been solved and a mechanism for 7αdehydrogenation proposed (Figure 5) (87).

Binding of 7α-

hydroxy bile acids elicits major conformational changes at
the substrate binding loop and C-terminal domain.

A two

step mechanism is proposed in which Tyr159 acts as a
catalytic base removing the C-7 hydroxy hydrogen.
Hydrogen bonding by Ser146 is hypothesized to stabilize
the intermediate. Regeneration of the catalyst occurs
through transfer of the acquired hydride from the phenolic
group on Tyr159 to Lys163 to position 4 of NAD+.

Lys163

serves two important roles: anchoring NAD+ through
bifurcated hydrogen bonding, and indirect hydride transfer
from Tyr159 to position 4 of NAD+ (87). Site directed
mutagenesis confirmed the role of these amino acids in 7αHSDH catalysis (88).

Analysis of the 7-oxo-GLCA bile acid
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Figure 5.

Proposed catalytic mechanism of bile acid
7α-dehydrogenation based on the crystal
structure and site-directed mutagenesis of
active site amino acids of the 7αdehydrogenation from E. coli. See text for a
description of catalysis. Reprinted with
permission from Tanaka et al. (87).
Copyright @ 1996 American Chemical Society.
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substrate/enzyme complex revealed tight binding of the
sterol with loose association for the glycine conjugate.
Binding of glycine and taurine conjugates of CDCA were not
significantly different from the free bile acid (87).

12α- and 12β-HSDH
12α/β-HSDH have been detected mainly among members of
the genus Clostridium.

NADP-dependent 12α-HSDH have been

detected in C. leptum (89), Clostridium group P (89),
while NAD-dependent 12α-HSDH activity was reported in Eg.
lenta (56), and C. perfringens (54).

12β-HSDH have been

detected in C. tertium, C. difficile and C. paraputrificum
(91, 92). 12α/β-HSDH characterized to date are
constitutively expressed, and non-inducible, with the
exception of the 12β-HSDH from C. paraputrificum which is
induced by 12-oxo-bile acid substrates (92). 12α/β-HSDH
generally have higher affinity for dihydroxy (DCA) than
trihydroxy bile acids (CA, iso-CA) and free vs. conjugated
bile acids.

The 12α-HSDH from C. leptum is an exception;

demonstrating higher affinity for CA conjugates than free
CA (89). 12α-HSDH appear to be repressed by the addition
of bile acid substrates (DCA>CDCA>CA) to the growth medium
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at 1 mM concentrations.

It has been suggested that these

enzyme activities should be repressed in bacteria
colonizing the large intestine (56, 92); although 12-oxobile acids have been detected at low levels in the feces
of healthy individuals (Figure 3) (93-94).

Benefits of bile acid hydroxysteroid oxidoreductases to
the bacterium
The oxidation of bile acid hydroxyl groups generates
reducing equivalents for cellular biosynthetic reactions
and possibly electron transport phosphorylation.

Bile

acid dehydrogenation is hypothesized to generate energy in
Ba. thetaiotaomicron (74).

Sherod and Hylemon (1977)

suggested that reduced pyridine nucleotides generated from
7α-hydroxy oxidation serve to generate ATP via a
cytochrome-linked electron transport chain in the presence
of electron acceptors (i.e., fumarate) (74).
Bile acids are potent antimicrobial agents provided
the proper concentration and proportion of hydrophobic
bile acids (CDCA, LCA, DCA) are present (95).

Alteration

of hydroxy group stereochemistry has marked influence on
the physiochemical properties of bile acids (96, 97).

The

38

epimerization of the 7α-hydoxy group of CDCA lowers the
hydrophobicity and toxicity of the bile acid (97).
Macdonald, White and Hylemon (1983) observed that C.
absonum grew on plates containing 1 mM UDCA, though was
unable to grow on plates containing 1 mM CDCA (82).
Furthermore, when cultured in the presence of 7-oxo-bile
acids only low concentrations of CA and CDCA were formed
while the majority of 7-oxo-bile acids were reduced to 7epi-CA and UDCA, respectively, by log phase C. absonum
(51).

UDCA has also been shown to act as a repressor of

7α/β-HSDH production in C. absonum suggesting UDCA is an
end-product (76).

The enzyme also displays markedly

higher affinity for CDCA than CA, the former being more
toxic.

In summary, dehydrogenation may serve functions

related to energy generation as well as attempts to
maintain low concentrations of more hydrophobic bile acids
in the bacterium’s microenvironment.

Interplay between HSDH enzymes in human liver and
intestinal bacteria
The co-evolution between host and gut flora is
evident when observing the interplay between liver and
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bacterial biotransforming reactions.

The liver

synthesizes bile acids in which the hydroxy groups are in
the α orientation.

In the α-hydroxy orientation, one face

of the molecule is hydrophobic while the other side is
hydrophilic.

This translates to efficient solubilization

of lipid molecules through formation of mixed micelles
capable of efficient emulsification while remaining
soluble in aqueous environments.

Generation of β-hydroxy-

bile acids by microbial enzymes alters the efficiency of
micelle formation due to hydrophilic groups on both faces
of the sterol molecule.

The differences observed between

the composition of bile acids in serum and bile are a
result of the continual interplay between liver and
bacterial enzymes. Exposure of bile salts to intestinal
bacteria results in roughly 50% of bile acids requiring
reconjugation and low levels of bile acids returned to the
liver in the 3β-hydroxy orientation (98). Without a means
of epimerizing bile acid hydroxy groups in the human
liver, β-hydroxy bile acids would accumulate in the bile
acid pool.

Interestingly, the liver seems to “allow” the

accumulation of UDCA (7β-hydroxy) in the biliary pool as
in the case of therapeutic administration of CDCA (99).
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The protective effects of UDCA observed in clinical
studies (100), as well as cell culture studies (97, 101)
may provide an evolutionary explanation for this
phenomenon.

The biochemistry and molecular biology of bile acid 7α/βDehydroxylation
Introduction
Secondary bile acids (DCA, LCA) predominate in human
feces (Figure 3).

Therefore, 7α-dehydroxylation is the

most quantitatively important bacterial bile salt
biotransformation in the human colon.

The rapid rate of

conversion of primary to secondary bile acids is
surprising given that current estimates suggest this
metabolic pathway is found in roughly 0.0001% of the total
colonic flora (102-104).

Human intestinal bacteria

capable of bile acid 7α-dehydroxylation have been isolated
(104, 105) and 16s rDNA phylogenetic analysis has led to
their classification to the genus Clostridium (106-108).
Unlike bile acid oxidation and epimerization, 7α/βdehydroxylation appears restricted to free bile acids.
Removal of glycine/taurine bile acid conjugates via BSH
enzymes is thus a prerequisite for 7α/β-dehydroxylation by
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intestinal bacteria (109-112).

Some intestinal bacteria

are capable of both 7α/β-dehydroxylating activities (113),
while 7β-dehydroxylation activity is absent in other
intestinal 7α-dehydroxylating bacteria (113).
Epimerization of UDCA (7β-hydroxy) to CDCA (7α-hydroxy)
via 7β-HSDH produced by members of the gut flora result in
subsequent 7α-dehydroxylation.

In this regard, it would

appear the presence of 7β-dehydroxylation activity is more
of a luxury than a necessity.
Elucidating the bile acid 7α/β-dehydroxylation pathway
Samuelsson (1960) administered [6α-3H, 6β-3H, 8β-3H][24

14

C] CA to bile duct cannulated rabbits and rats (114).

Analysis of the products recovered following exposure to
intestinal bacteria revealed a differential loss of the
[6β-3H] during 7α-dehydroxylation of CA.

Previous work

showed complete retention of the 7β-3H in [7β-3H]-[24-14C]CA during 7α-dehydroxylation in the rat intestine (115,
116).

These data led Samuelsson (1960) to propose a

mechanism for CA 7α-dehydroxylation involving two steps:
diaxial trans-elimination of the 7α-hydroxy group and 6βhydrogen atom followed by reduction through transhydrogenation of the 6β and 7α positions of the cholen-6-
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oic acid intermediate forming DCA (114). Björkhem et al.
(1989) showed the formation of a 3-dehydro-4-cholenoic
acid intermediate following the differential loss of the
5βH in vitro and in vivo using a [3β-3H]-[24-14C] and [5β3

H]-[24-14C]-labeled CA (117).

Hylemon et al. (1991)

subsequently observed accumulation of multiple bile acid
intermediates in cell extracts of Clostridium scindens
induced by CA (Figure 6) (118).

These radiolabeled CA

intermediates were identified by mass spectrometry, then
chemically synthesized and added to cell extracts of CA
induced C. scindens.

Each [24-14C] CA intermediate was

converted into [24-14C] DCA in cell extracts prepared from
CA induced cultures of C. scindens.

These observations

suggested that the 7α-dehydroxylation mechanism was more
complex than the two-step mechanism proposed by Samuelsson
et al (1960).

Furthermore, these data demonstrated that

bile acid 7α-dehydroxylation was a multi-step pathway in
C. scindens and suggested the presence of multiple bile
acid inducible genes (bai).
The induction of 7α-dehydroxylation activity in C.
scindens by unconjugated C24 primary bile acids resulted in
the appearance of several new polypeptides as observed on
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Figure 6.

Accumulation of [24- C]CA intermediates
during 7α-dehydroxylationin cell extracts of
C. scindens VPI 12708. Cell extracts were
prepared from either CA-induced (I) or
control (C)cells. This figure was modified
from Hylemon et al. (118). Copyright@ 1992
American Society for Biochemistry and
Molecular Biology, Inc.
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one and two-dimensional SDS-PAGE (119, 120).

Purification

and N-terminal sequencing of these bai polypeptides
facilitated cloning of bai genes through design of
degenerate probes (121-123).

Northern blot analysis

indicated the presence of a large CA inducible (≥ 10 kb)
mRNA transcript and a smaller transcript (< 1.5 kb) in C.
scindens (121, 124).

These studies led to the discovery

of a bai regulon encoding at least 10 open reading frames
(Figure 7).

Individual bai genes have been subcloned into

E. coli and the functions of many determined (58, 67, 123,
125-130, Hylemon P.B., unpublished data).

The proposed

bile acid 7α/β-dehydroxylation pathway in C. scindens is
shown in Figure 8. A bai operon has also been
characterized from C. hiranonis (59), though the following
discussion of the 7α/β-dehydroxylation pathway will center
on C. scindens from which the functions of the gene
products have been determined.

bai genes: a regulon for 7α/7β-dehydroxylation
The transport of unconjugated primary bile acids into
C. scindens is facilitated by the baiG gene product which
belongs to a major pump/facilitator superfamily of protein
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Figure 7.

Gene organization of the bile acid-inducible
(bai) 7α/β-dehydroxylation operons
characterized in C. scindens VPI 12708. P
indicates the promoter region.
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transporters (126).

The baiG gene has been cloned into E.

coli and shown to encode a 50 kDa H+-dependent bile acid
transporter (126).

The BaiG facilitates transport of

unconjugated CA and CDCA but not the secondary bile acids
DCA or LCA (126). Computer-aided modeling suggests the
baiG polypeptide contains 14 membrane spanning domains
(126).
Following transport, ligation to coenzyme A (CoA) is
the first step in activating CA and CDCA for 7αdehydroxylation as several subsequent enzymatic steps are
specific for CoA conjugates.

The baiB gene was shown to

encode a 58 kDa bile acid CoA ligase (125).

CoA ligation

is ATP, CoA, Mg2+ dependent and also requires a free
carboxyl group on C24 bile acids (125).

CoA ligation may

function both to sterically hinder the constitutive 7αHSDH committing the bile acid to 7α-dehydroxylation and
trapping the bile acid inside the cell.
The 3α-hydroxy group is oxidized following CoA
ligation.

Oxidation of the 3-hydroxy group inhibits 7α-

hydroxy group dehydrogenation; favoring 7-dehydroxylation
over constitutively expressed 7α-HSDH in C. scindens (58,
80).

The baiA gene products encode 27 kDa polypeptides
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that have significant similarity with the short-chain
alcohol/polyol dehydrogenase gene family (58, 124).

Amino

acid multiple sequence alignment and comparison between
baiA gene products and other members of the short-chain
alcohol dehydrogenase family revealed a possible NAD(P)
binding site and catalytic active site (58).

Three baiA

genes have been cloned from C. scindens; the baiA1 and
baiA3 genes are monocistronic while the baiA2 gene is part
of the polycistronic bai operon (66, 67, 124). The baiA
genes from C. scindens were cloned in E. coli and shown to
encode 3α-HSDH (58).

The enzymes only recognize bile acid

CoA conjugates and can utilize either NAD+ or NADP+ as
electron acceptors (58). Interestingly, the different 3αHSDH of C. scindens share 92% amino acid sequence identity
with one another suggesting gene duplication.

The

physiological importance of multiple baiA genes remains
unclear.
The baiH gene encodes a 72 kDa polypeptide containing
661 amino acids (121).

The BaiH protein exists as a

homotrimer with NADH: flavin oxidoreductase activity
(121).

The baiH gene has been subcloned into E. coli,

purified and shown to contain 1 mol FAD, 2 mol iron, and 1
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mol copper per mol polypeptide subunit (129). The BaiCD
polypeptide shows considerable amino acid sequence
identity with the ‘Old Yellow Enzyme’ family, a putative
NADH oxidase from Li. monocytogenes, several 2,4-dienoyl
CoA reductases, as well as the baiH from C. scindens (121,
129).

The physiological function of the baiCD and baiH

gene products is currently unknown.
The baiF gene encodes a 47.5 kDa polypeptide
containing 426 amino acids which was shown to have bile
acid CoA hydrolase activity (122, 130).

However, the baiF

gene is hypothesized to encode a CoA transferase due to
reasons for energy conservation (Fig. 8) and homology to
the type III family of CoA transferases (131).

The first

few cycles of 7α-dehydroxylation would require ATP
hydrolysis (Figure 8); though ATP independent recycling of
the thioesterase intermediates via transfer of CoA from an
accumulated downstream intermediate, to incoming primary
bile acids would significantly conserve energy.

However,

this hypothesis remains to be tested.
7α-Dehydration of 3-dehydro-4-cholenoic acid and 3dehydro-4-chenodeoxycholenoic acid results in the
generation of a conjugated double bond in rings A and B
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Figure 8.

Proposed bile acid 7α-dehydroxylation
pathway in C. scindens VPI 12708(see text).
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forming a stable 3-dehydro-4,6-deoxycholdienoic acid and
3-dehydro-4,6-lithocholdienoic acid intermediates,
respectively.

The 7α-dehydration step results in the

largest calculated energy change (-9.4 kcals/mol) of any
reaction in this pathway, and the reverse reaction was not
detected in vitro (128).

The 19.5 kDa bile acid 7α-

dehydratase is encoded by the baiE gene (128).

This

enzyme showed no activity with 3-dehydro-4ursodeoxycholenoic acid (128).

The baiE gene product was

modeled based on the crystal structure of protein
homologues (secondary structure) ketosteroid isomerase
(KSI) and scytalone dehydratase (STD) (Figure 9) (Woodford
K et al. unpublished).

The putative active site/binding

pocket is shown in Figure 10.

A catalytic mechanism has

been proposed for the 7α-dehydration step based on the
conservation in secondary structure and site directed
mutagenesis of the key active site amino acids. Tyr30 acts
as a general acid withdrawing electron density from the 3oxo-group. This shift in electron density is hypothesized
to make the 6β-hydrogen labile for removal by the general
base His83 (assisted by Asp35).

His83 is thought to

donate its hydrogen to the 7α-hydroxy forming the water
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Figure 9.

Model of the bile acid 7a-dehydratase (baiE)
based on structural data from scytalone
dehydratase, nuclear transport factor 2, and
steroid D5-isomerase. The a-helices are
denoted by white strands, β-sheets are
denoted by the yellow backbone, and the blue
structure represents a steroid molecule
modeled into the binding/active site pocket.
Model kindly provided by Dr. Alexey G.
Murzin (Cambridge University).
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Figure 10.

Putative binding/active site pocket of bile
acid 7α-dehydratase. Putative active site
amino acid residues are shown in relation to
the bile acid substrate. See text for
discussion of the proposed catalytic
mechanism.
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leaving group which is stabilized by Asp106.

Site-

directed mutagenesis based on the proposed mechanism
supports the important role of the putative active site
amino acids in enzyme catalysis.

It is hypothesized that

the baiI gene encodes a bile acid 7β-dehydratase due to
amino acid sequence homologies between the baiE and baiI
gene products.
Genes involved in the reductive arm of the 7α/βdehydroxylation pathway have not been isolated.

These

genes should encode oxidoreductases catalyzing the
reduction of 3-dehydro-4,6-deoxycholdienoic acid → 3dehydro-4-deoxycholenoic acid → 3-dehydro-deoxycholic acid
→ DCA as well as a bile acid exporter to remove secondary
bile acid end-products from the bacterium (Figure 8).
Genes encoding putative transcriptional regulators have
been detected upstream of the bile acid inducible promoter
region (Table 3) (Mallonee DH and Hylemon PB; unpublished
data).

Additional studies will be required to determine

the mechanism of induction/repression of this pathway and
to identify additional bai genes.

The benefits of 7α/β-dehydroxylation to the bacterium
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The ability to utilize bile acids as electron
acceptors is an important niche for 7α-dehydroxylating
bacteria in the human colon.

The 7α/β-dehydroxylation

pathway requires multiple oxidative and reductive steps
with a net 2 electron reduction (Figure 8).

The

hypothesized energy benefits of this pathway assume,
however, that the baiF gene encodes a CoA-transferase and
the toxic end-products, the secondary bile acid, are
removed from the microenvironment in vivo (precipitation
and binding to insoluble fiber).

The generation of

secondary bile acids may also function to exclude bacteria
sensitive to these hydrophobic molecules.

Secondary bile acids and disease
In humans, DCA accumulates in the bile acid pool to
high levels in some individuals.

An increase in DCA in

the bile acid pool is associated with a decrease in CDCA
(Figure 11).

Unlike rodents, the human liver can not 7α-

hydroxylate DCA forming CA.

Hence, under normal

physiological conditions, there is no metabolic pathway
for removing DCA from the bile acid pool in man.

The

amount of DCA in the bile acid pool is a function of at
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Figure 11.

Relationship between the percentage of CDCA
and DCA in bile of patients at McGuire VA
Hospital (Richmond, VA) (P. B. Hylemon et
al., unpublished data).
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least three variables: 1) rate of formation and absorption
of DCA through the colon (input) (132); 2) colonic transit
time (133) and 3) colonic pH (134).
High levels of DCA in blood, bile and feces have been
correlated with an increased risk of cholesterol gallstone
disease and colon cancer, two major diseases of “Western
Society” (5, 135).

High levels of CA 7α-dehydroxylating

fecal bacteria have been correlated with increased amounts
of DCA in bile of a subset of cholesterol gallstone
patients (132).

Treatment of these cholesterol gallstone

patients (high DCA group) with antibiotics significantly
decreased the levels of fecal CA 7α-dehydroxylating
bacteria, DCA in bile and the cholesterol saturation index
in bile (132).

Early studies by Low-Beer and coworkers

(1978) reported that treating control individuals with
metronidazole, an antibiotic effective against anaerobic
bacteria, significantly decreased the cholesterol
saturation index of bile (135).

Moreover, excess DCA in

bile has been reported to decrease the nucleation time for
cholesterol crystallization (136, 137).

In total, these

results suggest a possible link between intestinal
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bacteria, DCA, and the risk of cholesterol gallstone
disease in some patients.
DCA and LCA have been linked to colon carcinogenesis
in a number of laboratory animal models and human
epidemiological studies (For reviews see 5, 138).

Most

animal studies conclude that DCA is a promoter of the
carcinogenesis process (139-142).

However, some

researchers argue that bile acids may cause DNA damage and
act as carcinogens in humans (138).

Higher levels of DCA

are found in the blood of colon cancer patients as
compared to control patients (98, 143).

Moreover, DCA is

a logical candidate for promoting colon carcinogenesis for
the following reasons: 1) it is found in fecal water in
high concentrations (> 100 μM) (138); 2) it can cross
biological membranes via passive diffusion; 3) it can
activate mammalian cell signaling pathways that are known
to be involved in promoting the carcinogenesis process.
In this regard, cell signaling pathways activated by DCA
in mammalian epithelial cells include: protein kinase C
(144); ERK 1/2 via the epidermal growth factor receptor
(101, 145, 146); β-catenin (147) and JNK 1/2 (148).
Secondary bile acids have been shown to cause apoptosis in
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colonic epithelial cells, and high concentrations of DCA
and LCA in stool may promote carcinogenesis by exerting
selective pressure for emergence of epithelial cell
mutants which are resistant to apoptosis (for example, via
loss of p53) (138). LCA has been found to be an excellent
activator of the vitamin D receptor (149, 150).
Activation of this receptor in intestinal epithelial cells
activates genes that metabolize LCA (150).

This may be a

protective mechanism that evolved to limit LCA toxicity to
intestinal epithelial cells.

Current trends and Future Issues
Bile salt metabolism is a widespread and fundamental
property of the gastrointestinal microflora encompassing
the most commonly isolated species of intestinal bacteria
including, but not limited to the genera Bacteroides,
Clostridium, Lactobacillus, Bifidobacterium, Eubacterium,
and Escherichia.

However, our current understanding of

the intestinal microbiology of bile salt modifications is
limited to cultivated species.

Discovering novel genes in

the gut microbiome (collective genomes of the GI flora)
encoding BSH, HSDH and enzymes involved in the 7α/βdehydroxylation pathway through molecular techniques will
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facilitate a much greater understanding of the diversity
and complexity of these reactions in the human colon.
Techniques such as PCR-denaturing gradient gel
electrophoresis (PCR-DGGE) can be utilized to measure the
diversity of organisms based on specific phylogenetic
markers such as 16s rDNA as well as functional genes,
potentially bile salt modifying enzymes (151, 152).
Measuring the true diversity of bile salt modifying
bacteria is crucial in studying the relationship between
the levels and activity of these bacteria and disease
risk.
Determining the conditions in which secondary bile
acids are formed in significant quantities and retained in
the enterohepatic circulation of certain individuals is
suggested to be important in the etiology of cholesterol
gallstone disease and colon cancer.

Since secondary bile

acids are formed exclusively through bacterial enzymatic
reactions, the study of microbes capable of bile acid
7α/β-dehydroxylation is important in understanding these
chronic gastrointestinal illnesses.

The goal of such

research is to find ways to block the source of secondary
bile acid production.

Long-term use of antibiotics to
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prevent 7α-dehydroxylation of bile acids would be
impractical.

The design of pharmaceuticals to block the

7α-dehydroxylation pathway is a possibility.

However,

this approach requires targeting microbial enzymes and
runs the risk of eventual drug resistance as with
antibiotics.

Alternatively, reducing secondary bile acid

production may be achieved through administering
specialized CA accumulating probiotic bacteria (153).
Studies with bifidobacteria and lactobacilli isolated from
human feces have shown their ability to assimilate CA
spontaneously in vitro (153, 154).

The mechanism for CA

uptake in lactic acid bacteria appears to be diffusion of
a hydrophobic weak acid through the membrane via the
transmembrane proton motive force (153, 154).

The higher

intracellular pH causes the bile acids to become trapped
due to ionization.
The use of specific bacteria as “drugs” to treat
chronic gastrointestinal illnesses caused in part by other
intestinal bacteria certainly has potential, though
rigorous studies are needed to demonstrate the
effectiveness of such therapies.

Overall, clinical trials

using probiotics to solve specific health disorders have
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been met with mixed results.

Discrepancies between

studies are due in part to different methodologies, choice
of probiotic strains, colony forming units (CFU)
administered/day and patient characteristics.

One

particular variable that would have to be addressed when
determining bile acid assimilation by lactic acid bacteria
in clinical trials is determining viability in vivo after
passage through gastric juice and bile.

A bacterium must

be alive in order to create a membrane potential capable
of accumulating bile acids.

Targeted delivery of

probiotic bacteria to the intestine in microencapsulated
form has shown promise in improving viability in the
presence of gastric conditions and bile (155, 156).
Another issue is whether the introduction of billions of
probiotic bacteria to the small bowel will have an effect
on bile acid input into the colon.

Significant bile salt

hydrolysis proximal to the terminal ileum reduces the
efficiency of bile salt uptake through high affinity
transport, allowing enhanced excretion of bile acids in
feces.

This principle is behind attempts at lowering

serum cholesterol using probiotics with bile salt
hydrolytic activity (157-159).

Thus, the choice in
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probiotic delivery mechanisms is important in addressing
both issues of bacterial viability as well as preventing
increased bile salt hydrolysis proximal to the terminal
ileum. The potential impact of probiotic bacteria in
reducing secondary bile acid formation in the human colon
through sequestering bile acids would be greatly reduced
if these same bacteria cause an increase in bile acid
input into the large intestine greater than their capacity
for sequestering bile acids.
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Clostridium hylemonae has yet to be determined.

Finally,

in

7α-dehydroxylating

for

activity

genes

CA

the

the

“reductive

arm”

of

the

bile

acid

dehydroxylating pathway have yet to be identified.

7αThese

genes are predicted to encode flavoproteins which reduce
the 3-oxo-Δ4,6-DCA intermediate to 3-oxo-Δ4-DCA and finally
to

3-oxo-DCA.

We

predict

the

existence

of

a

hydroxysteroid dehydrogenase which will reduce the 3-oxoDCA intermediate to the secondary bile acid DCA.

Finally,

we predict an ABC permease which will act to remove DCA
from the bacterial cell.

The objectives of these studies include:
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2) Subclone the baiCD and baiH genes from Clostridium
scindens

into

E.

coli

for

overexpression

of

recombinant protein.
3) Synthesize

appropriate

substrates

for

enzyme

assay

and determine reaction product identity by thin layer
chromatography and mass spectrometry

Objective

2:

Isolate

and

characterize

bai

genes

from

Clostridium hylemonae TN271
1) Isolate a fragment of the bai oxidative operon from
Clostridium hylemonae via polymerase chain reaction,
clone and sequence this product.
2) Perform

bi-directional

genome-walking

by

PCR

to

obtain the remainder of the genes and cis-elements in
this operon.
3) Characterize operon “in silico”
4) Determine mRNA initiation site(s).

Objective

3:

Identify

novel

bai

genes

in

intestinal

clostridia
1) Locate reductive gene(s) in Clostridium scindens and
Clostridium hylemonae
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2) Clone, overexpress and purify recombinant protein of
one reductive gene in E. coli
3) Synthesize bile acid substrate for characterization
of reductive gene product
4) Determine mRNA initiation site(s).

MATERIALS AND METHODS
Bacterial strains, culture media, and conditions
Clostridium scindens VPI 12708 (formerly Eubacterium
sp. strain VPI 12708) was routinely cultivated under
anaerobic conditions in Brain Heart Infusion (BHI) broth
containing sodium cholate (100 μM) and maintained as
previously described (111).

Clostridium hylemonae TN271

was a generous gift of Dr. Fusae Takimine, University
Riken, Japan.

C. hylemonae was cultivated under anaerobic

conditions in BHI containing 0.02 % fructose.

Clostridium

absonum (ATCC 27555) was purchased from ATCC. C. absonum
was initially grown in cooked meat broth for 24 hrs at
37˚C and subsequently stored at 4˚C and used for no more
than 3 weeks as starter culture source. The cells were
cultured in BHI supplemented with 0.2 % fructose (w/v). E.
coli BL21-CodonPlus (DE3)-RIL and ArcticExpression
Competent E. coli were purchased from Stratagene (La
Jolla, CA) and used for expression of recombinant
proteins. Recombinant E. coli cells were grown with
shaking in modified TYGPN (tryptone 20 g, yeast extract 10
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g, 0.8 % glycerol, 5 g Na2HPO4, 10 g KNO3, and 3 μM hematin
per liter; pH 7.0) containing 100 μg/ml ampicillin.

General PCR and recombinant DNA methods

Total genomic DNA from C. scindens VPI 12708 was purified
as described previously (169) and used as a template for
PCR amplification of the baiH gene using primers baiHFPstI (5’-TAGCACTGCAGGCCTATGTT-3’) containing PstI
restriction site and baiHR-SacI (5’-ATCAGAGCTCATTGCCTTCAC3’) containing SacI restriction site (Figure 12). The
expression vector for the baiCD gene from Clostridium
scindens VPI 12708 was constructed in pSPORT1 (Invitrogen,
Carlsbad, CA). The baiCD gene was cloned using primers
baiCDF-Sal1 (5’-CCGTCGACGGAGGAGTAACAAAATGAGTTACG-3’)
containing SalI restriction site and baiCDR-BglII (5’CGTAAGCTTCTAGATTGCCATTCCTGCGTC-3’) containing BglII
restriction site.

The baiJ gene was PCR amplified using

primers 12708baiJ-F (5’TGCATCTCCCTCGAGGGCACATTATGTTCCAGGC-3’) containing XhoI
restriction site (bold) and 12708baiJ-R (5’TACAGGTACCAAGCATTGACTGTCCCGATGCT-3’) containing KpnI
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Figure 12.

Schematic representation of cloning strategy
for baiH gene from Clostridium scindens VPI
12708. Primers baiHF-PstI and baiHR-SacI
(see text) with internally designed
restriction sites were used to amplify a 2.2
kb stretch encoding the baiH gene.
Following restriction digestion of both the
insert and vector, and GENECLEAN
purification of electrophoresed restriction
products, the 2.2 kb baiH insert was ligated
with T4 DNA ligase to the 4.1 kb pSport1
vector with PstI and SacI “sticky ends”
generating the 6.3 kb vector pSport1-baiH.

77

Forward primer carrying
PstI site
baiH
2.0 kb

baiG

PCR
PstI
5′

baiI
Reverse primer carrying
SacI site

baiH
2.2 kb

3′
SacI

PstI

PstI / SacI digestion

baiH
2.2 kb

PstI

SacI

baiH gene (2.2 kb)

SacI

T7
Promoter

Ligation

T7
Promoter

pSPORT1
LacI

(4.1 kb)

Amp

LacI

pSPORT1baiH

Amp

(6.3 kb)
LacII
promoter

Ori

LacI
Promoter

Ori

78

restriction site (bold). The baiL gene was PCR amplified
using forward primer baiLpETF (5’GTCAGAATTCCAGTTTGCCATGGAGG-3’) containing EcoRI
restriction site (bold) and reverse oligonucleotide
baiLpETR (5’ ATTCTCGAGCATATTCAGGAAGCCGGCGTCG-3’)containing
XhoI site (bold) for pET-21a(+) vector.
The PCR reaction mixture contained 100 ng of C.
scindens VPI 12708 genomic DNA, 100 pmol each primer, 0.3
mM dNTPs, Pfu polymerase buffer, and 2.5 U Pfu DNA
polymerase in a total volume of 50 μl.

Cycling parameters

included an initial 3 min denaturation at 94˚C followed by
30 cycles of amplification 94˚C for 35 s, 52˚C for 30 s
and 68˚C for 2 min followed by one additional 7 min
elongation at 68˚C. Amplification of the baiH PCR product
was performed on a DNA Thermal cycler (MJ research,
Watertown, MA).
The baiJ gene and all subsequent PCRs were performed
on an Eppendorf Mastercycler Gradient PCR thermocycler
(Eppendorf, Westbury, NY, USA).

The baiH PCR product and

pSport1 (Invitrogen, Carlsbad, CA) vector were doubledigested with PstI and SacI, gel purified (GENECLEAN spin
kit) and ligated with T4 DNA ligase (New England Biolabs).
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The baiJ PCR product and pT7-SBP-2 Expression vector
(Sigma, St. Louis, MO) were double-digested with XhoI and
KpnI, gel purified (GENECLEAN spin kit) and ligated with
T4 DNA ligase (New England Biolabs, Ipswich, MA, USA).
Plasmids were transformed into E. coli DH5α (Bio-line,
Randolph, MA) by electroporation using an Eppendorf 2510
electroporator at 2500V. The recombinant plasmids
(pSport1-baiH, pT7SBP2baiJ, p12708baiL) were purified from
E. coli DH5α and transformed into E. coli BL21-CodonPlus
(DE3)-RIL or ArcticExpress E. coli for overexpression.
The sequence was verified at the Virginia Commonwealth
University Nucleic Acid Core Facility using standard
primers.

Polyacrylamide gel electrophoresis and immunoblot analysis

Protein samples were separated and analyzed on a 10%
SDS-polyacrylamide gel electrophoresis (PAGE) (170).
Protein samples were prepared for SDS-PAGE by heating for
5 min at 100˚C in an equal volume of sample buffer (0.1 M
Tris-HCl, 5 % SDS, 0.9 % 2-mercaptoethanol (2ME), 20 %
glycerol, pH 6.8). Gels were stained with 0.2 % (w/v)
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Coomassie brilliant blue R-250 (Sigma, St. Louis, MO) in
ethanol: acetic acid: water (30:10:60, v/v/v). A broadrange protein weight marker (Bio-Rad, Hercules, CA) was
used for protein size determinations. For western blot
analysis, proteins were similarly separated by SDS-PAGE,
and electrophoretically transferred to a nitrocellulose
membrane by electroblotting using a Bio-Rad Immuno-Blot
assay kit.
Antiserum against purified baiH gene product was
raised in rabbits as described previously (121).
Detection of the baiH gene product on nitrocellulose
membranes was performed using a goat anti-rabbit alkaline
phosphatase conjugate.

Detection of the baiJ gene

product was performed using anti-Strep-Tactin Horse radish
peroxidase(HRP) conjugate (IBA, Gottingen, Germany).
Detection of the baiL gene product was performed using
Novagen HRP Anti-his tag monoclonal antibody (Novagen,
Madison, WI, USA).
Enzyme Assays
NADH:FOR activity was determined at 25˚C by
monitoring the oxidation of NADH at 340 nm (ε340=6.22 mM-
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cm-1) using a Beckman DU-640 spectrophotometer (Fullerton,

CA). The standard assay mixture (1 ml) contained 100 mM
sodium phosphate buffer (pH 6.8), 150 μM NADH, 150 μM FAD
and an appropriate amount of enzyme added to initiate the
reaction. Assays were performed under aerobic conditions
in a 1 ml quartz cuvette with a 1 cm pathlength. One unit
of NADH:FOR activity is defined as the amount of enzyme
catalyzing the oxidation of 1 μmol of NADH min-1mg-1 of
protein. Protein concentrations were determined according
to Bradford (171) using the Bio-Rad protein assay kit,
with BSA as standard for routine assays.
BaiH and BaiCD oxidoreductase activity assays were
performed in reaction mixtures containing the following:
50 mM sodium phosphate buffer (pH 6.8), 1.5 mM NAD+,

225

μM [24-14C]-3-dehydro-UDCA (3-oxo-7β-hydroxy) or [24-14C]-3dehydro-CDCA

(3-oxo-7α-hydroxy)

(specific activity of

0.01 μCi μmole-1 substrate) and purified recombinant BaiH
protein (100 μg) or 1 mg cell extract containing
overexpressed BaiCD.
BaiJ oxidoreductase activity assay was performed in
the following mixture:

100 mM sodium phosphate buffer (pH

6.8), 1.5 mM NAD+ (or NADP+), 90 μM [24-14C] 3-dehydro-
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DCA(~SCoA) (specific activity 550 DPM/nmole).

The

reaction mixture (500 μl) was incubated 37 oC for 30 min.
BaiJ reaction was initially brought to pH 10 with 5N NaOH
and boiled 30 min to hydrolyze CoA ester (125).

The pH

was then lowered to ~3 with 5 N HCl and bile acid
metabolites were extracted three times with 1 vol ethyl
acetate, dried under a stream of nitrogen gas, dissolved
in 15 μl MeOH, spotted, separated by thin layer
chromatography on Baker flex silica gel IB-2 plates (J.T
Baker Chemical Co, Philipsburg, NJ) using a solvent system
S1 (benzene:dioxane:glacial acetic acid 75:20:2 (v/v/v))
and radiolabeled bile acid metabolites were visualized by
autoradiography (Kodak MS film, Rochester, N.Y) (172).
Extracts prepared from E. coli containing pSport plasmids
without baiH or baiCD gene inserts served as negative
controls. Sections of TLC silica gel containing bile acid
reaction products were scraped and radioactivity
quantified by liquid scintillation spectrometry (Packard,
Meriden, CT).
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Expression and purification of recombinant baiH gene
product

E. coli BL21-CodonPlus(DE3)-RIL harboring pSport1baiH were grown in 5 ml of modified TYGPN medium
containing 100 μg of ampicillin per ml at 37˚C for 8 hrs.
The culture was stored at 4˚C overnight. The next day,
cells were collected by centrifugation (3,000 × g, 10 min)
and suspended in 5 ml of TYGPN medium containing 100 μg/ml
ampicillin. This cell suspension was used to inoculate 2
liter flasks containing 600 ml TYGPN broth medium
containing 100 μg/ml ampicillin. The cells were cultivated
at 37˚C with shaking at 250 rpm for about 3 hr to reach an
A600 of about 0.4 at which point the cultures were induced
by addition of isopropyl-β-D-thiogalactopyranoside (IPTG)
to 1 mM final concentration. Cultures were grown at 25˚C
for an additional 4 hr at which time the cells were
harvested by centrifugation at 5,500 × g, 15 min at 4˚C.
The cells were suspended in 400 ml of buffer A (50 mM
sodium phosphate buffer; pH 6.8, 2% (w/v) glycerol, 15 mM
of 2-mercaptoethanol (2ME)) cells were lysed by sonicating
twice for 10 min intervals and cell debris removed by
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centrifugation at 21,000 × g for 30 min. The supernatant
fluid containing soluble recombinant BaiH was removed for
further purification.
All purification methods were followed essentially as
described previously with some modifications (129). Frozen
cells were suspended in buffer A, disrupted by sonication
on ice, and centrifuged at 21,000 × g for 30 min. Protein
was concentrated and protein under 50 kDa removed using
Centriprep YM50 (50 kDa cut-off) concentrators (Millipore,
Billerica, MA). The protein solution was then applied to a
2 x 10 cm Protein–Pak DEAE 40HR column (Waters, Milford,
MA) equilibrated with buffer A. After the column was
washed with 60 ml of buffer A, NADH:FOR was eluted with a
500 ml linear gradient of NaCl (0 to 1.0 M) in buffer A at
a flow rate of 2 ml min-1. Fractions with a yellow color
and NADH:FOR activity were pooled and dialyzed overnight
against 2 L of the same buffer. The dialyzed solution was
loaded onto a 1.0 × 5.5 cm Cibacron blue 3GA agarose
column (Sigma, St. Louis, MO) equilibrated with buffer A.
The column was then washed with 100 ml of buffer A, and
protein partially eluted with 20 ml of buffer A containing
1 mM NADH, 1 mM FAD, and 20 mM dithiothreitol (DTT). The
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remaining protein was eluted with buffer A containing 1M
KCl. Active protein fractions eluted with NAD and FAD were
pooled and loaded onto a 1.0 × 6.4 cm Bio-Scale CHT5-1
hydroxyapatite column (Bio-Rad, Hercules, CA) equilibrated
with buffer C (5 mM potassium phosphate buffer pH 7.0, 2%
glycerol, 15 mM 2-ME). After the column was washed with
buffer C at 1ml min-1, active fractions were eluted with a
linear gradient of 0 to 0.5 M potassium phosphate (pH
7.0). The purified protein from this step was dialyzed
with buffer A, concentrated by a Centriprep YM50
concentrator and stored in buffer A containing 50%
glycerol (w/v) at -20 ˚C.

Protein remained active for 4

weeks under these conditions.

Expression and purification of the baiJ and baiL gene
product

E. coli Arctic ExpressBL21-CodonPlus(DE3)-RIL
harboring pT7SBP-baiJ (Figure 13) was grown in 5 ml of LB
medium (tryptone 10 g; yeast extract 5g; NaCl 10g) with
100 μg of ampicillin per ml at 37˚C for 8 hrs. The culture
was transferred to 2 Liter flasks containing 500 ml
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Figure 13.

Cloning strategy for baiJ gene from C.
scindens VPI 12708. The baiJ gene was PCR
amplified using primers 12708baiJ-F (5’TGCATCTCCCTCGAGGGCACATTATGTTCCAGGC-3’)
containing XhoI restriction site (bold) and
12708baiJ-R (5’TACAGGTACCAAGCATTGACTGTCCCGATGCT-3’)
containing KpnI restriction site (bold).
Double digestion of PCR product and vector
pT7SBP-2 with XhoI and KpnI, gel
purification and ligation resulted in vector
pT7SBP2baiJ.
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Modified TYGPN broth medium containing 100 μg/ml
ampicillin. The cells were cultivated at 18˚C with shaking
at 250 rpm for about 18 hr to reach an A600 of about 0.4 at
which point the cultures were induced by addition of IPTG
to 0.8 mM final concentration. Cultures were grown for an
additional 12 hr at which time the cells were harvested by
centrifugation at 5,500 × g, 15 min at 4˚C. The cells were
suspended in 40 ml of Strep buffer (50 mM sodium phosphate
buffer; pH 7.9, 15 mM of 2-mercaptoethanol (2ME) and 1M
NaCl) and the cells were lysed by sonicating twice for 15
min intervals. Cell debris was removed by centrifugation
at 21,000 × g for 30 min. The supernatant fluid containing
soluble recombinant BaiJ was removed for further
purification.
All purification methods using IBA Strep-tag
purification were followed according to the manufacturer
(IBA, Gottingen, Germany). Eluents were concentrated by
Centriprep YM10 (10 kDa cut-off) concentrators (Millipore,
Billerica, MA).
The baiL gene was expressed in E. coli BL21
CodonPlus(DE3)-RIL in a similar manor to the baiJ gene,
except at 25˚C and 3 hour growth following induction with
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IPTG.

Protein concentration was determined by Bradford

protein assay.

Enzymatic and biological preparation of bile acid
substrates

[24-14C]-CDCA was purchased from American Radiolabeled
Chemicals, Inc. (St. Louis, Mo), and determined to be
99.9% pure by TLC.

C. absonum expresses both 7α-HSDH and

7β-HSDH and can be used to efficiently epimerize CDCA to
UDCA (76, 77).

[24-14C]-UDCA was biologically synthesized

from [24-14C]-CDCA using Clostridium absonum ATCC 27555
grown in BHI.

C. absonum was induced at O.D600nm 0.4 by

addition of 200 μM sodium chenodeoxycholate (CDCA) plus 2
μCi of [24-14C]-CDCA for production of [24-14C]-UDCA (0.01
μCi μmole-1).

After 24 hr growth following induction, the

pH of the culture medium was lowered to ~pH 3 and bile
acid metabolites were extracted twice with ethyl acetate,
dried under a stream of nitrogen gas and dissolved in 100
μl of absolute methanol (MeOH). [24-14C] CDCA, [24-14C] 7oxo-LCA and [24-14C] UDCA were separated by TLC as
described above.

Non-radiolabeled CDCA and UDCA standards
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(Sigma, St. Louis, Mo, USA) were also chromatographed
along with the radiolabeled reaction products and this
portion of the plate stained with phosphomolybdic acid for
detection. Radiolabeled bands co-migrating with UDCA
standard (Sigma) were scraped and extracted with ethyl
acetate, dried, and suspended in MeOH.
[24-14C] UDCA was converted to [24-14C] 3-dehydro-UDCA
(3-oxo-7β-hydroxy) enzymatically using commercially
available 3α-HSDH (Sigma) in the following reaction
mixture: 0.5 ml total volume 50 mM sodium phosphate buffer
(pH 6.8), 1 U 3α-hydroxysteroid dehydrogenase, 1.5 mM NAD+,
100 μM unlabeled UDCA and 1 μCi

[24-14C]-UDCA. The

reaction mixture was allowed to incubate for 4 h at 37

o

C.

Bile acids were separated by TLC as described above and
radiolabeled bile acid reaction products were detected by
autoradiography.
[24-14C] 3-oxo-DCA was produced from commercially
available [24-14C] CA and non-labeled CA (Sigma).

1 μCi

[24-14C] CA and 5μl 100 mM CA (500 nmoles) was added to 5
ml BHI and inoculated with C. scindens VPI 12708 and grown
48 hrs at 37˚C.
the usual manner.

The reaction products were extracted in
The concentrated reaction products were

91

separated by TLC in solvent system S1 (172).

The band

corresponding to DCA standard was scraped and [24-14C] DCA
was extracted with ethyl acetate and concentrated under
nitrogen gas.

The pellet was resuspended in 50 mM sodium

phosphate buffer and reacted with commercially available
3α-HSDH in the presence of 100 μM NAD+ as co-substrate.
Substrate and product were separated by TLC and band
corresponding to [24-14C] 3-oxo-DCA (Rf=1.74; Solvent SI)
was extracted (118).

Chemical synthesis of bile acid substrates

3-oxo-DCA-CoA is hypothesized to be a common
substrate for both the baiJ and baiL gene products.

Thus,

3-oxo-DCA was synthesized from commercially available DCA
essentially as described by Jones et al. (1949) and
Danielsson et al. (1962) with some modifications (173,
174).

Toluene was substituted for benzene in the reflux

step as well as the chromatography.

Briefly, 5 grams of

deoxycholic acid was methylated overnight in 250 ml
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absolute methanol and 3 ml concentrated sulfuric acid.
The solvent was evaporated under nitrogen gas and the
crude methyl ester was resuspended in chloroform and
chromatographed over 100 g silicic acid with a step-wise
gradient of acetone in chloroform up to 25%.

The DCA-

methyl ester was then oxidized in 140 ml toluene and 55 ml
acetone with 5.3 g aluminum tert.-butoxide under reflux
for 18 hours.

After cooling, the reaction mixture was

poured into an equal volume 2N sulfuric acid and
emulsified.

The toluene layer was separated and washed

once again with 2N sulfuric acid followed by equal volumes
of 7% sodium hydrogen carbonate (twice), and water (once).
The toluene layer was then dried under CaCl2 and
evaporated.

The methyl ester was hydrolyzed overnight in

2 M methanolic potassium hydroxide.

The crude acid was

added slowly to 0.5 N HCl and filtered under vacuum.

The

crude acid was dissolved in ethyl acetate, dried with
sodium sulfate, concentrated under nitrogen gas and
chromatographed on 100 g silicic acid with an increasing
gradient of acetone in toluene.

Fractions eluted with 15%

acetone in toluene yielded semi-pure 3-oxo-DCA as observed
on thin layer chromatography. Identity of 3-oxo-DCA was
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confirmed by comparison of Rf value after reaction with 3αHSDH in the presence of 150 μM NADH.

Commercially

available deoxycholic acid (Sigma) was used as a standard.
Material used in enzyme reactions was scraped from TLC
plate and purified by ethyl acetate extraction.
The sodium hydrogen carbonate fraction was acidified
with dilute (10% v/v) sulfuric acid and allowed to
precipitate overnight.

The precipitate was vaccum

filtered and worked up and purified as described above.
Pure 3-oxo-DCA was esterified to coenzyme A by the
method of Killenberg and Dukes (1976) which was a slight
modification of Shah and Staple (1968) (175, 176).
Tetrahydofuran and methylene chloride were distilled prior
to use and γ-collidine was dried over sodium sulfate. 3.5
mg [24-14C] 3-oxo-DCA (550 DPM/nmole) was added to 700 μl
dry methylene chloride and incubated ten minutes at room
temperature.

250 μl of methylene chloride containing 1.4

μl ethyl chloroformate was added and the solution was
magnetically stirred on low for one hour.

The solvent was

then evaporated under nitrogen gas and the pellet was
suspended in 600 μl tetrahydrofuran.

The tetrahydrofuran

solution was slowly added to 600 μl solution of 62.5 M CoA
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in water (pH 8.0).

After fifteen minute incubation, the

pH was lowered to 5 with 1% perchloric acid and the
organic solvent evaporated under nitrogen gas.

The

aqueous layer containing 3-oxo-deoxycholyl-CoA was washed
three times with 2 vol diethyl ether.

The aqueous

solution was acidified with 170 ml 10% perchloric acid and
the 3-oxo-deoxycholyl-CoA was collected by centrifugation
at 15,000 x g for 30 minutes.

The pellet was stored at -

80˚C overnight and used the next day.
Purification and mass spectrometry of BaiCD and BaiH
reaction products
The analysis and identification of BaiH catalyzed
bile acid reaction product was carried out on a Shimadzu
HPLC (Kyoto, Japan) with a SIL-HTC Autosampler by reversephase HPLC using a Brownlee RP-300 (Perkin Elmer,
Wellesley, MA) C8 7m 2.1 i.d. × 100 mm column. The mobile
phase consisted of 10 mM ammonium acetate (solvent A) and
10 mM ammonium acetate in acetonitrile (solvent B). The
column was equilibrated in solvent A. After injection of a
5 ml sample of the bile acid, solvent B was increased from
0-100% at 10% min-1. The column was regenerated by
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switching back to solvent A and re-equilibrating for 5
min. The flow rate was 0.2 ml min-1 and the eluted material
was passed into the electrospray ionization interface of a
MDS Sciex/Applied Biosystems API 4000 Q Trap (Foster city,
CA) operating in the negative ion mode. Mass spectra were
recorded over a 350-700 m/z range.

Genome-walking by polymerase chain reaction

Genome-walking DNA libraries were prepared using the
Clontech Universal Genome-Walker Kit according to the
manufacturer.

DNA was prepared essentially as described

previously (177) with a few alterations.

To produce high

molecular weight DNA (~50 kb), pipetting steps during
phenol/phenol:chloroform:iso-amyl alcohol were changed to
pouring the aqueous phase, which prevents substantial DNA
sheering.

An 18 gauge needle was used to pierce the very

bottom of 50 ml falcon conical tubes following
centrifugation and the organic phase was emptied.

DNA was

then precipitated by addition of 10% 3N sodium acetate and
3 volumes of absolute ethanol, washed and resuspended in
TE buffer, ph 7.6, overnight with agitation at 45 ˚C.
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DNA quality was determined on a 0.5% agarose gel
containing 75 μg/ml ethidium bromide.

Prior to

electrophoresis, the DNA sample was heated to 65˚C.

The

gel was run 18 hours at 25 V overnight along with a High
Molecular Weight DNA Marker (Invitrogen).

DNA >48 kb was

restriction digested and adapter ligated using
GenomeWalker kit. Genomic DNA libraries were stored at 20˚C.

Oligonucleotides were designed using Primer3

software with Tm values between 60˚C and 70˚C with ≥ 45%
G+C and ≥ 25 mer in length.
PCR reactions were prepared using Advantage cDNA
Polymerase Kit or Advantage 2 Polymerase Kit (Clontech) as
follows:

40 μl ddH2O, 5 μl 10x Advantage PCR buffer, 1 μl

dNTP mix (10 mM each), 1 μl adaptor primer AP1 (10 μM), 1
μl gene-specific primer (10 μM), 1 μl Advantage Polymerase
mix (50X) and 1 μl adaptor-ligated DNA restriction library
template.

Reaction mixtures were mixed briefly and tubes

quick spun.

“Touchdown” PCR amplification was performed

on Eppendorf Mastercylcer Gradient PCR machine using the
following parameters:

95˚C for 25 s, 72˚C for 3 min (7

cycles); 94˚C for 25 s, 67˚C for 3 min (32 cycles); 67˚C
for 7 min, hold 4˚C.

Products (5 μl) were separated by
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electrophoresis on a 1% agarose/EtBr gel and visualized on
a Fotodyne analyzer.

PCR products of interest were

GENECLEAN purified from the gel and ligated into a pCR8 GW
TOPO TA Cloning vector (Invitrogen) and transformed into
TOP 10 Chemically Competant E. coli according to the
manufacturer (Invitrogen).

Colonies were cultivated in LB

broth containing 100 μg/ml spectinomycin.

Plasmids were

purified using Qiagen Miniprep Spin Kit according to the
manufacturer.

Sequencing was performed at the Nucleic

Acid Research Facility, School of Medicine, Virginia
Commonwealth University on ABI 3700 Sequencer using
oligonucleotides synthesized by Integrated DNA
Technologies (Coralville, IA, USA).

SMART-RACE Polymerase Chain Reaction
C. scindens VPI 12708 as well as C. hylemonae were
cultivated in 400 ml BHI containing 0.02% fructose to an
O.D.600nm 0.3 (C. scindens) or 0.2 (C. hylemonae) at which
point the cultures were induced 3 times at hourly
intervals with 50 μM CA.

One hour after the third

induction, 1 ml culture was transferred to a serum bottle
containing [24-14C] CA (0.5 μCi/500 nmoles) and incubated
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37˚C 30 minutes.

A non-induced control was also tested

for 7α-dehydroxylation activity.
13,000 x g for 30 min at 4˚C.

Cells were centrifuged

The cell pellet was

suspended in 1 ml TE buffer and cells transferred to 1.5
ml microcentrifuge tube and spun 1 min at 13,600 x g.

The

supernatant was decanted and bacterial cells were stored
in RNAlater solution (Ambion, Austin, TX, USA) and stored
at - 70˚C until further processing.
Once 7α-dehydroxylating activity, and thus induction,
was confirmed by presence of [24-14C] DCA in [24-14C]
activity assay, total RNA was extracted using the Ribopure
Bacteria RNA extraction kit (Ambion) essentially according
to the manufacturer with the exception that cells were
broken on a Mini-bead beater (Biospec Products Inc,
Bartlesville, OK, USA) at 3,000 rpm for two cycles of 1
min.
37˚C.

Optional DNase treatment was performed for 1 hour at
Some of the RNA was poly-A tailed prior to cDNA

synthesis using the A-Plus Poly(A) Polymerase Tailing Kit
(Epicentre Biotechnologies, Madison, WI) according to the
manufacturer with a 15 minute extension time.

cDNA was

generated using the SMART-RACE cDNA synthesis kit
(Clontech) according to the manufacturer starting with 1
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μg total RNA. 5’CDS primer and 3’CDS primer (Clontech)
were used to make 5’ RACE ready cDNA and 3’ RACE ready
cDNA, respectively, when poly-A RNA was used as the
template; whereas gene-specific primers replaced 5’CDS
primer and 3’ CDS primer when total bacterial RNA was used
as template. Reaction was carried out for 1.5 hrs at 42˚C
and terminated by addition of 50 μl TE buffer pH 7.6 and
heating at 70˚C for 7 minutes.

SMART RACE PCR of 5’ ends

was performed using the Advantage-GC 2 PCR Kit (Clontech)
according to the manufacturer’s instruction.

0.5 μl GC-

Melt was added to each 50 μl reaction volume along with
2.5 μl cDNA sample.

A nested PCR was performed when

product concentration was low or to reduce non-specific
products.

PCR products were excised from agarose gel and

purified using the GENECLEAN Spin Kit (MP Biomedicals,
Solon, Ohio).

The purified PCR product was then cloned

into a pCR8 GW TOPO TA cloning vector (Invitrogen),
transformed into TOP 10 Chemically Competent E. coli
(Invitrogen) and selected on LB agar containing 100 μg/ml
spectinomycin.

Plasmids containing insert were sequenced.

Sequence analysis and Assembly
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Sequence ABI files were edited and assembled using
Vector NTI software (Invitrogen, Carlsbad, CA, USA), as
well as CAP3 Sequence Assembly Program
http://pbil.univ-lyon.fr/cap3.php. Pairwise alignments
were performed to determine percent identity/similarity
using EMBOSS Needle program
http://www.ebi.ac.uk/emboss/align/. Homology searches were
made against the UniProt database.

Multiple sequence

alignments were prepared using T-COFFEE
http://tcoffee.vital-it.ch/cgi-bin/Tcoffeecgi/index.cgi
(178) or CLUSTALW2
http://www.edi.ac.uk/Tools/clustalw2/index.html with some
manual editing based on structural data.

Sequence

conservation within multiple alignments was emphasized
using the BOXSHADE utility
http://www.ch.embnet.org/software/BOX_form.html.Protein Mr
calculations were performed using the Compute pI/MW tool
on the Expasy Proteomics Server
http://www.expasy.ch/tools/pitool.html. Open reading
frames (ORF) were detected using the ORF Finder Program
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http://www.ncbi.nlm.nih.gov/gorf/gorf.html and searched
against Genbank by BLAST analysis (179).
Clostridium scindens VPI 12708 baiH (AAC45417) and
Clostridium hiranonis baiCD (AAF22846) genes were
sequenced previously (59).

Secondary structural

predictions were carried out with the PSIPRED program
(http://bioinf.cs.ucl.ac.uk/psipred/) (180, 181).
Secondary structural predictions of the BaiH gene product
were compared with the known secondary structure from the
crystal structure of 2, 4-dienoyl CoA reductase (dcr) from
Escherichia coli (182).

Nucleotide sequence accession number

The baiC and baiD genes from C. scindens were
originally reported as separate genes, however, after
discovery that the baiCD is a single gene product in C.
hiranonis, the baiC and baiD gene region was resequenced
from C. scindens and found to encode a single gene (D.H.
Mallonee and P.B. Hylemon, unpublished data).

Also, a

baiH gene has been located downstream of the bai operon in
C. hiranonis and has not been reported previously (J.E.
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Wells and P.B. Hylemon, unpublished data).

GenBank

accession numbers for the baiCD gene from C. scindens VPI
12708 is U57489 and the baiH gene from C. hiranonis TO931
is AF210152.

Genbank accession numbers for the

baiBCDEFGHI operon from C. hylemonae TN271 is (EU675332).
The baiA gene from C. hylemonae TN271 can be found using
accession number (EU675329).

Genbank accession numbers

for the baiJKL genes from C. scindens VPI 12708 and C.
hylemonae TN721 are (Eu675330) and (EU675331),
respectively.

RESULTS
Characterization of the BaiCD and BaiH
Amino acid sequence alignment and secondary structural
prediction of the BaiH.
Protein-protein BLAST searches of the baiH gene
product suggests homology with a family of pyridinenucleotide dependent flavoproteins (Table 4) including
NADH oxidase from Thermoanaerobacter brockii (CAA47660)
(183), 2-enoate reductase from Clostridium tyrobutyricum
(CAA71086) (184) and Moorella thermoacetica (CAA76082)
(184), 2, 4-dienoyl-CoA reductase from several bacterial
species, and Old yellow enzyme (OYE) from
Thermoanaerobacter tengcongensis (NP_623692) (185).

E.

coli 2, 4-dienoyl CoA reductase (dcr) (AAC76116) is a 73
kDa protein which uses NADPH as an electron donor and
contains a 4Fe-4S cluster, 1 mol FMN, and 1 mol FAD per
mole subunit (182). The dcr gene product from E. coli
shares 32 % identity and 49 % similarity at the amino acid
sequence level with the baiH gene product from C. scindens
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VPI 12708.

A 2.4 Å structure has been solved for the E.

coli dcr gene product allowing a basis of comparison for
secondary structure prediction of the baiH gene product
(Figure 14).

The predicted secondary structure of the

BaiH is very similar to that of the dcr gene product
suggesting a similar TIM-barrel fold.

It is interesting

to note the conserved cysteine consensus pattern of C(2X)-C-(2-3X)-C-(11-12X)-C between the BaiH, E. coli Dcr
and other homologues suggesting that the BaiH and BaiCD
contain 4Fe-4S centers.
Several baiCD and baiH homologues introduce carboncarbon double bonds.

This suggests that the baiCD and

baiH gene products encode flavoproteins which may
introduce carbon-carbon double bonds into the bile acid
structure.

Previously, we identified a 3-oxo-Δ4-cholic

acid intermediate in the bile acid 7α-dehydroxylation
pathway (117).

Because there are two homologous genes and

two stereochemistries differing about the 7-hydroxyl
between CA, CDCA (7α-hydroxy) and UDCA (7β-hydroxy), we
hypothesize that the baiCD and baiH introduce the Δ4-bond
in bile acids, recognizing one stereochemistry about the
7-hydroxyl or the other.
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Figure 14.

Amino acid sequence alignment of the BaiH
(AAC45417) from C. scindens VPI 12708 with
protein homologues: 2,4-dienoyl-CoA
reductase (dcr) (AAC76116) from E. coli, 2enoate reductase (CAA71086) from C.
tyrobutyricum, the baiCD gene product from
C. scindens (EF539210) and C. hiranonas
(AAF22846) and the baiH gene product from C.
hiranonis (EF539211) Secondary structural
elements based on the crystal structure of
DCR (182) are shown (below alignment).
Predicted secondary structural elements of
the BaiH protein are also shown (above
alignment). Arrows correspond to β-sheets
and loops to α helices. Residues
corresponding to FMN binding (■), FAD
binding (*), and cysteine residues involved
in a 4Fe-4S center (♦) from the crystal
structure of DCR are also shown. The
alignment was generated with the T-COFFEE
program (178) and sequence
similarities/identities highlighted with
Boxshade 3.1.
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12708baiH

12708H
TO931H
12708CD
TO931CD
enr
dcr

MDMKHSRLFSPLQIGSLTLSNRVGMAPMSMD-YEAADGTVPKRLADVFVRRAEGGTGYVMIDAVTIDSK----YPYMGNTTALDRDELVPQFKEFADRVKEAGSTLVPQIIH----PGPE
MDMKNSKLFSPLTIGSLTLNNRVGMAPMSMD-YEAADGTVPKRLADIFVRRAEGGTGYVTIDAVTIDSK----YKYMGNTTALDSDDLVTQFKEFATRVREAGSTLIPQVIH----PGPE
--MSYEALFSPFKVRGLELKNRIVLPGMNTK-MAKNKHDIGEDMIAYHVARAKAGCALNIFECVALCPAP-HAYMYMG----LYTDHHVEQLKKLTDAVHEAGGKMGIQLWH----GGFS
--MSYDALFSPFKIRGLELKNRIVLPGMNTK-MAKNKHDLSDDMIAYHVARAKAGCALNIFECVALCPAP-HAYMYMG----LYNDNHVAQLKKLTDAVHEVGGKMAVQLWH----GGFS
--MKNKSLFEPIKIGKVEVKNKISMAPMGAFGLVDNEGCYNQRAVDYYVERAKGGTGLIITSITKVENEIDKVVPGVIPIISINPGRFIMTSSEMTERVHAYGSKIFLQLTMGFGRSGAP
--MSYPSLFAPLDLGFTTLKNRVLMGSMHTG--LEEYPDGAERLAAFYAERARHGVALIVSGGIAPDLTG----VGMEGGAMLNDASQIPHHRTITEAVHQEGGKIALQILH-------T
■ ■

dcr

111
111
108
108
118
105

■

■

12708baiH

12708H
TO931H
12708CD
TO931CD
enr
dcr

SVCGYRHIAPLGPSANTNANCHVSRSISIDEIHDIIKQFGQAARRAEEAGCGAISLHCAHAYMLPGSFLSPLRNKRMDEYGGSLDNRARFVIEMIEEARRNVSPDFPIFLRIS------SICGYRHIAPLGPSVNTNANCHVSRAISVDEIHEIIKQFGQAARRVEEAGCGGIGLHCAHAYMLPGSFLSPLRNKRMDEYGGCLDNRARFVIEMIEEVRRNVSPDFPIMLRIS------PQMFFDETN----------TLETPDTLTVERIHEIVEEFGRGARMAVQAGFDAVEFHAAHSYLP-HEFLSPGMNKRTDEYGGSFENRCRFCYEVVQAIRSNIPDDMPFFMRADC-----PQMFFDKTN----------TLETPDTITVERIHEIVKEFGEGARRAVEAGFDAVEFHAAHSYLP-HEFLSPGMNKRTDEYGGNFENRCRFCFEVVEAIRANIPEDMPFFMRVDC-----GTLLTSQPVSASSVPNYWDPTVTCRELTTSEVEWIVAKFIQGAAIAQKAGFDGVEIHAVHEGYLLDQFTLSIFNRRTDKYGGDLRGRLQLPIEIVQGIKAQVGSDFPVGLRYSVKSCIKD
GRYSYQPHLVAPSALQAPINRFVPHELSHEEILQLIDNFARCAQLAREAGYDGVEVMGS-EGYLINEFLTLRTNQRSDQWGGDYRNRMRFAVEVVRAVRERVGNDFIIIYRLS-------

224
224
211
211
238
217

■
dcr

12708baiH

12708H
TO931H
12708CD
TO931CD
enr
dcr

-------GDERMIGGNSLEDMLYLAPKFVEAGVNMFEVSGG-TQYEGLEHIIPCQNKSRGVNVYEASEIKKVVGIPVYAVGKINDIRYAAEIVERGLVDGVAMGRPLLADPDLCKKAVEG
-------GDERMVGGNSLEDMLYLAPKFEAAGVSMLEVSGG-TQYEGLEHIIPSQNKSIGVNVHEASEIKKVVDVPVYAVGKINDIRYAAEIVERGLVDGVSIGRPLLADPDLCNKAKEN
-------IDELMEQTMTEEEIVTFINKCAELGVDVADLSRGNATSFATVYEVPPFNLAHGFNIENIYNIKKQINIPVMGVGRINTGEMANKVIEEGKFDLVGIGRAQLADPNWITKVREG
-------IDELMDEVMTEEEIVEFINRCADLGVDVADLSRGNAQSFATVYEVPPFNLQHGFNIENIYNIKKQIKIPVMGVGRINTGEMANQVIADGKFDLVGIGRAQLADQDWVAKVREG
WRQGGLPDEDYVEKGRDLEEGLESPQILEAAGYDELNTDVG--TYDAWYWSHPPLYQKDGLYLPYTQELEKVVKIPVIVAGKLGVPQEAEKALDEGGADMIGLARPLLSDAYWPKKVLSG
-------MLDLVEDGGTFAETVELAQAIEAAGATIINTGIG---WHEARIPTIATPVPRGAFSWVTRKLKGHVSLPLVTTNRINDPQVADDILSRGDADMVSMARPFLADAELLSKAQSG
■

336
336
324
324
356
327

■

dcr

12708baiH

12708H
TO931H
12708CD
TO931CD
enr
dcr

QFDEITPCASCGGSCISRSEAAPECH--CHINPRLGREYEFPDVPAEKSKKVLVIGAGPGGMMAAVTAAERGHDVTVWEADDKIGGQLNLAVVAPGKQEMTQWMVHLNYRAKKAGVKFEF
LFDEITPCASCGGSCISRTADRPQCR--CHINPRVGFEYDYPEVPAEKSKKVLVVGAGPGGMMAAVTAAERGHDVTLWEADTQIGGQINLAVVAPGKQEMTKWLSHLNYRAKKAGVKMVL
KEDLIRHCIGCDQGCYDAVINPKMKHITCTHNPGLCLEY-QGMPKTDAPKKVMIVGGGMAGMIAAEVLKTRGHNPVIFEASDKLAGQFRLAGVAPMKQDWADVAEWEAKEVERLGIEVRL
KEDLIRHCIGCDQGCYDAVINPQMTHITCTRNPHLCLEY-KGMPKTDEPKKVMIIGGGMAGILAAEVLKKRGHEPVIFEASDHLAGQFVLAGKAPMKEDWAAAAKWEAEEVARLGIEVRY
HPERIRPCIGCHVACLGRGFEGKPLS--CAVNPAAGRERYYEIRPAAIPKKVLIAGGGVAGMEAARMAVLRGHKVTLYESTDQLGGEIVPGSVPDFKIDDRRLLDWYRNEMKELKINVIF
RADEINTCIGCNQACLDQIFVGKVTS--CLVNPRACHETKMPILPAVQKKNLAVVGAGPAGLAFAINAAARGHQVTLFDAHSEIGGQFNIAKQIPGKEEFYETLRYYRRMIEVTGVTLKL
♦

dcr

♦

♦

♦

*

454
454
445
443
474
445

*

12708baiH

12708H
TO931H
12708CD
TO931CD
enr
dcr
dcr

NKEATAEDVKALAPEAVIVATGAKPLVPPIKGTQDYPVLTAHDFLRGKFVIPKGRVCVLGGGAVACETAETALENARPN--------------SYTRGYD----ASIGDIDVTLVEMLPQ
GKEATVENIKEFAPEAVIVATGARPLVPPIKGTQDYPVLTAHDFLRGKFVIPKGKVCVLGGGAVACETAETVLENARPN--------------AFTRGFD----ASIGDVDVTLVEMLPQ
NTEVTAETIKEFNPDNVIIAVGSTYALPEIPGIDSPSVYSQYQVLKG-EVNPTGRVAVIGCGLVGTEVAELLASRGAQV--------------IAIERKG----VGTGLSMLRRMFMNPE
NTKVTPELIEEFAPDHVVIAIGSDYVAPAIPGIDSDKVYTQYQVLKG-EVEPKGHVAVVGCGLVGTEVAQYLAARGAQV--------------TAIERKG----VGTGLSMLRRMFMNPE
NTEVTDKLVGKEQPDVVIVATGANDVKIKLPGMEKDKVSTAVDILNG-TKKSGKNVLIVGGGLVGCETALYLAKAGKKV--------------AIVEAKDKILDAGKPIPHMNKIMLEDL
NHTVTADQLQAF--DETILASGIVPRTPPIDGIDHPKVLSYLDVLRD-KAPVGNKVAIIGCGGIGFDTAMYLSQPGESTSQNIAGFCNEWGIDSSLQQAGGLSPQGMQIPRSPRQIVMLQ
*

12708baiH

12708H
TO931H
12708CD
TO931CD
enr
dcr
dcr

LLTGV----CAPNREPLIRKLK-SKGVHINVNTKIMEVTDHEVKVQRQDGTQEWLEGFDYVLFGLGSRNYDPLSETLKEFVPEVHVIG--DAVRARQASYAMWEGFEKAYSL
LLTGV----CAPNRTPLIRKLK-NKGVHINVNTKILEVTDHDVKVQRADGAEEWLKGFDYILFGLGSRNYDPISEQIKEFVPEVHVVG--DAKRARQASFAMWEAFEAAYSL
FKYYK----IAKMSGTNVTALEQGKVHYIMTDKKTKEVTQGVLECDAT-----------VICTGITARPSDGLKARCEELGIPVEVIG--DAAGARDCTIATREGYDAGMAI
FKYYK----INKMSGTNIVGIEPGKLHYIMTNKKTQEVTEGVLECDAA-----------VICTGITARPSEDLQEKCKELGVPFNVIG--DAAGARDARIATQEGYEVGMSI
IKKYN----IKVITGNSLLEVTDAGAVLIDSKFKQQEVSADTVVISIG------------------FKSNRKLYNKLHGKVTDLYLIG--DAYQAANIMDAIWSGNEIGLNC
RKASKPGQGLGKTTGWIHRTTLLSRGVKMIPGVSYQKIDDDGLHVVING--ETQVLAVDNVVICAGQEPNRALAQPLIDSGKTVHLIGGCDVAMELDARRAIAQGTRLALEI
*

*

669
661
639
639
667
672

556
556
544
544
579
564
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Purification of recombinant BaiH
Initially, the baiH gene was cloned into a pET24a (+)
vector with C-terminal hexa-histidine tag to make a BaiHHis recombinant.

The BaiH-His showed NADH:FOR activity in

crude extract prior to nickel affinity chromatography.
However, following nickel affinity chromatography, the
purified enzyme lost detectable NADH:FOR activity.
Problems with His-tag use has also been reported for the
YqjM protein from Bacillus subtilis; a baiH homologue
(186).

The quarternary structure of recombinant His-

tagged YqjM was reported to be altered by the His-tag
resulting in expression of an inactive enzyme.

This is

not the case with the baiH gene product as the enzyme
showed NADH:FOR activity in crude extract similar to
previously reported in recombinant BaiH lacking affinity
tag (129) before His-binding chromatography (data not
shown).

The BaiH is known to contain 1 mol copper per

subunit (129).

While the mechanism for this loss of

activity is not known, we speculate that the nitriloacetic
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acid, which chelates Ni2+, Cu2+, and Co2+, and in turn binds
the hexa-histidine tail, may have chelated copper from the
enzyme causing inactivation (187, 188).

Addition of

various concentrations of Cu2+ to the pure enzyme did not
restore activity. Therefore, we opted to clone the gene
into the pSport1 vector without an affinity tag.
SDS-PAGE analysis of the active fractions after CHT51 hydroxyapatite chromatography revealed a highly enriched
protein with a subunit molecular mass of 72 kDa that was
reactive against anti-BaiH antiserum (Figure 15).

The

specific activity and purification fold were dramatically
increased by Cibacron Blue 3GA and hydroxyapatite
chromatography (Table 5).

The baiH gene product was

purified 23–fold over the crude extract.

The final enzyme

preparation had a NADH:FOR specific activity of 16.4 U mg1

. NADH:FOR enzyme activity existed in bright yellow

fractions as observed previously (129).
Stereospecific NAD(H)-dependent 3-oxo-Δ4-cholenoic acid
oxidoreductase activity.
The hypothesis that the baiH gene product encodes an
NAD(H)-dependent 3-oxo-Δ4-cholenoic acid oxidoreductase was
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Figure 15.

SDS-PAGE and immunoblot analysis of baiH
gene product (NADH:FOR) overexpression and
purification
(a.) Proteins were separated
on a 10 % SDS-polyacrylamide gel and stained
with Coomassie Blue R-250. Lane 1, cell
free extract after IPTG induction (20 μg
loaded); Lane 2, flow-through from DEAE 40HR
(20 μg loaded); Lane 3, flow-through from
Cibacron Blue 3GA agarose (20 μg loaded);
lane 4, flow-through from Hydroxyapatite
CHT5-1 column (5 μg of purified enzyme
loaded). (b.) Immunoblot of SDS-PAGE using
anti-BaiH antiserum.
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tested by addition of substrates [24-14C] 3-dehydro-UDCA or
[24-14C] 3-dehydro-CDCA with NAD+ and purified BaiH.

A

single reaction product of more hydrophilic character was
detected by autoradiography following TLC when [24-14C] 3dehydro-UDCA and NAD+ were substrates (Figure 16).
Previous studies have shown the specificity of this enzyme
for NAD(H) (129) and the BaiH did not show 3-oxo-Δ4cholenoic acid oxidoreductase activity with NADP(H) (data
not shown). The bile acid metabolite generated following
BaiH catalyzed reaction with NAD+ was scraped from TLC
plates, pooled, further purified by ion exchange
chromatography and identified by electrospray mass
spectrometry (Figure 17). The deprotonated molecular ion
given by the product was 2 Da lighter than that given by
the 3-dehydro-CDCA substrate, consistent with a loss of 2
hydrogens from the substrate and potentially indicating a
3-dehydro-Δ4-CDCA structure.

Previous observations showed

loss of the 5β hydrogen during incubation of [5β-3H] [2414

C] CA to CA induced whole cells and cell extracts of C.

scindens VPI 12708 (118).

Taken together, these

observations strongly suggest the formation of a 3dehydro-Δ4-UDCA structure.
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Figure 16.

TLC autoradiograph of BaiCD and BaiH
catalyzed NAD(H)-dependent 3-oxo-Δ4-cholenoic
acid oxidoreductase activity assays. The
reactions were carried out in a 500 μl
volume consisting of 50 mM sodium phosphate
buffer (pH 6.8) containing 225 μM of each
respective substrate with a specific
activity of 0.01 μCi μmole-1. A: [24-14C] 3dehydro-CDCA standard, B: [24-14C] 3-dehydroUDCA, C: [24-14C] 3-dehydro-CDCA + 100 μg
cell-free extract of E. coli (plasmid, no
insert) D: [24-14C] 3-dehydro-CDCA + 1.6 U
purified BaiH, E: [24-14C] 3-dehydro-CDCA +
100 μg E.coli BL21(DE3) expressing baiCD. F:
[24-14C] 3-dehydro-UDCA + 100 μg E. coli
BL21(DE3) (plasmid, no insert), G: [24-14C]
3-dehydro-UDCA + 100 μg cell-free extract
ofE.coli BL21(DE3) expressing baiCD, H:
[24-14C] 3-dehydro-UDCA + 1.6 U purified
BaiH. All reactions were performed with 1.5
mM NAD+ as co-substrate.

UDCA

3-dehydro-UDCA

3-dehydro-CDCA

A

B

C

D

E

F

G

H

I

3-dehydro-4-UDCA

3-dehydro-4-CDCA

3-dehydro-UDCA

3-dehydro-CDCA
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Figure 17.

HPLC and mass spectrometry analysis of BaiH
catalyzed bile acid reaction products. The
bile acid metabolites produced by purified
baiH gene protein were separated by TLC,
scraped and further purified by reversephase HPLC-ESI-MS. The initial mobile phase
was 10 mM NH4OAc; after injection bound
materials were eluted by a 0-100 % linear
gradient of acetonitrile in 10 mM NH4AOc at
10 % min-1. The eluate was passed into the
electrospray interface operating in the
negative ion mode. Ions eluting from m/z
350-700 were recorded and analyzed. The
upper trace is a selected ion chromatogram
for m/z 389. The mass spectra for the peak
at 11.52 min were summed and presented in
the bottom trace. The m/z 389.2 ion
corresponds to the expected [24-14C] 3dehydro-4-UDCA product.
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In addition, the baiCD gene was overexpressed in E.
coli BL21 (DE3) and tested for 3-oxo-Δ4-cholenoic acid
oxidoreductase activity.

The baiCD gene product was

detected by SDS-PAGE at the expected molecular mass of 70
kDa (Figure 18).

Addition of baiCD overexpressed E. coli

cell extract to reaction mixture containing 1.5 mM NAD+
resulted in a product of greater hydrophilicity than the
starting substrate [24-14C] 3-dehydro-CDCA (Figure 16).
This reaction product was not obtained using cell-extract
of E. coli BL21(DE3) containing pSport1 vector without
baiCD gene insert.

BaiCD did not recognize the substrate

[24-14C] 3-dehydro-UDCA. The product derived from reaction
with [24-14C] 3-dehydro-CDCA was scraped from TLC plates,
pooled and subjected to mass-spectrometry (Figure 19).
The major mass ion was 2 amu less than the 3-dehydro-CDCA
substrate and thus consistent with the loss of 2 hydrogens
from the substrate bile acid and potentially a 3-dehydroΔ4-CDCA structure.

Figure 20 illustrates the reactions

catalyzed by the baiCD and baiH gene products.

119

Figure 18.

SDS-PAGE of cell-extract of recombinant E.
coli BL21(DE3) overexpressing baiCD gene.
(M) Marker (UI) uninduced, (I) induced 1 mM
IPTG. 30 μg protein loaded and gel stained
with Coomassie brilliant blue R-250. A
large band at ~ 70 kDa was detected in IPTG
induced cell-extracts indicating
overexpression of baiCD gene.
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Figure 19.

HPLC and mass spectrometry analysis of BaiCD
catalyzed bile acid reaction products. The
bile acid metabolites produced by cellextract of E. coli overexpressing baiCD gene
were separated by TLC, scraped and further
purified by reverse-phase HPLC-ESI-MS. The
initial mobile phase was 10 mM NH4OAc; after
injection bound materials were eluted by a
0-100 % linear gradient of acetonitrile in
10 mM NH4AOc at 10 % min-1. The eluate was
passed into the electrospray interface
operating in the negative ion mode. Ions
eluting from m/z 350-700 were recorded and
analyzed. The upper trace is a selected ion
chromatogram for m/z 389.
The mass spectra
for the peak at 11. 59 min were summed and
presented in the bottom trace. The m/z
389.3 ion corresponds to the expected [2414
C] 3-dehydro-4-CDCA product.
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Figure 20.

Proposed reactions catalyzed by the baiCD
and baiH gene product. R group may be the
carboxylic acid or the coenzyme A conjugate.
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Isolation of bai genes from Clostridium hylemonae
TN271
Identification and Characterization of the baiBCDEFHGI
operon

Apart from basic biochemical characteristics and 16s
rDNA sequence, little is known about C. hylemonae.
Previously, our laboratory performed activity assays on
cultured 7α-dehydroxylating bacteria and found that these
organisms clustered into two groups based on relative rate
of conversion of [24-14C] CA to [24-14C] DCA (189).

Much

effort has been focused on the “high activity strains” C.
scindens and C. hiranonas, however, organisms such as C.
hylemonae, described as a “low activity strain” has
received little characterization (See Intro). Recent data
indicates that C. hylemonae may play a significant role in
bile acid metabolism in the human colon based on in vivo
studies where this species was found to be a numerically
predominant 7α-dehydroxylating bacterium (190).
Therefore, characterization of the bile acid 7dehydroxylating pathway in this organism is important.
Genes involved in the bile acid 7α-dehydroxylating pathway
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have yet to be isolated and sequenced from any “low
activity strain”.

We were thus interested in elucidating

the gene organization, gene and promoter sequence, as well
as upstream regulatory genes and comparing these elements
to “high activity strains” to see whether there are
obvious differences that might underly the ten fold
differences in relative rate of bile acid 7αdehydroxylation (189).
Wells and Hylemon (2000) designed redundant PCR
primers targeting the baiCD gene which are aimed at
detecting 7α-dehydroxylating bacteria in the human colon
(59).

Wells and Hylemon (2000) reported detection of the

baiCD gene of C. hylemonae TN271 using these
oligonucleotides.

Therefore, these primers were used to

amplify a 1.2 kB segment of the baiCD gene from C.
hylemonae which was subsequently cloned into a pCR8 GW
TOPO TA vector and sequenced (Figure 21).

BLAST analysis

of the sequence data and CLUSTALW alignment of the
nucleotide and translated amino acid sequence verified the
identity of a baiCD gene in C. hylemonae.

We hypothesized

that the bai genes involved in the oxidative arm of the
bile acid 7α-dehydroxylation pathway (baiA – baiI) would
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Figure 21.

Region of partial baiCD gene from C.
hylemonae TN271 used to design upstream and
downstream genome-walking PCR primers.
Sequence represents sense-strand of baiCD
gene, arrows denote direction of
amplification and grey font represents
regions of primer design.
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WalkUP1Nest
GAAGGCCGGGAGGAACTTATACGCCACTGCATTGGCTGCGACCAGGGCTGTTATGACGCAGTCATCGATCCAAAGATGAAACACATCACATGTACCCGTAATCCG

105

WalkUP1
ATGCTCTGTCTGGAGTATAAAGGACTTCCGAAGACTGCCGCGCCCGAGAAAGTTATGATCGCAGGCGGCGGGATGGCCGGGCTCTTTGCGGCGGAAGTGCTGAAG

210

AAAAGAGGACATGAGCCGGTCATCTTTGAAGCGTCCGACAGGCTTGCAGGCCAGTTTACGCTTGCCGGTGTGTCACCGATGAAGCAGGACTGGGCGGCGGCTGCA

315

AAGTGGGAGGCAGAAGAGATCGGACGGCTTGGGATCGAGTTTCATCTGAATACGCCCGTGACGCCAAAGCTGATCGAACAATTTGCCCCAGACCGTGTCATCATC

420

WalkDS1
WalkDS1Nest
GCAACAGGATCCGAATATACAGCTCCCGCTATACCGGGGATAGACGGCCCGAATGTGTATACCCAGTATGAGGTGCTAAGAGGAGAAGCCTCCCCTGCCGGTCAT

525

GTGGCAGTTATCGGATGCGGGCTGGTAGGAGCGGAGGTTGCGGAGCTGCTTGCATCCAGGGGAGCGCAGGTCACTGCCCTGGAGAAAAAGGGGGTCGG

623
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be located on a polycistronic operon flanking the baiCD
gene.

Therefore, a bidirectional genome-walking by PCR

strategy was used to isolate the remaining bai genes.
A slight modification of the method of Ridlon et al.
(2005) was utilized to prepare genomic DNA (>50 kb) from
both C. scindens VPI 12708 and C. hylemonae TN271 for
genome-walking by PCR (see Materials and Methods) (Figure
22) (177).

Restriction libraries derived from this DNA

sample yielded PCR products averaging 2 kB with a range of
0.7 kb to 4 kb.

The limit of this technique, according to

the manufacturer (Clontech GenomeWalker Universal Kit) is
around 6 kB. Upstream genome-walking PCR using primer
WALKUP1 and subsequent nested amplification using primer
WALKUP1Nest resulted in 2,139 bp of sequence data which
overlapped the baiCD gene data by 673 bp resulting in a
2,690 bp contig (Figure 23). Analysis of this data
revealed the 5’ end of the baiCD gene.

A second open

reading frame (ORF) was detected 19 bp upstream of the
baiCD gene.

BLAST results suggest this ORF encodes an

AMP-dependent coenzyme A ligase with highest identity to
the baiB gene from C. hiranonis.

Continued upstream

genome-walking resulted in a PCR product of 1,964 bp
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Figure 22.

Preparation of genomic DNA for genomewalking
by
PCR
restriction
libraries.
Representative
0.4%
agarose/EtBr
gel
showing 1, 2, and 3 μg genomic DNA from C.
scindens VPI 12708.
Size comparisons made
with Invitrogen’s High Molecular Weight DNA
ladder.
Electrophoresis was performed at
25 volts for 18 hours.
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M 1 2 3

43 kb
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Figure 23.

Genome-walking by PCR Upstream of partial
baiCD gene in Clostridium hylemonae TN271.
PCR products amplified using WALKUP1 and
WALKUP1NEST PCR primers (Table 6).
“M” is
marker “D”, “E”, “P”, “S” and “EN” represent
genome-walking restriction library templates
digested with DraI, EcoRV, PvuII. and StuI,
respectively.
“EN” represents nested PCR
amplification of EcoRV primary PCR product
diluted 1:50.
The PCR product generated
from nested amplification was purified by
GENECLEAN and ligated into a pCR8 GW TA TOPO
cloning vector (2.8 kb) to yield vector
p271CDUP1 (4.9 kb).
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a.
M
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(Figure 24).

Assembly of this data resulted in a 4,586 bp

contig containing the complete baiB gene.

The 1.5 kb baiB

gene is predicted to encode a 57.7 kDa polypeptide similar
in size to the reported 58 kDa subunit recombinant BaiB
polypeptide from C. scindens VPI 12708 (125).

Two

additional interesting features were identified within
this sequence data.

First, a conserved bile acid

inducible promoter was located on the sense strand 49 bp
upstream of the baiB gene (Figure 25) (59, 191).

SMART-

RACE PCR analysis of the cDNA from a CA induced culture of
C. hylemonae led to the identification of the mRNA start
site which appears in a short purine rich stretch
corresponding to the ribosome binding site (Figure 26).
Interestingly, the distance between the mRNA start site in
the baiB polycistronic operon in C. hylemonae is only 11
bp from the initiation codon while in the “high activity
strains” there is a distance of 108 bp in C. hiranonis
(59) and 68 bp in C. scindens (191).

As proof of

principle, SMART RACE PCR was also performed on the baiB
gene of C. scindens VPI 12708, whose mRNA initiation site
was previously determined by primer extension (191).

The

results obtained in the present study agree with those of
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Figure 24.

Second upstream genome-walking by PCR from
partial baiCD gene in Clostridium hylemonae
TN271. a.) PCR products amplified using
WALKUP2 and WALKUP2NEST PCR primers (Table
6). Nested PCR product (DN=DraI template,
nested primer amplification product)
purified from 1% agarose gel by GENECLEAN
Spin Kit and ligated into pCR8 GW TOPO TA
cloning vector to make vector p271CDUP2
(b.).
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Figure 25.

Boxshade of CLUSTALW alignment of bai
promoters upstream of baiB gene between C.
hylemonae TN271, C. scindens VPI 12708 and
C. hiranonis sp. strain TO931. Putative 10 element is indicated below alignment.
Transcription initiation sites (TIS)
highlighted in yellow (See Fig 26 for TIS
data for C. hylemonae).
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Figure 26.

SMART RACE PCR analysis to determine TIS for
the baiB transcript in Clostridium hylemonae
TN271. (a.) RT-PCR analysis of C. hylemonae
TN271 cDNA generated from CA induced (I) and
uninduced (UI) cultures. Primers against
baiB gene (above) and gyrA gene (below) were
used to determine whether baiB transcript
was expressed. Below RT-PCR is the
corresponding [24-14C] CA activity assay
performed prior to RNA isolation of I and UI
cultures of C. hylemonae. [24-14C] DCA is
detected only in CA induced (50 μM) culture.
(b.) 5’ SMART RACE PCR of baiB transcript
using RACEB325 oligonucleotide against cDNA
from induced culture of C. hylemonae TN271.
PCR product was purified by GENECLEAN Spin
Kit and cloned into a pCR8 GW TOPO TA
cloning vector and sequenced. (c.) TIS for
baiB transcript (underlined; direction of
transcription designated by arrow). “*”
designates conserved bai promoter elements
(See Figure 25), putative ribosome binding
site in bold, “†” designates mRNA start site
determined for baiB in C. scindens, “‡”
designates mRNA start site for baiB in C.
hiranonis sp. strain TO931, italics
indicates anticodons with corresponding
amino acids (below).
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ATATTATCCAATGTCATAGAGTATGTAAGTGTTAAAGTTATATCAAAGGAGGGCGAAATATGGACTTG
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Mallonee et al. (1990) providing proof of principle and
additional evidence for the TIS of the baiB operon in C.
scindens VPI 12708 (Figure 27) (191).
The second notable feature is a conserved 47 kDa
AraC/XylS transcription factor located on the anti-sense
strand upstream of the bai promoter. Figure 28 illustrates
the conserved helix-turn-helix motifs identified in the
amino acid sequence of the “bile acid regulatory A” gene
(barA).

Additional genome-walking upstream of the barA

did not result in ORFs predicted to be involved in bile
acid metabolism.
Downstream genome-walking from the baiCD fragment
yielded a PCR product of 1,131 bp which increased contig
length to 5,625 bp (Figure 29).

This stretch of sequence

resulted in completion of the 1.9 kb baiCD gene predicted
to encode a 70 kDa polypeptide.

In the first section,

overexpression of the recombinant baiCD gene from C.
scindens VPI 12708 in E. coli resulted in a 70 kDa
polypeptide as estimated by SDS-PAGE (Figure 18). In
addition, 46 bp downstream of the baiCD gene we located a
510 bp ORF predicted to encode the 19.8 kDa bile acid 7αdehydratase (baiE gene).

Dawson et al (1996) reported
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Figure 27.

Determination of transcription initiation
site for baiB gene from Clostridium scindens
VPI 12708 based on SMART RACE PCR analysis.
Alignment shows determination of
transcription initiation site (TIS) (arrow,
underline) based on alignment of SMART RACE
sequence data (SR7, SR8) with baiB gene and
upstream region from Clostridium scindens
VPI 12708 (12708baiB). TIS is determined
based on the first base following 3’ end of
SMART II A oligo sequence (boxed region)
(5’-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3’).
This nucleotide (underlined, arrow) must
also correspond to the known sequence of the
upstream region of the gene. The TIS
determined through SMART RACE analysis
agreed with primer extension analysis
performed by Mallonee et al (1990) (191).
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Figure 28:

ClustalW alignment of bile acid regulatory A
gene (barA) between C. hylemonae TN271, C.
scindens VPI 12708 and C. hiranonis sp.
strain TO931. Regions highlighted in red
are predicted helix-turn-helix motifs shared
between members of the Arac/XylS family of
transcription factors.
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12708barA
TO931barA
TN271barA

M-PNTIKSKPICGSPVHS------------------VFTGKDKYLRLQKHTISDITPPIC 41
M-KEIPKSKSICGRPVHS------------------VYVDKDKYLRMQTYHINDITPPTS 41
MISNNPTSVSKIDLKKEKTDERSYKIQIDLRQASPFFFSGRDKYLRLQKHCISDITPPIS 60
: : .* . .
..
.: .:*****:*.: *.***** .

12708barA
TO931barA
TN271barA

ENESLFILVNSGCGTITINGVEFPFEQSTFVWLQSYHTFTIKADSDDPLELSICVYDYPL 101
ENESLFVLVKQGYGSIIINGVEFKLKVGAFLWLQSYHTFTIKCESDEPLELKICVYDYPL 101
ENESIFVFVTGGSGAITINGVSFPLKRGSFIWLQSYHTFTIRAGSVQPLLMSVCVYDYPL 120
****:*::*. * *:* ****.* :: .:*:**********:. * :** :.:*******

12708barA
TO931barA
TN271barA

SSFLALREPSPDTVDAIMVALPVIRLEGVYQQKIRDLFDEFEKEDSCFDPGSSLIKVSIL 161
SSFLTFREPTPTTIDAIMDATPVVYLEGKFLERVYDLFDDFEEFDDFYDPGSSLIKVSIL 161
SSFLTFHEPEPGTVDAIIDAPPVISLDGARLDKIEALFHEFEEEDSCFDPGSALIKVAVL 180
****:::** * *:***: * **: *:*
::: **.:**: *. :****:****::*

12708barA
TO931barA
TN271barA

GQFAYFFIKHGIHQSQKDQDKDWPLGWQATLYIGSHFAEDITAESVAERFSTNASTLNRE 221
GELSKIFIDHSMRVFAKEEPSPKPLGWNAILYISEYFGKDLTAEKVAKIFDSNATTLNRE 221
GQFANFFIHHSIKQHRPETNCERPLGWKAVLYISAHFAEDLTSQSVAAHFGSAAAVLNRE 240
*::: :**.*.::
:
****:* ***. :*.:*:*::.** *.: *:.****

12708barA
TO931barA
TN271barA

LRNISGYNFAHTLNRVRVNIASGALLYEDMSLSYVAEHSGFSSEVAFYRIFKKYTGTTPL 281
LRNISGYNFIQTLNRVRVNIAASALLYEDMSLSYIATHSGFSSEVVFYRIFKQYVGVTPV 281
LRLISGYSFSQFLNRVRVNIASVALLYDGMSLSYVAAHSGFTSEVAFYRIFKKYMGTTPI 300
** ****.* : *********: ****:.*****:* ****:***.******:* *.**:

12708barA
TO931barA
TN271barA

EYRKQMLESGE-KVYRGMIMSQMLMDVLNHSYASFSSPIDIKDTSKSLYLSESVIRELVQ 340
EYRKQIINHNEDKVYRGMIMSTSLMQILNHAYDNFSSSVDLKDASKSLFLSESTIRNIIF 341
EYRNQLLNDGS-GVYRGMIMSTTLMEVLNHTYSSFSEPVDIKEASKRLYISESVIRDLVY 359
***:*::: .. ******** **::***:* .**..:*:*::** *::***.**:::

12708barA
TO931barA
TN271barA

EKFGASYKDITVLTRLRHAAALLLTTNLPVLDVAVNVGFNCSRSFSRAFNKLYKMTPGEY 400
DRFGTNYKYIIFFNRIRHSEALLLTTDLPILDIAINVGFNCSRSFSRAFNKFHNMTPSEY 401
ETFRSHYKDLAVLTRIRHAEALLLTTDLPIVDIAVNVGFNCSRSFTRTFT-----SPGRR 414
: * : ** : .:.*:**: ******:**::*:*:**********:*:*.
:*..

12708barA
TO931barA
TN271barA

RSLYRGGENQ- 410
RNKYRGVNRDE 412
PRVP------- 418
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Figure 29.

Downstream genome-walk (DS1) from baiCD gene
from Clostridium hylemonae TN271.
a.)
Agarose gel of DS1 products using Dra1 (D),
EcoRV (E), PvuII (P), StuI (S) restriction
libraries of C. hylemonae TN271 genomic DNA
as template with adaptor primer AP1 and
gene-specific primer WALKDS-1 (See Table 6).
b.) “DN” and “EN” represent nested PCR
amplification using nested adaptor primer
AP2 and gene-specific primer WALKDSNEST1
(See
Table
6).
C.)
Schematic
representation of TA cloning of GENECLEAN
purified
“DN”
product
(arrow)
into
pCR8/GW/TOPO TA vector (2.8 kb) yielding 3.9
kb vector p271DNCDDS1.
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overexpression of the 19 kDa baiE gene from C. scindens
VPI 12708 (128).

Multiple sequence alignment of this ORF

with the baiE genes from C. scindens VPI 12708 and C.
hiranonis sp. strain TO931 revealed >80% amino acid
sequence identity and conservation of active site amino
acids predicted through computer modeling and sitedirected mutagenesis data (Figure 30) (Hylemon et al
unpublished data).

Continued downstream GW-PCR resulted

in a 3,856 bp PCR product which when added to the previous
alignment results in a contig of 9,291 bp (Figure 31).

An

ORF was located 25 bp downstream of the baiE gene 1,275 bp
in length predicted to encode a 47 kDa polypeptide in the
Type III CoA transferase family of proteins.

BLAST

analysis suggests this gene encodes the baiF gene product.
Ye et al (1999) previously determined the Mr of the
recombinant baiF from C. scindens VPI 12708 to be 47.5 kDa
(130). A second ORF, 1.4 kb in length, was located 53 bp
downstream of the baiF gene whose deduced amino acid
sequence suggests this gene encodes a 49.5 kDa AraJ-like
efflux permease.

BLAST analysis suggests this ORF encodes

the baiG gene product. Mallonee et al (1996) overexpressed
the 50 kDa baiG gene product in E. coli and showed that it
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Figure 30.

Boxshade of CLUSTALW alignment of 7αdehydratase gene (baiE) between C. hylemonae
TN271, C. scindens VPI 12708, and C.
hiranonis sp. strain TO931. Asterisks
denote conserved active site amino acids
predicted by computer modeling and sitedirected mutagenesis (Hylemon et al.
unpublished data).
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Figure 31.

Second downstream genome-walk (DS2) from
baiCD gene from Clostridium hylemonae TN271.
a.) Agarose gel of DS2 products using Dra1
(D), EcoRV (E), PvuII (P), StuI (S)
restriction libraries of C. hylemonae TN271
genomic DNA as template with adaptor primer
AP1 and gene-specific primer WALKDS-2 (See
Table 6). b.) “EN” and “PN” represent
nested PCR amplification using nested
adaptor primer AP2 and gene-specific primer
WALKDSNEST2 (See Table 6).
C.) Schematic
representation of TA cloning of GENECLEAN
purified “PN” product (arrow) into
pCR8/GW/TOPO TA vector (2.8 kb) yielding 6.6
kb vector p271PNCDDS2.
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is involved in transporting primary bile acids across the
bacterial membrane (126).

Further analysis revealed a

partial ORF 19 bp downstream of the baiG gene encoding an
“Old Yellow Enzyme” like FMN oxidoreductase with the baiH
gene from C. hiranonis sharing the highest amino acid
identity.

The third downstream GW-PCR resulted in

completion of the bai oxidative operon (Figure 32).

The

2,019 bp baiH gene was completed and the deduced amino
acid sequence suggested this gene encodes a 71.7 kDa
polypeptide. The baiH gene from C. scindens VPI 12708 has
been shown to encode a 72 kDa polypeptide (Figure 5)(121,
129).

Finally, the 549 bp baiI gene was located 38 bp

downstream of the baiH gene and predicted to encode a 21.8
kDa polypeptide.

The complete bai oxidative operon from

C. hylemonae is represented schematically in Figure 33 and
compared to the gene organization in C. scindens and C.
hiranonis.

Table 6 lists oligonucleotides used in

isolation and sequencing of the baiBCDEFGHI operon in C.
hylemonae.

Table 7 compares amino acid sequence

identity/similarity between C. hylemonae and C. scindens.
Clearly, there is a high degree of conservation both
between the genes and several of the intergenic regions;
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Figure 32.

Third downstream genome-walk (DS3) from the
baiCD gene of Clostridium hylemonae TN271.
a.) Agarose gel of DS3 products using Dra1
(D), EcoRV (E), PvuII (P), StuI (S)
restriction libraries of C. hylemonae TN271
genomic DNA as template with adaptor primer
AP1 and gene-specific primer WALKDS-2 (See
Table 6). b.) “DN” represents nested PCR
amplification using nested adaptor primer
AP2 and gene-specific primer WALKDSNEST2
(See Table 6).
C.) Schematic
representation of TA cloning of GENECLEAN
purified “DN” product (arrow) into
pCR8/GW/TOPO TA vector (2.8 kb) yielding 5.9
kb vector p271DNCDDS3.
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Figure 33.

Schematic representation and comparison
of the bai oxidative operons of C.
hylemonae TN721 and C. scindens VPI
12708. See Table 7 for comparison of
amino acid sequence identity and other
parameters. Notice the high degree of
conservation in gene organization, with
the exception of the baiA gene, present
in both C. scindens and C. hiranonis
though conspicuously missing from the bai
oxidative operon of C. hylemonae TN271.
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not surprising given the close phylogenetic relation
between these species as determined by neighbor-joining of
16s rDNA sequences of 7α-dehydroxylating bacteria and
other gut microbes (106).

One of the most striking

observations is the fact that the baiA gene is not found
within this operon in C.hylemonae as it is in C. scindens
and C. hiranonis. We predict that the baiA gene will be
found as a single cistron with a bai promoter region as
observed in C. scindens with the baiA1 and baiA3 genes
(67).

Taken together, these data indicate that genes

located on the 9.5 kb bai oxidative operon of the “low
activity strain” C. hylemonae TN271 are highly conserved
both in organization as well as amino acid sequence with
the homologous bai polycistronic operons identified in the
“high activity” species C. scindens and C. hiranonis with
the exception of the baiA gene.
The ability of C. hylemonae TN271 to 7β-dehydroxylate
UDCA has not been reported in the literature.

Therefore,

C. hylemonae and C. scindens were induced with 50 μM CA
for 2 hrs and tested for the ability to 7α-dehydroxylate
[24-14C] CA and [24-14C] CDCA as well as 7β-dehydroxylate
[24-14C] UDCA for 30 minutes (Figure 34) at 37˚C as well as
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Figure 34.

Autoradiographs of TLC of 7α-dehydroxylation
and 7β-dehydroxylation activity assay
reaction products. (a.) C. scindens VPI
12708 induced with 50 μM CA during mid-log
phase in BHI. 1 ml culture inoculated in 1
ml activity assay consisting of BHI
containing 0.1 μCi/2 μmole bile acid
incubated 37˚C for 30 min. Lane 1: [24-14C]
CA activity assay of CA induced culture of
C. scindens. Lane 2: [24-14C] CA activity
assay of uninduced culture of C. scindens.
Lane 3:[24-14C] UDCA activity assay of CA
induced culture of C. scindens. Lane 4:
[24-14C] UDCA activity assay of uninduced
culture of C. scindens. Lane 5:[24-14C]
chenodeoxycholic activity assay of uninduced
activity assay. Lane 6 represents [24-14C]
CDCA activity assay of cholic acid induced
culture of C. scindens. The same order
applies in (b.) for cultures of C.
hylemonae. Arrows depict positions of nonradiolabelled bile acid standards. Induced
cultures of C. scindens and C. hylemonae
were able to 7α-dehydroxylate both CA and
CDCA (lanes 1 and 6) while only C. scindens
was able to 7β-dehydroxylate UDCA (lane 3).
Uninduced cultures showed no activity
against bile acid substrates. Solvent
system was S1 according to Eneroth (172).

162

1
LCA

a.

DCA
CDCA
UDCA
CA

LCA

b.
DCA
CDCA
UDCA

CA

2

3

4

5

6

163

overnight incubation (Data not shown).

Both C. scindens

and C. hylemonae were able to 7α-dehydroxylate both CA and
CDCA resulting in [24-14C] DCA and [24-14C] LCA,
respectively.

However, while C. scindens was able to 7β-

dehydroxylate UDCA, we were unable to detect 7βdehydroxylation activity by C. hylemonae despite sequence
data that indicated the presence of genes encoding enzymes
suggested to be involved in 7β-dehydroxylation.

It is

currently unclear why this activity is not present.

Isolation and characterization of a baiA gene in
Clostridium hylemonae TN271

The 27 kDa baiA gene product from C. scindens VPI
12708 catalyzes the first oxidative step in the bile acid
7α-dehydroxylating pathway following ATP-dependent CoA
ligation (125).

As noted in the previous section, and

illustrated in Figure 33, the baiA gene was not found in
the oxidative polycistronic bai operon in C. hylemonae.
Therefore, redundant primers were designed based on a
multiple sequence alignment of baiA genes from C. scindens
and C. hiranonis (Figure 35).

A PCR product of 722 bp was
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Figure 35.

Design of degenerate PCR oligonucleotides
for isolation of the baiA gene in C.
hylemonae TN271.
Clustal alignment of
baiA1, baiA2 and baiA3 genes from C.
scindens VPI 12708 and the baiA gene from
C. hiranonis sp. strain TO931.
Arrows
indicate direction of PCR primers, the
sequence of sense and antisense primer is
shown below alignment.
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baiA1
baiA3
baiA2
baiATO931

ATGAAACTTGTACAGGACAAAATTACAATTATCACAGGCGGAACCCGTGGAATCGGATTC
ATGAAACTTGTACAGGACAAAATTACAATTATCACAGGCGGAACCCGTGGAATCGGATTC
ATGAATCTCGTACAAGACAAAGTTACGATCATCACAGGCGGCACAAGAGGTATTGGATTC
ATGAACTTAGTACAGGACAAAATAGTTATAATAACAGGTGGAACAAGTGGTATAGGTCTT
***** * ***** ****** *
** ** ***** ** ** * ** ** ** *

60
60
60
60

baiA1
baiA3
baiA2
baiATO931

GCAGCAGCAAAACTCTTTATTGAGAATGGAGCAAAAGTCTCCATATTTGGCGAGACCCAG
GCAGCAGCAAAACTCTTTATTGAGAATGGAGCAAAAGTCTCCATATTTGGCGAGACCCAG
GCCGCTGCCAAAATATTTATCGACAATGGCGCAAAAGTATCCATCTTCGGAGAGACGCAG
TGCGCAGCAAAAATATTCATGGATAACGGTGCAACAGTTTCTATATTCGGAAAAACTCAG
** ** *** * ** ** ** ** ** **** *** ** ** ** ** * ** ***

120
120
120
120

baiA1
baiA3
baiA2
baiATO931

GATCGCGAATGTATATCTGTTCCTTGCATCCGACCTGGCTAGCGGCATCACGGCTACGAC
GATCGCGAATGTATATCTGTTCCTTGCATCCGACCTGGCTAGCGGCATCACGGCTACGAC
GATCGCTAATGTATACCTGTTCCTGGCATCTGACTTGGCAAGCGGCATTACGGCTACTAC
AATAGCTAACACTTACTTATTCTTAGCTTCTGACTTAGCTAGTGGTATAACAGCTACAAC
** ** **
** * *** * ** ** *** * ** ** ** ** ** ***** **

719
719
719
719

baiA1
baiA3
baiA2
baiATO931

GATCAGCGTAGATGGGGCTTACAGGCCATAG--GATCAGCGTAGATGGGGCTTACAGGCCATAG--GGTCAGCGTAGACGGGGCTTACAGACCATAA--TGTAAGCGTTGACGGTGCTTATAGACCATCATAA
* ***** ** ** ***** ** ****

750
750
750
753

baiA271F: 5’-CAG GYG GMA CMM GWG GWA THG G-3’
baiA271R: 5’-GGR CTR TAA GCM CCR TCW TCG C-3’
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obtained, sequenced and predicted to encode the baiA gene
by BLAST search (Figure 36).

The complete 789 bp gene

encoding a predicted 27.9 kDa protein was obtained
following bidirectional genome-walking from the initial
sequence data (Figure 37).

Sequence analysis upstream of

the baiA gene revealed a conserved bai promoter and RBS
(Figure 37).

Regions identified as highly conserved

within bai promoters showed 100% identity between the
upstream baiB promoter and that of the baiA promoter.

5’

SMART RACE analysis suggests the mRNA initiation site is
56 bp upstream of the baiA gene (Figure 37).

Figure 38

displays an alignment of the baiA gene from C. hylemonae
with baiA genes from C. scindens and C. hiranonis.

Identification and characterization of novel genes
suggested to be involved in bile acid metabolism
in Clostridium hylemonae and Clostridium scindens

The 3.3 kb contig containing the baiA and upstream
bai promoter was further analyzed for additional ORF
potentially involved in the reductive arm of the bile acid
7α/β-dehydroxylation pathway (Figure 39; Figure 40) (Table
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Figure 36.

Isolation of partial baiA gene from C.
hylemonae TN271 using degenerate PCR
oligonucleotides designed from conserved
regions of C. scindens and C. hiranonis baiA
genes. Arrow indicates PCR product
corresponding to partial baiA gene as shown
in nucleotide sequence alignment. PCR
product was cloned into a pCR8 GW TOPO TA
cloning vector resulting in vector p271OXA.
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1000 bp
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3.52 kb
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Figure 37.

Isolation of baiA gene from C. hylemonae
TN271 and characterization of upstream
promoter elements. (a.) Schematic
representation of sequence alignment and
location of baiA gene relative to PCR
product alignment. (b.) CLUSTALW alignment
of C. hylemonae TN271 oxidative baiB
promoter (TN271Oprom) with baiA promoter
(TN271Aprom). Boxed regions correspond to
conserved bai promoter elements. (c.)
Results of 5’ SMART RACE PCR analysis of
baiA cDNA from CA induced culture (See
Figure 20). mRNA initiation site (bold,
underlined) indicated by arrow which points
in direction of transcription. Italicized
letters indicate 5’ end of baiA gene with
corresponding amino acids (below).

c.

b.

a.
baiA1

TATCCAATGTCATAGAGTATGTAAGTGTTAAAGTTATATCAA 42
TATCCAATGTCATAACGTAC-TAAGTGTTAAAGTTATATCAA 41
************** *** *********************

P

WalkDNA1

RBS
ATGTCATAACGTACTAAGTGTTAAAGTTATATCAACGGGAATTAAAGTTTTAGCACATATAAGCAAAGCTAAACGCAGGAAAAGGAAGGAAATTCATGAAA
*******
*******
*********
M K

TN271Oprom
TN271Aprom

WalkUPA1

baiA271
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Figure 38.

CLUSTALW alignment of amino acid sequence of
baiA genes from C. hylemonae TN271, C.
scindens VPI 12708 and C. hiranonis sp.
strain TO931. The baiA gene encodes a 3αhydroxysteroid dehydrogenase specific for
cholyl-CoA (58).

MNLVQDKVTIITGGTRGIGFAAAKIFIDNGAKVSIFGETQEEVDTALAQLKELYPEEEVL 60
MKLVQDKITVITGGTRGIGFTAAKIFIENGAKVSIFGETKEEVDTALAELKELYPEEEVL 60
MNLVQDKIVIITGGTSGIGLCAAKIFMDNGATVSIFGKTQEEVDAAKAELKETHPDKEVL 60
*:*****:.:***** ***: *****::***.*****:*:****:* *:*** :*::***
GFAPDLTSRDAVMAAVGQVAQKYGRLDVMINNAGITSNNVFSRVSEEEFKHIMDINVTGV 120
GFAPDLTSRDAVMAAVRAVAEKYGRLDVMINNAGITMNTVFSRVTEEAFKHMMDINVIGV 120
GFAPDLTNRDEVMAAVGAVAEKYGRLDVMINNAGVTSSNVFSRVSPEEFTYLMDINVTGV 120
*******.** ***** **:*************:* ..*****: * *.::***** **
FNGAWCAYQCMKDAKKGVIINTASVTGIFGSLSGVGYPASKASVIGLTHGLGREIIRKNI 180
FNGAWAAYQCMKGAQQGVTINTASVTGIYGSLSGIGYPASKAGVIGLTQGLGREIIRKNI 180
FHGAWAAYHCLKGEKK-IIINTASVTGIHGSLSGVGYPTSKSAVVGFTQALGREIIRKNI 179
*:***.**:*:*. :: : *********.*****:***:**:.*:*:*:.**********
RVVGVAPGVVNTDMTNGNPPEIMEGYLKALPMKRMLEPEEIANVYLFLASDLASGITATT 240
RVVGVAPGVVDTDMTKGLPPEILEDYLKSFPMKRMLKAEEIANVYLFLASDLASGITATT 240
RVVGVAPGVVNTPMVGNIPDEILDGYLSSFPMKRMLEPEEIANTYLFLASDLASGITATT 239
**********:* *. . * **::.**.::******:.*****.****************
VSVDGAYRP------------- 249
VSDDGAYSPRANSTQLFVQVGI 262
VSVDGAYRPS------------ 249
** **** *

12708
TN271
TO931

12708
TN271
TO931

12708
TN271
TO931

12708
TN271
TO931

12708
TN271
TO931

172

173

Figure 39.

Genome-walking PCR upstream of partial baiA
gene of Clostridium hylemonae TN271. A
nested PCR product derived from PvuII
restriction library template (PN) ~2.5 kb
was purified by GENECLEAN and ligated into
pCR8 GW TOPO TA vector to produce vector
p271PNUP1A.

174

M PN

a.

3.0 kb
2.0 kb
1.6 kb

b.
A

PN AUP1

2.5 kb
T1

attL1

TA cloning site

T2
attL2
pUC ori

p271UP1A
5.3 kb
Specr

A

175

Figure 40.

Downstream genome-walking PCR (DS1) from
baiA gene of Clostridium hylemonae TN271. A
nested PCR product derived from EcoRV (EN)
restriction library template ~2.3 kb was
purified by GENECLEAN and ligated into pCR8
GW
TOPO
TA
vector
to
produce
vector
p271ENDS1A.
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8).

An ORF was located 235 bp upstream of the baiA gene.

The putative 732 bp gene was predicted to encode a 26 kDa
short chain dehydrogenase/reductase.

Members of this

family include the baiA gene which encodes a 3α-HSDH.
However, these two gene products shared only 19% amino
acid sequence identity and 35% similarity.

This ORF is of

interest because we expect the final reductive step in the
pathway to encode a 3α-HSDH recognizing 3-dehydro-DCA
and/or 3-dehydro-LCA.

A second partial ORF was located 67

bp upstream of the putative short chain dehydrogenase.
Intriguingly, this ORF was suggested to encode a type III
CoA transferase whose highest sequence identity was that
of the baiF gene from C. scindens VPI 12708.

A second

upstream genome-walk resulted in a PCR product 2,107 bp in
length which increased the current contig length to 4,949
bp (Figure 41).

The baiF homologue sequence was completed

and found to be 1,332 bp in length and predicted to encode
a 49.5 kDa polypeptide.

The baiF gene product from C.

scindens VPI 12708 was previously overexpressed in E. coli
and reported to encode a 47.5 kDa CoA hydrolase (130);
however, recent data suggests this gene product belongs to
the Type III family of CoA transferases (131).

The baiF
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Figure 41.

Second genome-walking PCR upstream of baiA
from C. hylemonae TN271. a.) Nested PCR
obtained from PvuII restriction digest (PN)
of C. hylemonae genomic DNA template. b.) 2
kb product GENECLEAN purified from agarose
gel and ligated into pCR8 GW TOPO TA vector
resulting in vector p271UP2A.
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and this second ORF share 60% amino acid sequence
identity, 75% amino acid similarity.

Figure 42 shows an

amino acid sequence alignment between the baiF gene and
the putative CoA transferase.
Directly upstream, 52 bp from the hypothetical CoA
transferase gene was another partial ORF with a flavin
binding domain.

Further genome-walking resulted in 760 bp

of sequence data and completion of this 1,722 bp ORF
encoding a putative 62 kDa flavoprotein (Figure 43).
BLAST analysis suggested this gene product encodes a
flavoprotein similar to fumarate reductases and 3ketosteroid-Δ1-dehydrogenases.

The former can likely be

ruled out due to the lack of four conserved N-terminal
heme binding sites (CXXCH) found in fumarate reductases
such as that of Shewanella putrefaciens MR-1, whose
structure has been solved (192).

The latter possibility

was of particular interest because we expect one of the
reductive genes to encode a 3-oxo-Δ4-steroid
oxidoreductase.

A fourth upstream genome-walk resulted in

a 2,765 bp of additional sequence data which increased
contig length to 7,993 (Figure 44).

This additional

sequence data allowed analysis upstream of the putative 3-
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Figure 42.

Boxshade of CLUSTALW amino acid sequence
alignment of baiF gene product of C.
hylemonae and a predicted Type III CoA
transferase which we have named the baiK
gene (See text).
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Figure 43.

Third upstream genome-walking PCR from baiA
gene of C. hylemonae TN271.
a). Agarose
gel of DS2 products using Dra1 (D), EcoRV
(E), PvuII (P), StuI (S) restriction
libraries of C. hylemonae TN271 genomic DNA
as template with adaptor primer AP1 and
gene-specific primer WALKDS-2 (See Table 6).
b.) “EN” and “PN” represent nested PCR
amplification using nested adaptor primer
AP2 and gene-specific primer WALKDSNEST2
(See Table 6). “M” represents 1 kb DNA
ladder. C.) Schematic representation of TA
cloning of GENECLEAN purified “DN” product
(arrow) into pCR8/GW/TOPO TA vector (2.8 kb)
yielding 3.56 kb vector p271DNCDUP3.
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Figure 44.

Fourth upstream genome-walking PCR from baiA
gene of Clostridium hylemonae TN271. a.)
Nested PCR obtained from EcoRV (EN)
restriction digest of C. hylemonae genomic
DNA template. b.) 2.7 kb product GENECLEAN
purified from agarose gel and ligated into
pCR8 GW TOPO TA vector resulting in vector
p271UP4A (5.5 kb)
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oxo-Δ4-steroid oxidoreductase gene for a bai promoter
sequence.

Indeed, we located a putative bai promoter 24

bp upstream of this ORF (Figure 45).

Additional conserved

bai promoter regions were not found in any other portions
of this contig.

5’ SMART RACE PCR was performed on the

putative 3-oxo-Δ4-steroid oxidoreductase gene and the mRNA
start site was determined at the very 5’ end of the
conserved bai region suggesting the promoter is located
upstream of this conserved region (Figure 46).

It is

quite possible that this conserved region is a promoter
region for both the baiA and baiB operons; however, this
region does not appear to be a promoter for the baiJKL
genes.

The functional significance of this conserved

region remains to be elucidated.
For the sake of simplicity in description we will
provide a preliminary name to these gene products
following the sequence of nomenclature ending with the
baiI gene on the oxidative operon.

This first ORF

encoding the putative 3-oxo-Δ4-steroid oxidoreductase will
be called the baiJ gene.

The baiF homologue will be named

the baiK gene and the putative short chain dehydrogenase
will be referred to as the baiL gene.
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Figure 45.

Identification of conserved bai promoter
elements upstream of the putative baiJ gene
of Clostridium hylemonae TN271.

conserved

-10
element

12708
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Figure 46.

Determination of transcription initiation
site for baiJ gene from Clostridium
hylemonae TN271 based on SMART RACE PCR
analysis.
Alignment above shows
determination of transcription initiation
site (TIS) based on alignment of SMART RACE
sequence data (SR3, SR4) with baiJ gene and
upstream region from Clostridium hylemonae
TN271 (TN271D4). TIS is determined based on
the first base following 3’ end of SMART II
A oligo sequence (italics) (5’AAGCAGTGGTATCAACGCAGAGTACGCGGG-3’). This
nucleotide (underlined, arrow) must also
correspond to the known sequence of the
upstream region of the gene. Therefore, the
TIS is 47 bp upstream of the ATG start site
(underlined). RBS=ribosome binding site.
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SR3
SR4
TN271D4

CTAATACGACTCACTATAGGGCAAGCAGTGGTATCCACGC-AGAGTACGCGGGAGAAAAA
CTAATACGACTC-CTATAGGGCAAGCAGTGGTATCCACGC-AGAGTACGCGGGAGAAAAA 58
-----------TTAAATTATACAGGCTGATTTTTAGATGTTAGAATA-AAAGCAGAAAAA 48
**
** ** *
* * * * *** **
* *******

SR3
SR4
TN271D4

CATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATGCGATGGCAAACTATGTA 119
CATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATGCGATGGCAAACTATGTA 118
CATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATGCGATGGCAAACTATGTA 108
************************************************************

SR3
SR4
TN271D4

CCAGGCACGTACGAAGGTATCGGTCACGGATACCAGGGCAGGCTTATCGTGAATGTAACA 179
CCAGGCACGTACGAAGGTATCGGTCACGGATACCAGGGCAGGCTTATCGTGAATGTAACA 178
CCAGGCACGTACGAAGGTATCGGTCACGGATACCAGGGCAGGCTTATCGTGAATGTAACA 168
************************************************************

SR3
SR4
TN271D4

GTTACGGAAGATGAGATCACGGAGGTTAAAATCATCAAACATAAGGAAGTGCGGGGGCTT 239
GTTACGGAAGATGAGATCACGGAGGTTAAAATCATCAAACATAAGGAAGTGCGGGGGCTT 238
GTTACGGAAGATGAGATCACGGAGGTTAAAATCATCAAACATAAGGAAGTGCGGGGGCTT 228
************************************************************

SR3
SR4
TN271D4

GCGTGGGACCTTCCCACATCCCCTGTCGAGGTGATGCCGCCTCAAATTGTCAAATATCAG 299
GCGTGGGACCTTCCCACATCCCCTGTCGAGGTGATGCCGCCTCAAATTGTCAAATA---- 294
GCGTGGGACCTTCCCACATCCCCTGTCGAGGTGATGCCGCCTCAAATTGTCAAATATCAG 288
********************************************************

TN271 baiJ start site:

RBS

AGAAAAACATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATG
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Isolation of the baiJ gene from C. scindens VPI 12708 and
elucidation of conserved baiJKL genes.

A necessary question immediately arose: are these
genes conserved in other 7α-dehydroxylating bacteria?

To

answer this question, the baiJ gene from C. hylemonae
TN271 was analyzed for short 7-8 amino acid stretches with
regions of low codon degeneracy.

Amino acids 183-189

(EEMCYNY) and 394-401 (NEWSYQYH) were selected as sites of
lowest degeneracy, a section whose nucleotide sequence
would result in an expected PCR product of 654 bp (Figure
47).

A codon usage table was prepared using sequence data

from bai genes from C. scindens VPI 12708 using the codonW
program (Figure 48).

This table allowed design of least

degenerate oligonucleotides for an attempt at isolation of
the baiJ gene from C. scindens VPI 12708 (Table 9).
Amplification using forward primer Delta4F1 and each of
the reverse primers Delta4R1, Delta4R2 and Delta4R3 each
resulted in a product around 650 bp (Figure 49) (See Table
9 for primer sequences).

The 650 bp PCR product amplified

using Delta4F1 and Delta4R2 primers was excised from the
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Figure 47.

Amino acid sequence of baiJ gene from
Clostridium hylemonae TN271. Residues
highlighted in green have one or two
possible codons. Bold regions correspond to
amino acids 183-189 (EEMCYNY) and 394-401
(NEWSYQYH). These regions were selected
based on low codon degeneracy which will be
used to design oligonucleotides to
potentially isolate the baiJ gene from
Clostridium scindens VPI 12708.
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Figure 48.

Codon usage table for Clostridium scindens
VPI 12708 and design of redundant
oligonucleotides for isolation of the baiJ
gene from C. scindens VPI 12708. a). Codon
usage table generated using bai genes from
Clostridium scindens as input (U57489). b).
Design of forward and reverse degenerate
oligonucleotides based on regions identified
in Figure 45.
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a.

b.
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Figure 49.

Isolation of partial baiJ gene from
Clostridium scindens VPI 12708. a). PCR
products generated from amplification with
primers Delta4F1 and Delta4R2 from both
Clostridium hylemonae TN271 and Clostridium
scindens VPI 12708 genomic DNA templates.
b). 0.65 kb PCR product from Clostridium
scindens VPI 12708 was GENECLEAN purified
and cloned into a pCR8/GW/TOPO TA vector
generating a 3.45 kb vector p12708D4deg.
c.) CLUSTALW alignment of sequence data
obtained from p12708D4deg insert against
baiJ gene from Clostridium hylemonae TN271.
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agarose gel, GENECLEAN purified, cloned into a pCR8 TOPO
TA cloning vector and both strands sequenced.

An

alignment of the partial baiJ sequence obtained from C.
scindens against the baiJ gene from C. hylemonae TN271
shows the high degree of amino acid sequence conservation
(Figure 49).

The partial baiJ gene from C. scindens was

used to design bidirectional genome-walking PCR
oligonucleotides to both complete the gene sequence and
obtain information about any flanking ORF.
The first upstream genome-walk from the partial baiJ
gene resulted in a 1,330 bp product (Figure 50).

Addition

of this sequence data to the partial baiJ sequence
resulted in a contig of 1.8 kb.

This sequence data

contained the 5’ end of the baiJ gene.

A conserved “bai

promoter region” was located directly upstream of the baiJ
gene and shared a high degree of sequence identity with
the putative bai promoter region found upstream of the
baiJ gene of C. hylemonae (Figure 51).

SMART RACE

analysis of the 5’ end of the baiJ gene revealed the TIS
upstream of the putative conserved bai “promoter” region
(Figure 52).

These results were similar, but not

identical to the TIS of the baiJ gene from C. hylemonae
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Figure 50.

Genome-walking PCR upstream of partial baiJ
gene of Clostridium scindens VPI 12708. a.)
Nested PCR products obtained from DraI (DN)
and EcoRV (EN) restriction digest of C.
scindens genomic DNA template. Due to
larger size, product “EN” was isolated,
cloned and sequenced. b.) 1.3 kb product
GENECLEAN purified from agarose gel and
ligated into pCR8 GW TOPO TA vector
resulting in vector p12708D4ENUP1 (1.3 kb).
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Figure 51.

BOXSHADE of CLUSTALW alignment of upstream
conserved bai promoter elements located
upstream of baiJ genes of Clostridium
scindens VPI 12708 and Clostridium hylemonae
TN271.

-10
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Figure 52.

Verification of bile acid induction and 5’
SMART RACE PCR analysis of baiJ transcript
from C. scindens VPI 12708. (a). TLC
autoradiograph (Top) between CA induced (I)
and CA uninduced (UI)cultures of C. scindens
VPI 12708. RT-PCR (Below) of baiB gene
comparing cDNA produced from RNA isolated
from CA I and CA UI cultures of C. scindens
VPI 12708 using primers baiB12708RTF (5’-GAT
GAG CAG GGC TTA TCT GTA CTT T-3’), and
baiB12708RTR (5’-GTA TCT CTT TCC CTG TCT CAA
TGA C-3’)and compared to gyrA gene. (b). 1%
Agarose gel stained with ethidium bromide
showing 5’ RACE PCR products using genespecific primer SR12708D1 (5’-TTC TAT GTC
CTC ATC CGT TGC CCC TG-3’). Lane “M” is a 1
kB DNA marker, lanes 1, 2, and 3 represent
PCR products obtained at various annealing
temperatures (62˚C, 64˚C, 66˚C,
respectively). Arrow indicates band that
was isolated, and sequenced. (c). Schematic
representation of TIS obtained from 5’RACE
sequence data. “†”= TIS position obtained
from 5’RACE of C. hylemonae TN271 baiJ gene
(Figure 46). “‡”= TIS position determined
by primer extension (Mallonee et al. 2000)
and 5’RACE (Figure 27) for the baiB gene
from C. scindens VPI 12708. “▪” represents
TIS position determined by primer extension
analysis of the baiB gene from C. hiranonis
sp. strain TO931. “◊” represents TIS
position determined by 5’RACE PCR of baiB
gene from C. hylemonae TN271 (Figure 26).
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†
‡ ▪ ◊
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TN271.

The TIS, located upstream of this conserved

region, effectively rules this region out as the bai
promoter.
In addition, a partial ORF was found 128 bp upstream
of the baiJ gene on the antisense strand.

A BLAST search

of the ORF suggested this gene belonged to the LysR family
of transcription factors.

Due to the proximity of the TIS

of the baiJ gene to the LysR like gene on the opposite
strand, it is very likely that the baiJ promoter overlaps
the LysR-like gene.

A second upstream genome-walk

resulted in a 4.0 kb PCR product which increased the
contig to 5.7 kb (Figure 53).

This sequence data

completed the remainder of a 960 bp gene encoding a
deduced 36.2 kDa polypeptide predicted to encode a
transcriptional regulator in the LysR family.

A second

ORF located on the anti-sense strand relative to the baiJ
gene was found 73 bp upstream of the putative
transcription factor.

This 465 bp ORF was predicted to

encode a 17.8 kDa polypeptide in the Tryptophan-rich
sensory protein (TspO)/ mitochondrial benzodiazepine
receptor (MBR) homolog family of signal transduction
integral membrane proteins.

Further upstream, and on the
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Figure 53.

Second upstream genome-walking PCR (UP2)
from partial baiJ gene of Clostridium
scindens VPI 12708. a). Agarose gel of UP2
products using Dra1 (D), EcoRV (E), PvuII
(P), StuI (S) restriction libraries of C.
scindens VPI 12708 genomic DNA as template
with adaptor primer AP1 and gene-specific
primer 12708WalkUP2 (See Table 6). b.) “DN”
and “SN” represent nested PCR amplification
using nested adaptor primer AP2 and genespecific primer 12708WalkUP2N (See Table 6).
A positive clone was obtained for product
“SN”, so this was used for sequencing. “M”
represents 1 kb DNA ladder. C.) Schematic
representation of TA cloning of GENECLEAN
purified “SN” product (arrow) into
pCR8/GW/TOPO TA vector (2.8 kb) yielding 6.8
kb vector p12708D4SNUP2.
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same strand relative to the baiJ gene, we located the
baiA1 gene and promoter region which has been previously
reported (122).

This gene was located directly upstream

of the TspO homologue.

It is interesting to note that

the baiA gene and baiA promoter located in C. hylemonae
was found in proximity to this putative reductive bai
operon.
The initial genome-walk downstream of the partial
baiJ gene resulted in a PCR product 1,929 bp in length
(Figure 54).

Alignment with the previous sequence data

resulted in a contig of 7,114 bp.

This additional

sequence data resulted in completion of the 1,722 bp baiJ
gene predicted to encode a 61.2 kDa polypeptide.

Amino

acid sequence identity of the baiJ gene is highly
conserved between C. scindens and C. hylemonae (89%)
(Figure 55).

In addition, a partial baiK gene was located

37 bp downstream of the baiJ gene in C. scindens.

A

second downstream genome-walk resulted in a fragment 3,366
bp in length increasing the contig length to 10.13 kb.
The 1,314 bp baiK was completed and predicted to encode a
49.1 kDa polypeptide.

The baiL gene, 732 bp in length,

was located 79 bp downstream of the baiK gene.

The
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Figure 54.

Downstream genome-walking PCR (DS1) from
partial baiJ gene of Clostridium scindens
VPI 12708. a.) Nested PCR products obtained
from DraI (DN) and EcoRV (EN) and StuI (SN)
adaptor ligated restriction libraries of C.
scindens VPI 12708 genomic DNA templates.
Due to larger size, product “EN” was cloned.
b.) 1.9 kb product GENECLEAN purified from
agarose gel and ligated into pCR8 GW TOPO TA
vector resulting in vector p12708D4ENDS1
(4.7 kb).
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Figure 55.

Boxshade representation of CLUSTALW amino
acid sequence alignment of putative 3-oxo-Δ4reductases (baiJ) between Clostridium
scindens VPI 12708 and Clostridium hylemonae
TN271.
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deduced amino acid sequence suggests this gene encodes a
26.4 kDa polypeptide.

In addition, a partial ABC

transport protein was located 85 bp downstream of the baiL
gene in C. scindens.

This short intergenic distance

suggests this gene may be found on the same operon.
Indeed, we hypothesize that an additional ABC transporter
will be involved in translocating DCA and LCA into the
extracellular environment (Figure 8).

A short 850 bp

genome-walk (Figure 56), and a fourth genome-walk of 3 kb
(Figure 57) resulted in completion of the ABC transport
gene 1854 bp in length, encoding a deduced 70.3 kDa
polypeptide.

In addition, two ORF were located directly

downstream of the ABC transport protein. BLAST analysis
suggests this ORF encodes a flavoprotein with the highest
similarity to guanine deaminases.

The second ORF is

predicted to encode a flavoprotein with greatest
similarity to xanthine dehydrogenases and 4hydroxybenzoyl-CoA reductases.
Figure 58 is a schematic representation of the
putative reductive bai operons in both C. scindens VPI
12708 and C. hylemonae TN271.

Some notable features

include the similar organization of the baiJKL genes,
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Figure 56.

Third genome-walking PCR downstream (DS3) of
baiJ gene product in Clostridium scindens
VPI 12708. a). Agarose gel of DS3 products
using Dra1 (D), EcoRV (E), PvuII (P), StuI
(S) restriction libraries of C. scindens VPI
12708 genomic DNA as template with adaptor
primer AP1 and gene-specific primer
12708WDS3 (See Table 6). b.) “DN” and “SN”
represent nested PCR amplification using
nested adaptor primer AP2 and gene-specific
primer 12708WDS3N (See Table 6). Attempts to
clone product “SN” were unsuccessful. While
“EN” was smaller in size, the specificity
was high and attempted cloning yielded
several positive clones. “M” represents 1
kb DNA ladder. b.) Schematic representation
of TA cloning of GENECLEAN purified “EN”
product (arrow) into pCR8/GW/TOPO TA vector
(2.8 kb) yielding 3.65 kb vector
p12708D4ENDS3.
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Figure 57.

Genome-walking PCR downstream (DS4) of
partial baiJ gene of Clostridium scindens
VPI 12708. a.) Nested PCR products obtained
from DraI (DN) restriction digest of C.
scindens VPI 12708 genomic DNA template.
b.) 3.0 kb product was GENECLEAN purified
from agarose gel and ligated into pCR8 GW
TOPO TA vector resulting in vector
p12708D4DNDS4 (5.8 kb).
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Figure 58.

Schematic representation of putative
reductive genes from Clostridium scindens
VPI 12708 and Clostridium hylemonae TN271.
The baiA genes encode 27 kDa 3αhydroxysteroid dehydrogenases. The baiJ
genes encode 62 kDa flavoproteins.
The
baiK genes encode a predicted 49 kDa Type
III CoA transferase similar to the baiF.
The baiL genes encode 27 kDa proteins of the
short chain reductase family. Finally, the
baiM encodes a predicted ABC transport
protein hypothesized to function as a
secondary bile acid efflux protein. “P”
represents conserved bai “promoter” region.
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upstream conserved elements with the oxidative bai
upstream region, and proximity of TIS.

Interestingly, the

upstream ORFs are not conserved between C. scindens and C.
hylemonae.

Each region includes an ORF predicted to

encode a transcription factor of a different family of
proteins on opposite strands.

In addition, the ORF

immediately upstream of the baiJ gene from C. hylemonae
TN271 is predicted to encode an 18 kDa 4Fe-4S ferrodoxin
presumably involved in shuttling electrons.

This ORF was

not located adjacent to the baiJKL genes from C. scindens.
Finally, the baiA gene and conserved upstream “promoter”
appear to cluster around the baiJKL genes.

Isolation of a partial baiJ gene in Clostridium hiranonis
sp. strain TO931

The baiJ gene from C. hylemonae TN271 and C. scindens
VPI 12708 are very similar at the amino acid sequence
level.

Designing oligonucleotides for isolation of the

same gene from more distantly related species can be
difficult with such high sequence identities.

Attempts

were made to isolate the baiJ gene from C. hiranonis using
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redundant primers in Table 9 without success. Therefore, a
multiple sequence alignment was prepared with the amino
acid sequence of the baiJ gene product against several
homologues in the databases.

This way, regions could be

detected that would normally be highly conserved within
this family of flavoproteins.

Two gene products were

selected for the alignment: 1). ZP_01362869.1, a fumarate
reductase flavoprotein subunit precursor from Clostridium
sp. OhILAs (2) ZP_00802728.1, a Flavocytochrome C from
Alkaliphilus metalliredigenes QYMF.

These protein

sequences were then aligned with the 12708 baiJ using
ClustalW (Figure 59).

Two regions of high amino acid

sequence identity with low codon degeneracy spanning a 282
bp stretch within the baiJ gene were identified (Figure
59).

A codon usage table was prepared using bai gene

sequences from C. hiranonis sp. strain TO931 (accession
no. AF210152) (Figure 60).

These primers were used to

isolate a 657 bp gene product corresponding to what
appears to be a partial baiJ gene of C. hiranonis sp.
strain TO931 (Figure 61).

A genome-walking library will

have to be constructed for C. hiranonis sp. strain TO931
to elucidate the remaining gene and flanking regions;
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Figure 59.

Boxshade of CLUSTALW alignment between the
baiJ gene product from Clostridium scindens
VPI 12708 and flavoprotein homologues.
ZP_01362869.1 represents the GenBank
accession number for the fumarate reductase
flavoprotein subunit precursor from
Clostridium sp. OhILAs and ZP_00802728.1
represents the GenBank accession number for
the Flavocytochrome c from Alkaliphilus
metalliredigenes QYMF. Arrows represent
regions of high amino acid conservation and
low codon degeneracy which will be used to
design oligonucleotides to attempt to
isolate the baiJ gene from more distantly
related 7α-dehydroxylating clostridia.
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Figure 60.

Codon Usage Table for Clostridium hiranonis
sp. strain TO931. The CodonW program was
used with bai gene sequences from C.
hiranonis sp. strain TO931 as input (GenBank
accession no. AF210152).
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Figure 61.

Isolation of putative baiJ gene from
Clostridium hiranonis sp. strain TO931. a.)
Agarose gel of PCR products derived from
amplification with primers TO931D4F (5’-GCW
GCW GAY TCW ATA GAA GAA TTA GC-3’), and
TO931D4R (5’-TTC WCC WGC WGC TAA WCC WGG
TAT-3’) against (-) no DNA, (12708)
Clostridium scindens VPI 12708 genomic DNA,
(TO931) Clostridium hiranonis sp. strain
TO931. A single PCR product was obtained
from C. hiranonis sp. strain TO931. b.) PCR
product (arrow) was cloned into a
pCR8/GW/TOPO TA vector to obtain a 3.05 kb
vector pD4TO931. c). Boxshade alignment of
multiple sequence alignment of C. hylemonae
TN271 baiJ (TN271baiJ), C. scindens VPI
12708 baiJ (12708baiJ) and partial sequence
of C. hiranonis sp. strain TO931 baiJ.
Asterisks signify amino acids corresponding
to gene region where primers anneal.
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however, this data represents a significant step in
possibily recovering these putative reductive genes from a
third 7α-dehydroxylating clostridial species present in
the human colon.

Cloning and Overexpression of baiL gene in Escherichia
coli.
The baiL gene is predicted to encode a 26 kDa
polypeptide in the 3-ketoacyl-acyl carrier protein
reductase (fabG) family (Figure 62).

We predict this

protein will convert 3-oxo-DCA(~SCoA) and/or 3-oxoLCA(~SCoA) to the secondary bile acids DCA(~SCoA) and
LCA(~SCoA), respectively.

Therefore, the strategy for

characterizing this gene product was to clone the baiL
gene from C. hylemonae TN271 into a pET21(a+) vector,
overexpress the recombinant protein in E. coli codon plus
BL21(DE3) and test 3α-hydroxysteroid oxidoreductase
activity with substrates NAD(P)H and [24-14C] 3-oxo-DCA or
NAD(P) and [24-14C] DCA

(See Material and Methods).

After cloning (Figure 63) and sequencing of the
vector insert to verify proper reading frame, the BaiL was
overexpressed in E. coli (Figure 64a).

The BaiL protein
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Figure 62.

Boxshade of CLUSTALW amino acid sequence
alignment of baiL genes from Clostridium
scindens VPI 12708 and Clostridium hylemonae
TN271 with similar short chain
dehydrogenases/3-keto acyl reductases.
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Figure 63. Cloning strategy of baiL gene from C. scindens
VPI 12708.
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Figure 64.

Overexpression of recombinant baiL gene from
Clostridium hylemonae TN271 in E. coli BL21
(DE3). “M” stands for Kaleidograph protein
standard, Lane 1= 30 μg soluble protein from
IPTG uninduced E. coli, Lane 2= 25 μg
insoluble protein from IPTG uninduced E.
coli, Lane 4= 30 μg soluble protein from 1
mM IPTG induced E. coli, Lane 5= 10 μg
insoluble fraction 1 mM IPTG induced E.
coli, Lane 6= 15 μg insoluble fraction IPTG
induced E. coli, Lane 7= 30 μg insoluble
fraction 1 mM IPTG induced E. coli. a).
Cultivation in LB broth b). Cultivation in
LBS broth (See Text).
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was highly expressed, though found in inclusion bodies.
Several attempts were made with different colonies, ranges
of IPTG concentration (0.1-1mM), temperatures (18˚C to
37˚C) and media (LB, TYGPN).

Indeed, we attempted the

sorbitol/betaine method (medium LBS) of Blackwell and
Horgan (1991) although results were similar between LB and
LBS (Figure 64b) (193).

We verified expression of His-tag

using anti-hexahistidine antibodies in the insoluble, but
were unable to detect any soluble recombinant BaiL-His
(Figure 65).
The baiL gene was also cloned in a pET24(a+) vector
as well as a pSport1 vector from both the SP6 and T7
promoters and overexpressed.

In each case, the BaiL was

located in the insoluble fraction.

Attempts at refolding

by solublization in 8M urea followed by step-down buffer
exchanges with urea in the presence of DTT and arginine
were unsuccessful in producing soluble protein.

Cloning and overexpression of the baiJ gene product in
Escherichia coli.
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Figure 65.

Western blot analysis of baiL expression in
soluble and insoluble fractions of IPTG
induced E. coli cell extracts. Protein
samples were electrophoresed on an SDS-PAGE
gel (12%) and electroblotted onto
nitrocellulose. The blot was probed with
anti-hexahistidine antibody. Lane S=soluble
fraction from 1 mM IPTG induced E. coli
whole cells; Lane IS= insoluble fraction
solubilized in 8.5 M urea. Each lane
contains 20 μg protein. Expected size of
recombinant baiL gene product is 27 kDa.
Position of molecular weight markers shown
to left of blot.
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The baiJ gene is predicted to encode a 3-oxo-Δ4DCA(~CoA) oxidoreductase.

To test this hypothesis, the

baiJ gene was PCR amplified with primers 12708baiJ-F (5’TGCATCTCCCTCGAGGGCACATTATGTTCCAGGC-3’) and 12708baiJ-R
(5’-TACAGGTACCAAGCATTGACTGTCCCGATGCT-3’).

Double

digestion of the pT7-SBP-2 expression vector and PCR
product with XhoI and KpnI restriction endonucleases and
ligation resulted in the pT7SB2baiJ vector (Figure 13).
The vector was initially transformed into E. coli DH5α and
subsequently cloned into expression host E. coli
ArcticExpress BL21(DE3).

After verifying the sequence and

reading frame of the insert, the BaiJ gene was
overexpressed by IPTG induction (0.8 mM).

The

ArcticExpress strain was chosen so that growth and thus
expression could be slowed to allow for less inclusion
body formation which was observed for the baiL gene.
Figure 66 shows the purification and immunoblot detection
of the recombinant BaiJ gene product.

The strep-tag was

chosen based on results with the BaiH protein which lost
activity following Ni+ affinity chromatography.

The

strep-tag recognizes biotin, which should not result in
chelation of metals or flavins.

The BaiJ polypeptide was
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Figure 66.

SDS-PAGE and Western immunoblot of elution
fraction after biotin binding chromatography
of overexpression of recombinant BaiJ-SBP
fusion protein. 10 μg protein was loaded
onto a 12% polyacrylamide gel. MW (kDa)
marker represented to left of SDS-PAGE (a)
and right of immunoblot (b). Expected size
of recombinant fusion protein: ~66 kDa.

243

75
75
50
37

50

244

purified to about 95% based on visual inspection of SDSPAGE of eluent fraction.

The eluent was concentrated by

centrifugation on Centriprep YM10 (10 kDa cut-off)
concentrators.

The concentrated material was yellow in

color; indicative of bound flavins such as observed for
the BaiCD and BaiH proteins (121).
Synthesis of bile acid CoA thioester was tested by
differential solubility.

CoA esters of bile acids are

water soluble at low pH, while free bile acids precipitate
and can be extracted into organic solvents; particularly
relatively hydrophobic bile acids such as 3-oxo-DCA. 30 μl
CoA conjugate sample (90 μM; 25,000 DPM) was added to 500
μl reaction buffer (100 mM sodium phosphate, pH 6.8) and
the pH was lowered to 3 with 1N HCl.

The sample was

extracted three times with two volumes ethyl acetate.

The

ethyl acetate fraction and 10μl aqueous phase were counted
by liquid scintillation.

The aqueous phase was then

brought to pH 10 with 5N NaOH and boiled 30 min.

The pH

was then lowered to 3 with 10 N HCl and extracted three
times with two volumes ethyl acetate.

Again, the ethyl

acetate fraction and the aqueous phase were counted.
Figure 67 shows that radioactivity is extracted only after
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Figure 67.

Measurement of radioactivity in both aqueous
and organic phase before and after sodium
hydroxide treatment. This assay was used to
provide evidence for the presence of a CoA
conjugate based on relative solubility.
Ethyl acetate (ETOAC) extraction “before
NaOH” represents organic extraction of the
aqueous phase containing bile acid CoA
conjugates. The pH was lowered to 3 with 1N
HCl. Free bile acids are expected to
partition to the organic phase, while
conjugates are expected to remain in the
aqueous phase. “After NaOH” represents the
DPM value in the organic and aqueous phase
once the aqueous phase from the first
extraction was increased to pH 10 with 5 N
NaOH, boiled for 30 min, and lowered to pH 3
with 5 N HCl. Extraction of the aqueous
phase resulted in the majority of
radioactivity partitioning in the organic
phase, suggesting hydrolysis of CoA
thioester.
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boiling at pH 10, suggesting that the CoA thioester is
being hydrolyzed.
Initial enzyme assays were run for 30 min at 37˚C in
a 500 μl volume of 100 mM sodium phosphate buffer
containing 90 μM [24-14C] 3-oxo-deoxycholyl-CoA (or the
free acid) (550 DPM/nmole), 150 μM NAD(P)(H) and 30 μg
purified BaiJ.

When 3-oxo-DCA and NADP were substrates, a

product of greater hydrophilicity than the substrate was
obtained whose Rf value was even lower than the commercial
DCA standard (Figure 68).

This strongly suggests the 3α-

hydroxyl group is reduced in addition to an oxidation
reaction.

Additional characterization will be required to

determine the function of this enzyme.

In summary, the 62

kDa BaiJ gene was expressed and purified and initial
enzyme assays suggest this polypeptide metabolizes bile
acids; however, this enzyme does not appear to have 3-oxoΔ4-DCA oxidoreductase activity.

Isolation of the gyrA gene: housekeeping gene for
normalizing RT-PCR in C. scindens and C. hylemonae.
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Figure 68.

Autoradiograph of a thin layer
chromatography of BaiJ reaction products.
Standards (not shown) are represented by
arrows. 3-oxo-DCA and 3-oxo-DCA~SCoA (90
μM; 25,000 DPM) were used as substrates in a
500 μl reaction volume. The reaction
buffer, 100 μM sodium phosphate (pH 6.8),
containing 150 μM pyridine nucleotide
(labeled) and 30 μg purified recombinant
BaiJ-SBP.
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Future characterization and studies of bai gene
expression by RT and qRT PCR requires normalization using
“housekeeping genes”.

Several studies have used the gyrA

subunit in this capacity (194, 195).

At the time of study

there was no genomic data for any 7α-dehydroxylating
bacterium in the databases, which has since changed
(currently Clostridium scindens VPI 12708 and Clostridium
scindens ATCC 35704 by our lab and Jeffrey Gordon’s lab,
respectively).

The strategy for isolating the gyrA

subunit from Clostridium hylemonae TN271 was to generate a
multiple sequence alignment of several gyrA genes from
various species of Clostridia in addition to two gyrA
genes from Alkaliphilus oremlandii OhILAs.

After a

multiple alignment was generated and searched for regions
of low codon degeneracy based on a codon usage table
generated for C. hylemonae TN271 (Figure 69) two regions
of high sequence identity and low codon degeneracy were
identified.

Figure 70 illustrates these regions in Logo

form along with redundant oligonucleotide variations based
on these sequence regions.

PCR amplification using

sixteen combinations of forward and reverse redundant
oligonucleotides resulted in five positive reactions
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Figure 69.

Codon usage table for Clostridium hylemonae
TN271. The CodonW program was used to
generate table using baiJ, baiK and baiL
gene sequences as input.
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Figure 70.

Design of degenerate oligonucleotides for
isolation of the gyrA gene from C. hylemonae
TN271. A CLUSTALW alignment was prepared
from the gyrA gene from the following
organisms: Alkaliphilus oremlandii OhILAs
(ABW17577.1; EAT31502.1 ), C. perfringens
str. 13 (NP_560923.1), C. beijerinckii NCIMB
8052 (YP_001307153.1), C. tetani E88
(NP_780806.1), C. acetobutylicum ATCC 824
(AAK77994.1).
Short stretches of conserved
amino acids were examined manually within
this alignment for low codon degeneracy.
Two regions were found spanning 235 amino
acids which would give a PCR product of 705
bp.
a). Logo representation of conserved
residues 77-84 (C. tetani gyrA) identified
in multiple sequence alignment of gyrA genes
as highly conserved and low in codon
degeneracy. Lowest degenerate forward
primers (gyrAF1, gyrAF2) are listed. b.)
Logo representation of residues 299-307 (C.
tetani gyrA) identified as highly conserved
and containing residues with low codon
degeneracy. The sense strand reverse
translated is shown below amino acid
residues (bold) with wobble based listed as
“N”. “Rev Comp” is the reverse
complementary strand for reverse
oligonucleotides (gyrAR-gyrAR8).

254

Primer Name

Sequence

G
K
Y
H
P
H
G
D
5’-GGN AAN TAN CAN CCN CAN GGN GAN-3’

a.

gyrAF1
gyrAF2

GGV AAR TAY CAY CCG CAY GGV GAY
GGV AAR TAY CAY CCH CAY GGV GAY

Primer Name
b.
Rev
Comp

Sequence

R
E
G
M
R
I
C
I
E
5’CGN GAN GGN ATG CGN ATN TGN ATN GAN 3’
5’TCN ATN CAN ATN CGN ATN CCN TCN CGN 3’

gyrAR
gyrAR2
gyrAR3
gyrAR4
gyrAR5
gyrAR6
gyrAR7
gyrAR8

TCK
TCK
TCK
TCK
TCK
TCK
TCK
TCK

ATR
ATR
ATR
ATR
ATS
ATS
ATS
ATS

CAK
CAK
CAK
CAK
ACC
ACC
ACC
ACC

ATS
ATT
ATT
ATS
ATS
ATT
ATT
ATS

CGC
CTC
CTC
CGC
CGC
CTC
CTC
CGC

ATK
ATK
ATK
ATK
ATK
ATK
ATK
ATK

CCY
CCY
CCY
CCY
CCY
CCY
CCY
CCY

TCS
TCT
TCS
TCT
TCS
TCT
TCS
TCT

CG
CT
CG
CT
CG
CT
CG
CT
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(Figure 71).

Cloning of PCR product derived from primer

pair gyrAF1/gyrAR4, sequencing of this product and
alignment of the deduced amino acid sequence suggests the
gyrA gene has been isolated. Primers gyrAF1 and gyrAR8
were used to isolate the partial gyrA gene from C.
scindens VPI 12708 (data not shown) which was cloned into
a pCR8/GW/TOPO, sequenced and aligned with section of gyrA
gene from C. hylemonae TN271.

Following this data, the

entire gyrA gene from C. scindens VPI 12708 was detected
by local BLAST search of the 13X coverage of the C.
scindens VPI 12708 genome (Ridlon JM, Alves J, Kang D,
Hylemon PB and Buck G unpublished data).

A multiple

sequence alignment of the gyrA genes from C. hylemonae
TN271, C. scindens VPI 12708 and gyrA genes from
clostridial genome data available from GenBank (Figure
72).

A set of RT-PCR primers were designed to detect the

gyrA gene of C. hylemonae TN271 (gyrATN271F 5’ACTTTGACGAGACAGAAAAAGAACC-3’; gyrATN271R 5’CAGTATATGTTCGATCGTCGT) (primers used in Figure 26) and C.
scindens VPI 12708 (gyrA12708F 5’ATCTATGGAGCACTGGTAAATATGG-3’; gyrA12708R 5’AGTTAGGAGCAAAATCAACCGTATC-3’) which showed high
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Figure 71.

PCR amplification of gyrA gene from
Clostridium hylemonae TN271. Combinations
of oligonucleotides listed in Figure 65 were
used against 50 ng C. hylemonae TN271
genomic DNA template. Combinations of
primers used in PCR reaction are as follows:
Lane M= 1kb DNA ladder; Lane 1= gyrAF1,
gyrAR; Lane 2=gyrAF1, gyrAR2; Lane 3=gyrAF1,
gyrAR3; Lane 4=gyrAF1, gyrAR4; Lane
5=gyrAF1, gyrAR5; Lane 6=gyrAF1, gyrAR6;
Lane 7=gyrAF1, gyrAR7; Lane 8=gyrAF1,
gyrAR8; Lane 9=gyrAF2, gyrAR; Lane
10=gyrAF2, gyrAR2; Lane 11=gyrAF2, gyrAR3;
Lane 12=gyrAF2, gyrAR4; Lane 13=gyrAF2,
gyrAR5; Lane 14=gyrAF2, gyrAR5; Lane
13=gyrAF2, gyrAR5; Lane 14=gyrAF2, gyrAR6;
Lane 15=gyrAF2, gyrAR7; Lane 16=gyrAF2,
gyrAR8. 750 bp PCR product from Lane 4 was
cloned into a pCR8/GW/TOPO TA vector
generating a ~3.5 kb vector p271gyrA.
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Figure 72.

Boxshade alignment of gyrA gene product from
C. scindens VPI 12708 with other clostridial
and bacterial gyrA genes. Alkaliphilus
oremlandii OhILAs (ABW17577.1; EAT31502.1 ),
C. perfringens str. 13 (NP_560923.1), C.
beijerinckii NCIMB 8052 (YP_001307153.1), C.
tetani E88 (NP_780806.1), C. acetobutylicum
ATCC 824 (AAK77994.1).

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

---MLEKRGNIVPINIEKEMKNSYIDYSMSVIVGRALPDVRDGLKPVHRRILYSMIELGITPDKPHKKSARIVGDVLGKYHPHGDTA
---MLEKRGNIVPINIEKEMKNSYIDYSMSVIVGRALPDVRDGLKPVHRRILYSMIELGITPDKPHKKSARIVGDVLGKYHPHGDTA
---MSLNEGKVIPIDINKEMKKCYIDYAMSVIVGRALPDVRDGLKPVHRRILYSMQELGLYPERGYRKCARIVGEVLGKYHPHGDSS
---MDFNEGKVIPVDIKNEMKKCYIDYAMSVIVGRALPDVRDGLKPVHRRILYSLQELGLTPEKGYRKCARIVGDVLGKYHPHGDSS
MNYMNNNEGKVLEVDIKQEMKKCYIDYAMSVIVGRALPDVRDGLKPVHRRILYSMYELGLSPEKSYRKCARIVGDVLGKYHPHGDSS
----MLNEGKVLPVDISSEMKKCYIDYAMSVIVSRALPDVRDGLKPVHRRILYSMHELGLTPEKGYRKCARIVGDVLGKYHPHGDSS
--MEDNIFDKVHEVDLKKTMETSYIDYAMSVIASRALPDVRDGLKPVQRRILYSMIELNNGPDKPHRKCARIVGDTMGKYHPHGDSS

85
85
85
85
88
84
86

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

VYDAMVRLAQDFSMRYMLVDGHGNFGSVDGDGAAAMRYTEARLSKMAMEMIRDINKDTVDYRPNFDESLKEPSVLPSKFPNLLVNGS
VYDAMVRLAQDFSMRYMLVDGHGNFGSVDGDGAAAMRYTEARLSKMAMEMIRDINKDTVDYRPNFDESLKEPSVLPSKFPNLLVNGS
VYDALVRMAQDFSLRYMLVDGHGNFGSVDGDSAAAMRYTEAKMNKIASEMLRDINKNTVDFIPNFDGEEKEPVVLPSRYPNLLVNGS
VYDALVRMAQDFSMRYMLVDGHGNFGSVDGDSAAAMRYTEAKMNKIAVEMLRDINKNTVDFMPNFDGEEQEPVVLPSRFPNLLVNGS
VYDALVRMAQDFSIRYTLVDGHGNFGSVDGDSAAAMRYTEAKMGKITIEMLRDINKNTVDFTPNFDGSEKEPSVIPSRFPNLLVNGS
VYGALVRLAQDFNLRYTVVDGHGNFGSVDGDSAAAMRYTEAKMNKIALEMVRDIGKNTVDFIPNFDGEEKEPVVLPSRFPNLLVNGS
IYGALVNMAQEWSTRYPLVDGHGNFGSVDGDGAAAMRYTEARLSKISMELTADINKDTVDFAPNFDETEKEPVVLPARFPNLLVNGT

171
171
171
171
174
170
172

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

NGIAVGMATNIPPHNLGEVIDGVVTLIDN-----SEAQVEDLMEHIKGPDFPTAATIMGTEGIKEAYTTGRGRIKVRAKASIEEVNK
NGIAVGMATNIPPHNLGEVIDGVVTLIDN-----SEAQVEDLMEHIKGPDFPTAATIMGTEGIKEAYTTGRGRIKVRAKASIEEVNK
SGIAVGMATNIPPHNLGEVIDGTIALIDN-----PELTSLELMTYIKGPDFPTAGIIMGKSGIRAAYETGKGRIVVRAKAEIEEE-N
SGIAVGMATNIPPHNLAEIIDGTIMLIDN-----PESTVLELMTKITGPDFPTGATIMGKAGIRAAYETGKGKIIVRANAEIEEE-N
SGIAVGMATNIPPHNLCEVIDGINMLIED-----PDTTILELMSKIKGPDFPTAGIIMGKSGIRSAYETGRGKVIMRAKAEIEEE-K
AGIAVGMATNIPPHNLGEVIDGITMLIDN-----PEATILELMAQIKGPDFPTAGIIMGKSGIRAAYETGRGKITVRAKSEIEVEDN
SGIAVGMATNIPPHNLNEIINAVVKIIDDQIEDKEETTIEEILKIIKGPDFPTGGMILGTRGIEEAYRTGRGKIRVRAVTDIETMPN

253
253
253
253
256
252
259

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

EEVNKGRQQIIITEIPYQVNKARLIEKIAELVRDKKVEGISDLRDESDREGMRIVIELKRDANANVVLNKLYKHTQLEDTFGVIMLA
EEVNKGRQQIIITEIPYQVNKARLIEKIAELVRDKKVEGISDLRDESDREGMRIVIELKRDANANVVLNKLYKHTQLEDTFGVIMLA
EEE-NGRHKIIVTELPYQVNKAKLIEYIADLVKDKKITGISDLRDESDREGMRMVIELKRDANPNVTLNLLYKHTKMQDTFGVIMLA
EEE-NGRHSIIVTEIPYQVNKAKLVENIADLVKDKKITGISDLRDESDRDGMRIVIELKRDANPSVVLNLLYKHTKLQDTFGIIMLA
EEE-KGRYRIIVTELPYQVNKAKLIENMAELVKDKRIDGISDIRDESDREGMRIVVEIKRDSNPNVVLNQLYKHTKMQDTFGVIMIA
EVEDNGKQKIIITEIPYQVNKARLVESIADLVKDKRIVGISDLRDESDRDGMRIVIEIKKDANSNIILNQLYKHTRLQDTFGINMLA
ETMPNGKSRIIVTELPYMVNKARLIEKIAEMVRDKKIDGITDLSDQSSREGMRVVIELRKDVNANVLLNQLYKHTQLQDTFGVIMLA

335
335
334
334
337
334
341

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

IVNGEPKVLNLKEVLTHYLDHQKDIITRRTQFDLNKAEERAHILEGLKIAIDNLDEVIKLIRGSENTQIAKTGLMETFTLSEKQAQA
IVNGEPKVLNLKEVLTHYLDHQKDIITRRTQFDLNKAEERAHILEGLKIAIDNLDEVIKLIRGSENTQIAKTGLMETFTLSEKQAQA
LVDNQPQILNLKQVLVHYINFQKDVITRRTQFELNKAKERAHILEGLIIALDNIDEVINIIRSSKTSEIAKNTLIERFSLSEKQAAA
LVNNEPKVLNLKQILENYVEFQKEVITRRTIFDLNKAEARAHILEGLKIALDNIDEVISIIRNSNTTEIAKNTLMERFELSEKQSQA
LVDNEPKVLNLKEILVNYIEFQKEIIRRRTKFDLDKALARAHILEGLRIALDHIDEVISLIRSSKNADEARNGLMTKFSLTEKQAQA
LVDNRPEVLNLKQILQHYIKFQEQVIRRRTEFDLEKASARAHILEGLKIALDHIDEVISLIRGSKTAQEAKLGLMDKFGLSEKQAQA
LVNNEPRVMNILDMLNYYLQHQEEVVTRRTKYELNKAEERAHILQGLLIALDNIDEVIRIIRGSQTVQIAKAELMERFGLSEVQSQA

422
422
421
421
424
421
428

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

ILDMRLQKLTGLEIEKVEEEYEDLIKLINHFKEILANERLMLNIIKDELIEIKEKYGDERRTEITRAIGEINIEDMITEEEVVITLT
ILDMRLQKLTGLEIEKVEEEYEDLIKLINHFKEILANERLMLNIIKDELIEIKEKYGDERRTEITRAIGEINIEDMITEEEVVITLT
ILEMRLRRLTGLERDKIENEYNELMKLIDYLNAILASEERLLEVIKEELLEIKAKYSDERRTQIEKQENEIDIEDLIQEEDVVITLT
ILEMRLRRLTGLERGKIEEEYNELMKQIEYLKSILASEEKLLDVIKEELLEIKNRYSDERKSKIEKIVNEIDIEDLIQEEDVVITLT
ILDMRLQRLTGLERDKIEEEYNQLMETIKYLRDILNNEDLVLKIIKEELHEIKNKYGDERKTEIELNINEISIEDLIEEEEVVVTLT
ILDLKLQRLTGLEREKIEDEYNELMKTIAELKSILADENKILAIIRDELNEIKAKYGDERKTAIERAENDIDIEDLIQEENVVITLT
IVDMRLRALTGLEREKLENEYQELMKQIRELKAILADRKLLLGVIKEEILIIRDKYGDERRTSIGFDEFDISMEDLIPKEDVVITMT

509
509
508
508
511
508
515

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

HFGYIKRLPADTYKSQKRGGKGIAALTTREEDFVENLITSSSHDYLLFFTNFGRVYKLNVYEIPEARRQAKGTAIVNLIPLSPNETV
HFGYIKRLPADTYKSQKRGGKGIAALTTREEDFVENLITSSSHDYLLFFTNFGRVYKLNVYEIPEARRQAKGTAIVNLIPLSPNETV
HTGYIKRISSDVYSAQKRGGKGIQAMTTKEDDFVENVLVTSTHSNLLFFTTKGKVYKIKAYEVPDAGRTAKGTNLVNILPLEADEKI
HSGYIKRISADTYSSQRRGGKGIQAMSTKEDDFVEHLMITSTHSDVLFFTNKGRVYKLRAYEVHDAGRQAKGTNLINLIAIEPDEKI
NSGYIKRISSDAYSSQKRGGKGIQAMTTKEDDFVERVFITSTHSDLLFFTNIGKVYKLKAYEIPEAGRTAKGTNIVNLLPVDANEHV
HAGYIKRINADTYTSQKRGGRGIQAMTTKEDDFVENIFITSTHNNILFFTNKGRMYKLKAYQIPEAGRAAKGTNVVNLLQLDPNEKI
KLGYIKRMSHDTFKSQNRGGKGIKGMQTLKEDYVEELFMTHTHHYIMFFTNTGRVYRMKGYEIPEASRTSRGTAIVNLLQLMPGEKI

596
596
595
595
598
595
602

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

AATIPVGRQFDSKYLVLATKNGIIKKTQLSQFESTRKSGLIAISIREDDELIKVKLTDEDSEIILITAQGMSIRFKEQDVRDMGRSA
AATIPVGRQFDSKYLVLATKNGIIKKTQLSQFESTRKSGLIAISIREDDELIKVKLTDEDSEIILITAQGMSIRFKEQDVRDMGRSA
QTVLSFKDVQEDGYLFMGTKLGIVKKTPLKDFKNIRKNGLIALNLREGDELLRAKITYGDADIIFVTQDGNAIRFNETDVRPMGRTA
QTVLTVTDEKKEGFLFMGTKQGIVKKTPLSEFKNLRKNGLIAISLKDGDELLKVKNTYGDANIMVVTQNGYAVKFNERDVRSMGRTA
REVIALKKDLEEGYLIIGTKQGLIKKTSLNQFKNIRKNGIIAINLKDEDELLKVKVTRGDAEIIIVTQNGYAIRFSEKDVRPMGRNS
QAVISIKEFDEESFLVMCTKKGIIKKTVVGMYKNIRKSGLIAINLNDDDELVSVRITKGDDDIIIVTNKGLAIRFNEVDVRPLGRNA
SAVIPIEEYKDGEYLFMATKKGLVKKTPITEYAHVRKTGLAAITLREEDELIEVKYTDNDRDVLLVTKYGQCIRFDEKDVRPTGRTS

683
683
682
682
685
682
689

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

MGVKGINLSPKDHVVSMEIVEENKDLLVISEKGFGKRTDTSEYRLQTRGGKGIKTYNVTGKTGPLVGAKIVTDEDEVLLINNYGTVI
MGVKGINLSPKDHVVSMEIVEENKDLLVISEKGFGKRTDTSEYRLQTRGGKGIKTYNVTGKTGPLVGAKIVTDEDEVLLINNYGTVI
SGVKAISLREGDVAVCMDIAVEDEKLLVVSENGYGKRTNLDEYKVQNRGGIGLITYKVSDKTGKVVGATVCKEDDELMHYK-----SGVKAINLKEDDIAVCMDIAVDGEELLVISENGYGKRTPIAEYKLQNRGGVGLITYKISEKTGKLAGATICKVDDELMLINSSGVAI
TGVKAISLRKDDVAVSMDIVVEDEYVLTVTENGFGKRTLASEYTLQNRNGKGLITHRVTDKTGKIVSARVAKDSDELMLINSSNTAI
LGVKGITLKEDDFVVGMEVPNQESDVLVVSENGFGKRTHVGEYKCQHRGGKGLITYKVSDKTGKLVGVRMVEDGDELMLINNLGIAI
MGVRGMNLADRDEVIGMQLDSQGCDLLIVSEKGMGKRTSIEEFTCQNRGGKGVKCYKITEKTGNVVGVKAVNHDDEVMIINTEGIII

768
768
761
769
772
769
776

ABW17577.1
EAT31502.1
NP_560923.1
YP_001307153.1
NP_780806.1
AAK77994.1
12708gyrA

------------------------------------------------------------RLNVSNISKLGRNTKGVTLMRMEEDQSIITIALMASTENEEVEEGLTEE-----------------------------------------------------------------------RINVADISVTSRSAMGVTLMRTNEDEKVVAIAKILSSDDQETESGDEA--ESESEINNIEE
RICVSDVSITNRSAMGVTLMRTYEEEKILAIAKISSDEDSE-------------------RINVSDISTTSRNAMGVTLMRNNGDEKVLALAKINKDDSEQLEDSEEVSEVHDAEENNSEE
RMKCEGISVLGRVTSGVKLINLQEGDIVASIAKVRKGDEEPIDSVEDTDEES---------

819
828
813
830
828
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specificity against genomic DNA from their respective
target species.

While preliminary studies suggest gyrA

gene expression is not affected by bile acid induction,
additional work must be done to verify the gyrA gene as an
appropriate internal control for qRT-PCR.

This represents

an important step toward development of a quantitative
assay to measure bai gene expression in C. scindens VPI
12708 and C. hylemonae TN271.

In addition, these probes

have yet to be tested on C. hiranonis sp. strain TO931
genomic DNA and may result in isolation of this gene from
this organism as well.
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Discussion
The first life on earth evolved in an anoxic
environment.

For several billion years, microorganisms

have successfully exploited niches devoid of oxygen (196).
In fact, it is interesting to note that one of the most
densely inhabited environment on earth is the mammalian
large intestine (>1011 bacteria/gram wet weight feces)
(197, 198).

To put this in perspective, the adult human

body contains an order of magnitude more prokaryotic cells
(1014) than mammalian cells (1013).

The collective

bacterial genomes (termed “microbiome”) of the human
microflora encode an estimated 2-4 million genes,
surpassing the human genome by a staggering 100-fold
(199). Science continues to change the way we view
ourselves, and our place in nature.

Advances in genomics

and GI microbiology suggest that the human body should be
regarded as a superorganism-a complex ecosystem composed
of all three domains of life (eukaryote, prokaryote and
archaea) balanced by selective pressures from both the
top-down and the bottom-up (200).
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Intestinal bacteria and archaea can carry out
hundreds, if not thousands, of enzymatic reactions not
carried out by host cells.

Relman and Falkow (2001) have

called for the task of sequencing this microbiome, which
they have called ‘the second human genome project’ (201).
Intestinal microbes actively metabolize molecules of
endogenous and exogenous origin.

The products of this

metabolism then interact with host cells with both
beneficial and harmful consequences.

Bile acid metabolism

represents a particularly important aspect of microbial
metabolism of endogenous substrates due to enterohepatic
circulation, which allows accumulation of bacterial
products of bile acid metabolism.

Bile acids also

represent a strong top-down selection pressure on
potential colonizers (95).

A microbe must be prepared to

cope with mmol concentrations of bile salts and bile
acids. Bile resistance is a major factor used to screen
potential “probiotic” species (202). In addition, numerous
studies have shown that bile acids induce expression of
virulence genes in intestinal pathogens (95). Host-microbe
co-evolution has resulted in widespread acquisition of
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bile-salt metabolizing enzymes in all major gut colonizing
microbial species (See introduction) (95).
Interestingly, it appears that genes involved in bile
acid 7α/β-dehydroxylation are found in the tiniest
fraction of Firmicutes classified within various clusters
of the heterogenous genus Clostridium (189). 7αdehydration of bile acids represents a microbial pathway
which may significantly alter host physiology. Bile acids,
once regarded as simple detergents involved in lipid
digestion, are now recognized as potent signaling
molecules (203). A full understanding of the biology and
biochemistry of bile acid metabolism by intestinal
bacteria represents an important and challenging area of
research.

The current work represents a significant step

in understanding the biochemistry of bile acid 7α/βdehydroxylation by intestinal clostridia.
The current work provides strong evidence that the
baiCD and baiH gene products encode NAD+-dependent 3-oxoΔ4-cholenoic acid oxidoreductases recognizing 7α-hydroxy
and 7β-hydroxy bile acids, respectively (Figure 5).
Previously, we demonstrated loss of the 5β-hydrogen during
7α-dehydroxylation of [5β-3H] + [24-14C]-CA both in vivo
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and from cell extracts of CA induced C. scindens whole
cells suggesting introduction of a C4-C5 double-bond (118).
Addition of [24-14C] 3-oxo-Δ4-cholenoic acid to CA induced
whole cells and cell-extracts of C. scindens VPI 12708
resulted in conversion to [24-14C] DCA (117).

Subsequent

studies elucidated the first two steps of the bile acid
7α/β-dehydroxylation pathway; CoA ligation (125) and
oxidation of the 3α-hydroxy group producing a 3-dehydroCA-CoA intermediate (58). Collectively, these data
suggested the presence of an enzyme catalyzing the regionselective oxidation at C4-C5 yielding a 3-dehydro-Δ4-CA-CoA
intermediate. Others have speculated that the baiH and
baiCD genes were involved in C-C double bond
oxidation/reduction based on homology to enzymes with
similar function (204, 205).

The fact that there are two

homologous flavin oxidoreductases of similar Mr (70-72 kDa)
with 32 % identity and 46 % similarity that are coexpressed from a bai operon suggests a possible similar
function.
This hypothesis was tested by incubation of a crude
cell extract of E. coli overexpressing the baiCD gene with
[24-14C] 3-dehydro-UDCA or [24-14C] 3-dehydro-CDCA, and
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indeed the reaction yielded a 3-dehydro-Δ4-CDCA metabolite
as suggested by mass spectrometry (Figure 19).

3-dehydro-

UDCA did not appear to be a substrate of the baiCD gene
product.

Bile acid 7α-hydroxy groups are axial while 7β-

hydroxy groups are equatorial.

These data suggest that

the key to substrate recognition between the baiCD and
baiH is the stereochemistry of the 7-hydroxy group, whose
orientation apparently requires a different architecture
in the substrate binding pocket. Taken together these
results suggest these homologous enzymes act at an
analogous step in the 7-dehydroxylation pathway, and
therefore, two distinct branches of the oxidative arm of
the pathway exist in C. scindens and C. hiranonis.
The BaiH is a homotrimer composed of 72 kDa subunits,
each subunit containing 1 mol of FMN and 1 mol of FAD per
subunit.

BaiH is homologous to a class of flavoenzymes

involved in reduction of unsaturated fatty acids and
aldehydes (Table 2) (129).

Enoate reductase (enr) from

Clostridium tyrobutyricum catalyzes the reduction of C-C
double bonds of several α/β-unsaturated aldehydes as well
as cyclic ketones and methylketones (184). Enr is a
dodecamer with subunit Mr of 73 kDa each containing a 4Fe-
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4S cluster and 1 mol of FMN and 1 mol of FAD (206).

2, 4-

dienoyl-CoA reductase from E. coli is a 73 kDa monomeric
enzyme that reduces C-C double bonds with NADPH and
contains FMN, FAD as well as a 4Fe-4S cluster (182, 207).
The noxB gene from Archaeoglobus fulgidus encodes an NADH
oxidase of unknown physiological function (204).

The noxB

gene product is a 69 kDa monomer containing 1 mol FAD and
shares the same conserved ferrodoxin domain (C-2X-C-2-3XC-11-12X-C) with each of these proteins including the baiH
and baiCD gene products (204). The noxB-2 gene shares 98.9
% identity with the noxB-1 gene from A. fulgidus and is
found upstream of medium-chain acyl-CoA ligase in this
bacterium suggesting these genes are also involved in
fatty acid metabolism (204).

The more distantly related

Old Yellow Enzyme (OYE) family homologues are found both
in eukaryotes such as Saccaromyces cerevisiae (OYE1, OYE2)
(205) and S. carlsbergensis (OYE1) (208), as well as the
prokaryotes including Bacillus subtilis (YqjM) (209), and
Shewanella oneidensis (SYE1-SYE4) (210).

OYE genes have

been extensively characterized both biochemically and
structurally (206, 209, 211).

Numerous compounds act as

electron acceptors including various quinones, as well as
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α, β-unsaturated aldehydes and ketones which are reduced
at the olefinic bond (211); however, only recently have
physiologically relevant electron acceptors been
identified.

The oye2 and oye3 gene from Sac. cerevisiae,

sye1 from She. oneidensis, and the yqjM gene from B.
subtilis were shown to be inducible by small α/βunsaturated aldehydes during oxidative stress responses to
lipid peroxidation (186, 210, 212) and actin cytoskeletal
oxidative damage in yeast (213).

Detoxification does not

appear to be the function of the bile acid 7α/βdehydroxylating pathways, but rather the substrates appear
to serve as electron sinks to enhance fermentation (95).
Electron flow in the E. coli DCR as determined by
redox titrations (214), and crystallography (182) show
that two reducing equivalents are supplied to FAD by
direct hydride transfer and follow an electron flow from
FAD to a 4Fe-4S cluster to FMN and finally to the oxidized
substrate.

OYEs reduce C=C double bonds through a ping-

pong bi-bi mechanism in which FMN is reduced by NADPH,
followed by substrate binding and hydride transfer from
FMNH2 to the Cβ carbon of the substrate (215).

Additional
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studies will be required to determine the mechanism of the
reaction catalyzed by the baiCD and baiH gene products.
We observed low NAD(H)-dependent 3-oxo-Δ4-cholenoic
acid oxidoreductase activity based on the amount of
products formed, as observed by autoradiography of TLC
(Figure 16). However, we would predict that the
physiological substrates for these enzymes are the CoA
conjugates of 3-oxo-cholanoic acids.

This is based on the

observations that the baiA gene product encodes a 3αhydroxysteroid dehydrogenase that has high specificity for
coenzyme A conjugated bile acids (58).

However, large

quantities of the CoA derivatives of 3-dehydro-CDCA and 3dehydro-UDCA will have to be chemically synthesized to
test this hypothesis.

In this regard, we have detected

NAD(H)-dependent 3-oxo-Δ4-cholenoic acid oxidoreductase
activity using small quantities of enzymatically generated
radiolabeled CoA conjugates of 3-dehydro-UDCA and 3dehydro-CDCA (D. Kang, J.M. Ridlon, and P.B. Hylemon,
unpublished data).

Moreover, other members of this gene

family recognize substrates linked to CoA (Table II).
Future mechanistic and structural studies will require
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chemical synthesis of CoA conjugated bile acid
intermediates.
This is the first report of a gene product
specifically involved in 7β-dehydroxylation of UDCA.

We

predict that the baiI gene encodes a bile acid 7βdehydratase, based on its amino acid sequence identity (20
%) and similarity (40 %) with the baiE gene product as
well as co-expression of this gene product during CA
induction in C. scindens VPI. We have previously
demonstrated that the baiE gene encodes a bile acid 7αdehydratase (128).

Determining the function of the baiI

as well as identifying genes involved in reducing the 3oxo-4, 6-choladienoic structure to LCA will be the focus
of future of research.
In summary, these data indicate that the baiCD and
baiH genes encode NAD(H)-dependent 3-oxo-Δ4-cholenoic acid
oxidoreductases.

These results can account for the

ability of this organism to use UDCA as a substrate for
7β-dehydroxylation, and provide additional support for
formation of a 3-oxo-Δ4-cholenoic acid intermediate during
bile acid 7-dehydroxylation.
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Doerner et al (1997) demonstrated that 7α/βdehydroxylating bacteria cluster into two groups based on
relative rates of conversion of CA to DCA (189).

Our

current understanding of the molecular biology and
enzymology of bile acid 7α/β-dehydroxylation come from
study of C. scindens VPI 12708 and C. hiranonis sp. strain
TO931 which are “high activity strains” (1-7 nmol mg-1 h-1).
Genes involved in bile acid 7α/β-dehydroxylation have not
been identified in a “low activity” strain (0.05-0.16 nmol
mg-1 h-1).

Wells et al. (2003) detected the baiCD gene from

the low activity strain C. hylemonae TN271 which
facilitated design of bidirectional genome-walking PCR
primers (106).

The genome-walking by PCR technique is

useful for amplification of unknown stretches of DNA
provided at least a small amount of adjacent sequence data
is available for design of gene specific primers.

Adaptor

sequences are engineered and ligated to restriction
libraries of total genomic DNA.

These adaptor molecules

provide the second stretch of known sequence, allowing PCR
amplification between adaptor-specific and gene-specific
primers (216). PCR products up to ~4 kb were obtained in
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this study, with an average of 2 kb using a starting
genomic template >48 kb (Figure 21).
Two upstream genome-walking PCR products (Figures 22,
23) and three downstream genome-walking PCR products
(Figures 28, 30, 31) were cloned, sequenced and assembled,
along with the partial baiCD gene into a single contiguous
sequence of ~9.5 kb.

ORFs were identified by the ORF

Finder program and BLAST searches were used to determine
the putative function of these ORFs.

The gene

organization of the baiBCDEFGHI operon from C. hylemonae
TN271 was almost identical to the baiBCDEAFGHI operon from
C. scindens VPI 12708 (Figure 32).

Table 7 compares both

nucleotide and amino acid sequence identity/similarity
between bai genes from C. hylemonae TN271 and C. scindens
VPI 12708.

Nucleotide sequence identity was >65% and

amino acid sequence identities ranging from 61.4 to 88%
with similarity ranging from 76.6% to 94.8%.

The

upstream putative “promoter” regions were also found to be
highly conserved along with relative location of TIS
(Figures 24, 25).

Finally, a conserved transcriptional

regulator of the AraC/XylS family (barA) was located
upstream of the C. hylemonae TN271 baiB gene and
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“promoter” region on the antisense strand (Figures 27,
32).

It is unclear at present the reason for the 10 fold

difference in levels of bile acid 7α-dehydroxylating
activity between C. hylemonae TN271 and “high activity”
strains.

However, it is very likely that this regulation

is at the transcriptional level.

Indeed, design of qRT-

PCR oligonucleotides against genes in the baiBCDE(A)FGHI
operons from C. hylemonae and C. scindens VPI 12708 and
quantitation of message following bile acid induction
should provide the relevant information.

Isolation and

sequencing of the gyrA gene in the current study and
current genomic data for Clostridium scindens will allow
normalization of qRT-PCR results.

Finally, it is

interesting to note that C. hylemonae TN271, despite
having a baiH and baiI gene, were unable to 7βdehydroxylate UDCA over a 30 min or overnight incubation
following induction by CA (Figure 33).

It is unclear at

present the reason for this loss-of-function.
Importantly, this data represents the first
characterization of bai genes from a “low activity” 7αdehydroxylating bacterium.
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The baiA gene from C. hylemonae TN271 was isolated by
PCR amplification using redundant oligonucleotides whose
design was based on a nucleotide multiple sequence
alignment of baiA genes isolated from C. scindens VPI
12708 and C. hiranonis sp. strain TO931 (Figures 34, 35,
37).

5’ SMART RACE PCR analysis of the baiA transcript

revealed a TIS 56 bp upstream of the baiA gene and
downstream of the putative bai promoter region (Figure
36).

Gopal-Srivastava et al (1990) identified multiple

copies of the baiA gene in C. scindens VPI 12708, two of
which were monocistrons with conserved bai “promoters”
(67).
Completion of the baiA gene sequence, facilitated by
bidirectional genome-walking from the partial sequence
obtained with primers baiA271F and baiA271R (Table 8)
resulted in isolation of genes with predicted function
suggested to be involved in bile acid 7α/βdehydroxylation.

In silico (ORF Finder, BLAST) analysis

upstream of the baiA gene revealed a deduced 26 kDa short
chain dehydrogenase/reductase (baiL), a 49.5 kDa baiF
homologue (baiK) and a putative 62 kDa 3-keto-steroid Δ1dehydrogenase (baiJ).

Upstream of the baiJ gene was a
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conserved bai “promoter” region (Figure 44).

5’ SMART

RACE analysis suggests the TIS is at the very 5’ end of
this conserved region whle the TIS is downstream of this
conserved region in the baiB and baiA operons of both C.
scindens VPI 12708 and C. hylemonae TN271 (Figure 45).
This would suggest that the baiJ promoter is upstream of
this conserved region.
In order to determine whether these novel genes were
conserved in C. scindens VPI 12708, the baiJKL genes from
C. hylemonae were analysed for 7-8 amino acid stretches of
low codon degeneracy (Figures 46, 47).

A region within

the baiJ gene allowed design of redundant oligonucleotides
which allowed isolation of a partial baiJ gene from C.
scindens VPI 12708.

Several upstream and downstream

genome-walks resulted in identification of the baiJKL
genes in C. scindens VPI 12708 which were highly conserved
both in sequence and organization to the baiJKL genes from
C. hylemonae TN271 (Figure 56).

Elucidation of the TIS

for the baiJ gene provided similar results to those
obtained for TIS of the baiJ gene from C. hylemonae in
respect to the upstream position relative to the conserved
“promoter” region identified previously for the baiB and
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baiA genes from C. scindens VPI 12708 (124, 191),
Clostridium hiranonis sp. strain TO931 (59) and here for
the baiB gene of Clostridium hylemonae TN271 (Figure 26).
This brings into question whether this conserved region is
indeed a bile acid inducible promoter rather than a
repressor or operator sequence.

Figure 73 is a Weblogo

representation of a CLUSTALW alignment of these conserved
upstream regions between C. scindens VPI 12708, C.
hiranonas sp. strain TO931 and C. hylemonae TN271. Further
experimental work is necessary to determine the function
of these regions.
A particularly interesting find in this study is a
predicted Type III CoA transferase which appears to share
a common evolutionary history with the baiF gene (Figure
42). This gene has been given the preliminary name baiK
(Figure 58). Alignment of characterized type III CoA
transferases such as the crotonoyl-CoA (caiB) and yfdW
gene products from E. coli as well as the formyl CoA
transferase from Oxalobacter formigenes with the baiF and
baiK gene products from C. scindens VPI 12708 and C.
hylemonae TN271 demonstrates a remarkable degree of
conservation (Figure 74).

Numerous authors have
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Figure 73.

Logo representation of bai promoter regions
from Clostridium scindens VPI 12708,
Clostridium hiranonis sp. strain TO931 and
Clostridium hylemonae TN271.
Promoter
sequences from Figure 24 and Figure 49 were
aligned using T-COFFEE and FASTA format was
run in the Weblogo program
(http://weblogo.berkeley.edu/). Large
letters represent based of potential
biological relevance to promoter function.
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Figure 74.

Boxshade alignment of baiF and baiK genes
from C. scindens VPI 12708 and C. hylemonae
TN271 with homologues in the Type III CoA
transferase family. Proteins used in
alignment include: E. coli CrotonobetainylCoA:carnitine CoA-transferase (CaiB) (
P31572), E. coli Formyl-CoA transferase
(YfdWA) (P69902), Oxalobacter formigenes
formyl-CoA transferase (fCTOx) (AAC45298).
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speculated that CoA transfer proceeds through Asp169
acylation (217-219). Mutagenesis of Asp169 (D169A, D169S,
D169E) in the formyl-CoA transferase (FRC) from
O.formigenes resulted in abolition of, or appreciable
decrease in specific activity despite no significant
structural alterations (217).

The proposed catalytic

mechanism for the FCR suggests that formyl-CoA forms an
acid anhydride with Asp169 resulting in elimination of
SCoA.

-

The second substrate, oxalate, then

nucleophilically attacks the Asp169-formate anhydride
resulting in release of formate and formation of Asp169oxalate anhydride.

The anion

–

SCoA then attacks the

carbonyl carbon of oxalate resulting in release of oxalylCoA and regeneration of Asp169 (217).

Asp169 is conserved in

the baiF and baiK genes of C. scindens VPI 12708 and C.
hylemonae TN271 suggesting that these proteins act through
a similar mechanism (Figure 74).

Crystallization with

CaiB yielded crystals with only CoA bound suggesting
hydrolysis occurs in the absence of the CoA accepting
substrates (220).

This would provide a plausible

explanation for observed CoA hydrolase activity shown for
the baiF gene product in the absence of co-substrate
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(130).

We speculate that a similar mechanism is involved

in bile acid CoA transfer by the baiF and possibly the
baiK genes to that proposed for the FRC.

Isolation of a

3-oxo-Δ4-DCA~CoA intermediate from cell extracts of cholic
acid induced cultures of C. scindens VPI 12708 would
suggest that CoA transfer would occur at this step or
possibly following formation of 3-oxo-DCA or DCA.
Therefore, these three metabolites would substitute for
formate in the FRC model and cholyl-CoA would substitute
for oxalate in the FRC model.
There are several gene homologues in the oxidative
arm of the 7α/β-dehydroxylation pathway performing a
similar function but recognizing a distinct stereoisomer.
Indeed, in the present work, the baiCD and baiH gene
products were shown to act as 3-oxo-Δ4-steroid
oxidoreductases recognizing 7α-hydroxy and 7β-hydroxy bile
acids, respectively.

Additionally, the baiE was shown to

7α-dehydrate bile acids while the baiI is predicted to 7βdehydrate bile acids.

In each case, stereospecificity is

directed at the orientation of the 7-hydroxyl group.
However, in the reductive arm of the 7α/β-dehydroxylation
the only differences include hydroxylation at C12, and
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stereochemical differences about the A/B ring.

Assuming

the baiK gene is involved in bile acid CoA transfer, there
are a few possibilities: (1) one transferase recognizes
LCA (not hydroxylated at C12) while the other recognizes
DCA (hydroxylated at C12) (2) one transferase recognizes
DCA and LCA (A/B ring in “cis” orientation) while the
other transferase recognizes alloDCA and alloLCA (A/B ring
in “trans” orientation) (3) both transferases recognize
the same substrate(s); similar to the multiple copies of
the baiA genes (124). Testing these possibilities will
require acquisition of alloDCA (not available
commercially; highly concentrated in rabbit gallstones
(221)) and synthesis of 3-oxo-alloDCA(~SCoA).
The baiL gene is predicted to encode a 3-keto-acyl
reductase, similar in function to the baiA gene.

The

predicted function in terms of bile acid 7αdehydroxylation is NAD(P)H dependent 3α-hydroxysteroid
dehydrogenation resulting in DCA and LCA.

An attempt was

made to overexpress the baiL gene in E. coli as a hexahistidine tagged fusion protein.

Unfortunately, and

often, the production of biologically active recombinant
proteins is prevented by the formation of insoluble
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inclusion bodies.

Numerous variables were modified to

improve solubility including decreased temperature, IPTG
concentration, different media, various host strains, and
vectors.

However, while the protein was highly expressed,

I was unable to detect soluble BaiL by Western immunoblot
or NAD(P)-dependent 3α-HSDH activity against DCA.

It may

be necessary to experiment with additional fusion tags,
further decrease in temperature, or attempt expression in
a different host.

Shuttle vectors have been developed

between E. coli and gram-positive bacterial genera
including Clostridium (222).
The baiJ gene is predicted to encode a 62 kDa
flavoprotein similar to fumarate reductase and 3ketosteroid-Δ1-dehydrogenases.

Alignment of the baiJ gene

product with the fumarate reductase from Shewanella
putrefaciens MR-1, whose structure has been elucidated,
suggests the similarity between these proteins is in the
Rossman fold of the FAD-binding motif.

The BaiJ lacks the

cytochrome domain containing four conserved heme-binding
sites common to fumarate reductases (CXXCH) and there was
no conservation of active-site amino acids (data not
shown).

The baiJ gene was cloned into a pT7-SBP-2 vector
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containing an N-terminal Streptavidin Binding Peptide
(SBP) fusion tag.

IPTG induced overexpression of the BaiJ

polypeptide resulted in a soluble protein ~64 kDa which
was detected by anti-SBP antibody (Figure 66).

Initial

characterization of the enzyme with radiolabelled 3-oxoDCA and 3-oxo-DCA-CoA resulted in three products formed
when NADP was used as co-substrate.

The two hydrophobic

products were also detected when NAD+ was co-substrate.

A

substrate of greater hydrophilicity than DCA was detected
in the presence of NADP.

This class of enzyme is

predicted to metabolize C=C double bonds.

This

hydrophilic product is puzzling because the migration
suggests the 3-oxo group has been reduced.

Further, the

reduced migration may indicate oxidation of the bile acid
structure as there is no other source of reducing
equivalents.

It is possible that a double bond is being

introduced in the side-chain of the steroid rings.
Indeed, Δ22-bile acids have been identified in rats (223).
Additional studies will be required to determine the
identity of these bile acid metabolites.

These findings

may indicate a novel bile acid metabolic activity in C.
scindens VPI 12708.
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Future studies may include determining which genes
are co-transcribed in both the baiBCDEFGHI and baiJKL
operons from C. hylemonae TN271 and the baiJKLM operon
from C. scindens VPI 12708.

A sensitive method for

determining this would be PCR amplification of cDNA
fragments containing intergenic regions between adjacent
ORF’s.

Additionally, attempts to isolate bai genes from

C. leptum and C. sordellii using degenerate
oligonucleotides based on conserved regions in the
oxidative bai genes from C. scindens VPI 12708, C.
hylemonae TN271 and C. hiranonis sp. strain TO931 have
failed (Ridlon JM and Hylemon PB, unpublished data).

It

would be interesting to try and design degenerate
oligonucleotides to isolate the baiJKL genes, if present,
in C. leptum. This group of “low activity” organisms was
not detected by Southern blot (189) or by PCR using
primers against the baiCD gene (106).

Isolation of bai

genes from this organism could allow design of gene probes
which could be used to quantify levels of a wide group of
known 7α-dehydroxylating bacteria.

Additionally, large-

scale metagenomic sequencing will provide a wealth of
information which will, in the future, allow in silico
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mining of putative bai genes.

Another study of interest

would be to determine whether the baiF and baiK genes
encode bile acid CoA transferases, and determine
physiological substrate(s) through kinetic analysis.

The

limiting factor in such a study is chemical synthesis of
numerous bile acid intermediates as both free acids and
CoA conjugates. In addition, comparison of wild-type
proteins with site-directed mutagenesis of Asp169 would
provide additional evidence for a common mechanism of the
baiF and baiK with that of the FRC protein.
Finally, the major aim of research into bile acid 7αdehydroxylation is to identify targets for development of
specific inhibitors aimed at lowering 7α-dehydroxylation,
and thus secondary bile acids in individuals with high
levels (Figure 11).

A particularly interesting gene was

located upstream of the baiJKL genes and directly
downstream, and on the opposite strand relative to the
baiA gene in C. scindens VPI 12708 (Figure 58). The ORF
encodes a protein similar to the TspO/MBR family of cell
surface sensors.

TspO, or Tryptophan Rich Sensory

protein, is a negative regulator of photosynthesis in
response to light/oxygen.

The tryptophan rich region acts
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as part of a hydrophobic pore that acts in pumping
porphyrin across the cell wall.

Could it be that this

protein, in 7α-dehydroxylating bacteria, may be involved
in regulation of 7α-dehydroxylating gene expression and
efflux of hydrophobic secondary bile acids from the cell?
MBR, or mitochondrial peripheral benzodiazepine receptor,
has been shown to substitute for bacterial TspO (224) and
is thought to function in cholesterol transport across the
mitochondrial membrane.

If this gene product could be

shown to regulate bile acid repression/efflux, this could
serve as potential drug target; particularly because this
polypeptide is predicted to be located in the outer
membrane.

Also, an ABC transport protein was located

directly downstream of the baiL gene; possibly cotranscribed.

This suggests that this polypeptide may be

involved in efflux of secondary bile acids.

ABC

transporters have been targeted for chemotherapy due to
their ability to transport antibiotics and other
cytotoxins from the cell (225).

This protein, if involved

in bile acid efflux, may serve as a potential drug target.
A possible approach for studying the function of these
genes is insertional inactivation.

Recently, a new vector
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has been developed specifically for insertional
inactivation of clostridial genes, which has been named
ClosTron (226).

Phenotypic tests could be performed in

the presence and absence of bile acids.

Ultimately, a

goal for future research will be to identify a target for
drug development to lower secondary bile acid production
in patients with high levels of these cytotoxic, and cocarcingenic metabolites produced by the human microbiome.
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